rfhg_50091.1

Basic information about the TSS

---

TSS ID: rfhg_50091.1 Species: human Chr: chr3		Start: 129171241 End: 129171288 Strand: -
Source datasets	FANTOM5
Protocol	CAGE
TSS cluster detected*	1

  * The number of TSS cluster called data-sets (maximum 17)

cCREs annotation

---

Description:	dELS (EH38D3483383,EH38E2237102)
Category:	dELS

  * cCREs are candidates for cis regulatory elements generated from the subset of representative DNase hypersensitivity sites supported by either histone modifications or CTCF-binding data. Find more details here.

Gene and protein annotation

---

Nearest transcript id and distance: AY436367:116 GeneID: 7555 HGNC/MGI_ID: HGNC:13164 UniProt_ID: Q6T598 Nearer transcript ids and distances: KJ892400:-468 BT019613:-469 KU178397:-469 KU178398:-469 KU178399:-469 CU674132:-470 KJ897754:-470 AB463471:-472 view more...

Gene_name: CCHC-type zinc finger nucleic acid binding protein Gene_symbol: CNBP Gene_synonyms: CNBP1 RNF163 ZCCHC22 Gene_source: HGNC:13164

TATA-Box annotation

---

Distance to TSS:	-10034
Nearest PromoterID:	NM_001204890
Entrez ID:	100534599
Nearest Unigene:	Hs.512661
Nearest Refseq:	NM_001204890
Nearest Ensembl:	ENSG00000261796
Gene Name:	CCHC-type zinc finger nucleic acid binding protein
Gene Alias:	ISY1
Gene Type:	protein-coding
CpG%:	0.021277
GC%:	0.479167
TATA-Box(TBP)/Promoter/Homer Distance From Peak(sequence,strand,conservation):

TSS expression

Sample Category  All in vivo cell sample cell line sample tissue sample human bronchial epithelial cell sample CD19-positive B cell sample CD8-positive T cell sample CD4-positive T cell sample common myeloid progenitor sample human monocyte immature derived dendritic cell sample human endothelial cell of the aorta sample human cardiac fibroblast sample human dermal fibroblast sample human fibroblast of gingiva sample human fibroblast of periodontium sample granulocyte macrophage progenitor cell sample human hepatocyte sample human mesenchymal stem cell of umbilical cord-Sciencell sample human mesenchymal stem cell of adipose sample human mesenchymal stem cell of bone marrow sample mouse sample mouse granule cell sample mouse hepatocyte sample human neutrophil sample human osteoblast-Sciencell sample human osteoblast-Cell applications sample human renal glomerular endothelial cell sample human retinal pigment epithelial cell sample human skeletal muscle cell sample human aortic smooth muscle cell sample human smooth muscle cell of umbilical artery sample human urothelial cell sample cerebellar granule cell sample human sample mast cell- heparinase treated sample human mature adipocyte sample human cardiac mesenchymal precursor cell sample human mesenchymal precursor cell- ovarian cancer-left ovary sample human mesenchymal precursor cell- ovarian cancer-metastasis sample human mesenchymal precursor cell- ovarian cancer-right ovary sample human whole blood sample control treatment sample human adipose tissue - adult sample human brain - adult sample human parietal lobe - adult sample hippocampus - adult sample human CD14-CD16-positive Monocytes sample mouse cerebellum- embryo E13 sample mouse cerebellum- embryo E15 sample mouse cerebellum- embryo E18 sample human Monocyte-derived macrophages 0h after mock infection sample human Monocyte-derived macrophages 0h after udorn influenza infection sample human Monocyte-derived macrophages 2h after udorn influenza infection sample human Monocyte-derived macrophages 7h after udorn influenza infection sample human Monocyte-derived macrophages 24h after udorn influenza infection sample human Monocyte-derived macrophages 24h after mock infection sample mouse whole body- embryo E17.5 sample adenocarcinoma cell line sample small cell lung cancer cell sample carcinoma cell line sample teratocarcinoma cell line sample sarcoma cell line sample K-562 cell sample embryonic cell line sample epithelial cell line sample THP-1 cell sample gastrointestinal cancer cell sample acute myeloid leukemia cell line sample cervical cancer cell line sample squamous cell carcinoma cell line sample mesothelioma cell line sample NCI cell sample human nasal epithelial cell sample macrophage, TB infection sample iPS differentiation to neuron, control sample iPS differentiation to neuron, down-syndrome donor sample myoblast differentiation to myotubes, control sample H1 embryonic stem cells differentiation to CD34+ HSC sample 293SLAM rinderpest infection sample COBL-a rinderpest infection sample partial hepatectomy sample sham operation sample ES-OS25 embryonic stem cells sample ES-OS25 embryonic stem cells, untreated sample ES-46C embryonic stem cells, neuronal differentiation sample ES-OS25 embryonic stem cells, KD for exosomal component EXOSC3, biol_rep1 sample ARPE-19 EMT induced with TGF-beta and TNF-alpha sample hIPS sample

		Promoter select All p1@CNBP p2@CNBP p3@CNBP p4@CNBP p5@CNBP
Sample		p1@CNBP	p2@CNBP	p3@CNBP	p4@CNBP	p5@CNBP
293SLAM rinderpest infection, 00hr, biol_rep1	13541-145H4	210.78	45.19	74.03	37.40	2.53
293SLAM rinderpest infection, 00hr, biol_rep2	13542-145H5	224.57	44.51	77.49	33.79	1.82
293SLAM rinderpest infection, 00hr, biol_rep3	13543-145H6	216.82	47.07	75.04	37.81	1.74
293SLAM rinderpest infection, 06hr, biol_rep1	13544-145H7	194.40	31.39	67.57	36.18	1.66
293SLAM rinderpest infection, 06hr, biol_rep2	13545-145H8	217.09	33.52	73.11	35.99	2.02
293SLAM rinderpest infection, 06hr, biol_rep3	13546-145H9	197.30	34.89	81.40	41.86	1.94
293SLAM rinderpest infection, 12hr, biol_rep1	13547-145I1	268.65	51.64	61.44	45.54	2.61
293SLAM rinderpest infection, 12hr, biol_rep2	13548-145I2	230.35	53.29	57.16	31.97	1.45
293SLAM rinderpest infection, 12hr, biol_rep3	13549-145I3	228.04	52.79	50.22	30.99	1.28
293SLAM rinderpest infection, 24hr, biol_rep1	13550-145I4	214.46	38.83	71.29	54.48	1.16
293SLAM rinderpest infection, 24hr, biol_rep2	13551-145I5	207.78	34.76	72.76	46.49	2.02
293SLAM rinderpest infection, 24hr, biol_rep3	13552-145I6	184.57	36.59	67.49	58.14	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep1	13625-146H7	73.99	13.54	13.86	2.74	1.29
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep2	13626-146H8	79.38	12.18	12.93	3.01	1.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr00min, biol_rep3	13627-146H9	71.79	13.17	14.05	4.83	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep1	13628-146I1	70.42	10.81	11.57	2.77	2.26
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep2	13629-146I2	70.55	9.61	12.67	4.59	0.44
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr15min, biol_rep3	13630-146I3	78.46	11.81	13.50	1.69	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep1	13631-146I4	82.11	12.80	12.26	3.20	0.53
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep2	13632-146I5	77.63	11.88	12.79	2.71	0.90
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr30min, biol_rep3	13633-146I6	83.13	15.24	12.83	5.21	1.47
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep1	13634-146I7	74.92	12.95	15.71	3.28	0.52
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep2	13635-146I8	79.11	12.93	13.96	2.71	1.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 00hr45min, biol_rep3	13636-146I9	78.14	10.19	16.50	3.64	0.73
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep1	13637-147A1	81.01	11.35	14.19	3.61	0.77
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep2	13638-147A2	86.41	12.03	12.98	5.38	1.27
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr00min, biol_rep3	13639-147A3	100.00	9.34	18.13	3.85	1.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep1	13640-147A4	84.40	13.20	16.03	5.89	1.41
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep2	13641-147A5	90.78	16.15	14.54	3.39	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr20min, biol_rep3	13642-147A6	93.20	11.94	16.83	3.62	1.45
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep1	13643-147A7	88.13	11.51	12.98	4.61	0.63
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep2	13644-147A8	87.34	10.94	13.87	3.32	0.78
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 01hr40min, biol_rep3	13645-147A9	94.96	10.55	14.56	5.70	2.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep1	13646-147B1	128.16	22.27	17.15	7.92	1.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep2	13647-147B2	83.02	11.59	13.46	3.93	1.50
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr00min, biol_rep3	13648-147B3	91.21	14.56	13.03	4.60	0.96
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep1	13649-147B4	80.93	9.20	12.06	4.50	1.64
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep2	13650-147B5	87.04	12.29	13.70	2.82	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 02hr30min, biol_rep3	13651-147B6	98.86	15.40	12.96	4.86	1.89
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep1	13652-147B7	103.95	12.72	16.08	4.56	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep2	13653-147B8	99.75	9.18	11.53	5.41	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr00min, biol_rep3	13654-147B9	102.62	13.76	13.18	6.29	1.61
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep1	13655-147C1	85.20	9.28	11.81	5.27	1.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep2	13656-147C2	84.62	9.27	11.01	4.20	1.22
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 03hr30min, biol_rep3	13657-147C3	92.96	10.04	12.05	5.02	2.01
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep1	13658-147C4	95.15	12.80	12.33	3.95	0.93
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep2	13659-147C5	80.37	13.67	8.40	2.64	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 04hr00min, biol_rep3	13660-147C6	84.94	11.33	14.60	4.77	1.19
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep1	13661-147C7	72.77	7.66	8.38	4.07	0.72
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep2	13662-147C8	73.40	8.49	8.69	3.24	0.81
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 05hr00min, biol_rep3	13663-147C9	74.81	9.02	10.86	5.74	3.28
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep1	13664-147D1	71.38	9.34	8.45	4.67	2.00
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep2	13665-147D2	349.80	55.97	13.99	27.98	27.98
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 06hr00min, biol_rep3	13666-147D3	69.55	11.00	14.55	2.48	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep1	13667-147D4	68.60	9.28	8.28	3.31	1.33
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep2	13668-147D5	94.80	18.46	12.58	6.71	9.23
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 07hr00min, biol_rep3	13669-147D6	83.12	9.18	6.89	6.89	1.38
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep1	13670-147D7	60.93	8.43	7.78	1.94	0.97
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep2	13671-147D8	60.70	7.07	5.78	1.93	0.32
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 08hr00min, biol_rep3	13672-147D9	69.15	8.49	9.12	3.77	2.20
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep2	13674-147E2	52.88	8.46	6.35	3.53	0.71
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 12hr00min, biol_rep3	13675-147E3	57.76	8.97	10.09	2.24	1.12
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep1	13676-147E4	43.79	5.57	7.17	4.78	1.59
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep2	13677-147E5	56.40	10.87	5.44	5.44	1.70
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 16hr00min, biol_rep3	13678-147E6	49.71	6.50	6.17	1.95	0.65
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep1	13679-147E7	53.96	6.39	3.19	1.06	0.35
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep2	13680-147E8	177.80	32.33	32.33	16.16	16.16
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 24hr00min, biol_rep3	13681-147E9	134.26	7.90	39.49	0.00	23.69
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep1	13682-147F1	64.84	11.21	5.85	1.95	1.95
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep2	13683-147F2	76.86	10.41	3.97	0.50	0.99
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 42hr00min, biol_rep3	13684-147F3	65.68	13.14	3.75	1.88	0.94
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep1	13685-147F4	71.21	7.95	6.95	1.66	0.66
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep2	13686-147F5	78.57	12.99	6.19	2.47	1.86
ARPE-19 EMT induced with TGF-beta and TNF-alpha, 60hr00min, biol_rep3	13687-147F6	70.63	6.73	7.03	3.36	0.31
Adipocyte - breast, donor1	11376-118A8	110.71	18.85	17.26	8.55	0.95
Adipocyte - breast, donor2	11327-117E4	93.85	21.50	13.48	6.90	3.21
Adipocyte - omental, donor1	11473-119C6	121.76	17.81	17.18	11.20	1.15
Adipocyte - omental, donor2	11474-119C7	73.25	20.93	17.19	5.23	0.00
Adipocyte - omental, donor3	11475-119C8	95.79	19.43	10.38	6.36	0.33
Adipocyte - perirenal, donor1	11476-119C9	84.21	10.21	7.66	3.83	1.28
Adipocyte - subcutaneous, donor1	11259-116F8	51.68	9.90	6.60	4.40	0.00
Adipocyte - subcutaneous, donor2	11336-117F4	86.71	24.84	16.26	6.77	0.45
Adipocyte - subcutaneous, donor3	11408-118E4	75.59	14.77	17.38	3.48	0.87
Adipocyte differentiation, day04, donor1	13019-139D4	191.66	27.77	18.19	5.08	0.78
Adipocyte differentiation, day04, donor2	13022-139D7	91.37	9.52	15.19	4.89	0.26
Adipocyte differentiation, day04, donor3	13025-139E1	103.42	11.99	22.02	7.53	0.28
Adipocyte differentiation, day04, donor4	13028-139E4	106.39	12.34	16.46	2.94	0.00
Adipocyte differentiation, day08, donor1	13020-139D5	126.60	24.21	13.11	6.84	0.24
Adipocyte differentiation, day08, donor2	13023-139D8	104.90	14.20	10.97	3.55	0.32
Adipocyte differentiation, day08, donor3	13026-139E2	84.78	8.53	16.00	6.40	2.13
Adipocyte differentiation, day08, donor4	13029-139E5	97.38	18.92	8.90	1.11	0.00
Adipocyte differentiation, day12, donor1	13021-139D6	113.54	32.02	9.15	8.73	0.83
Adipocyte differentiation, day12, donor2	13024-139D9	92.68	16.83	8.79	3.77	0.25
Adipocyte differentiation, day12, donor3	13027-139E3	91.30	20.62	9.49	5.56	0.65
Adipocyte differentiation, day12, donor4	13030-139E6	72.46	18.57	8.53	4.26	0.00
Alveolar Epithelial Cells, donor1	11510-119G7	46.19	15.47	4.86	3.54	0.00
Alveolar Epithelial Cells, donor2	11590-120G6	9.32	2.15	1.43	0.72	0.00
Alveolar Epithelial Cells, donor3	11671-122G6	9.58	1.20	0.00	0.00	0.00
Amniotic Epithelial Cells, donor1	11533-120A3	66.92	14.21	12.41	7.20	0.00
Amniotic Epithelial Cells, donor2	11613-122A2	33.47	5.02	10.04	1.67	1.67
Amniotic Epithelial Cells, donor3	11694-123A2	41.09	12.33	5.75	2.47	0.41
Anulus Pulposus Cell, donor1	11248-116E6	124.72	23.91	18.65	4.00	0.46
Anulus Pulposus Cell, donor2	11463-119B5	82.53	21.06	8.08	3.43	0.73
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep1 (LK1)	12642-134G5	64.25	17.52	10.33	4.94	0.00
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep2 (LK2)	12740-135I4	61.21	12.59	8.25	4.34	0.43
Aortic smooth muscle cell response to FGF2, 00hr00min, biol_rep3 (LK3)	12838-137B3	68.49	10.70	12.84	6.42	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep1 (LK4)	12643-134G6	50.52	14.95	7.47	4.48	1.20
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep2 (LK5)	12741-135I5	61.97	15.18	7.59	3.79	0.00
Aortic smooth muscle cell response to FGF2, 00hr15min, biol_rep3 (LK6)	12839-137B4	38.94	15.18	7.92	4.62	1.32
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep1 (LK7)	12644-134G7	53.61	15.92	10.40	3.57	0.65
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep2 (LK8)	12742-135I6	63.11	13.59	10.68	4.37	0.00
Aortic smooth muscle cell response to FGF2, 00hr30min, biol_rep3 (LK9)	12840-137B5	43.35	13.07	6.53	2.97	0.59
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep1 (LK10)	12645-134G8	64.03	16.20	8.29	3.39	1.13
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep2 (LK11)	12743-135I7	60.96	18.87	8.71	3.63	0.73
Aortic smooth muscle cell response to FGF2, 00hr45min, biol_rep3 (LK12)	12841-137B6	42.63	12.54	3.76	2.51	1.25
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep1 (LK13)	12646-134G9	86.32	20.76	13.51	8.90	0.33
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep2 (LK14)	12744-135I8	57.32	10.92	9.55	2.73	0.00
Aortic smooth muscle cell response to FGF2, 01hr, biol_rep3 (LK15)	12842-137B7	63.03	19.45	11.31	4.22	0.15
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep1 (LK16)	12647-134H1	63.76	20.36	10.18	3.21	0.00
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep2 (LK17)	12745-135I9	54.79	17.19	9.07	4.16	0.57
Aortic smooth muscle cell response to FGF2, 02hr, biol_rep3 (LK18)	12843-137B8	58.80	12.30	8.29	6.41	1.34
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep1 (LK19)	12648-134H2	56.58	18.53	5.85	0.00	0.98
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep2 (LK20)	12746-136A1	60.04	16.59	8.62	3.81	0.33
Aortic smooth muscle cell response to FGF2, 03hr, biol_rep3 (LK21)	12844-137B9	45.63	12.01	8.41	3.60	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep1 (LK22)	12649-134H3	81.42	17.70	17.70	17.70	0.00
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep2 (LK23)	12747-136A2	55.06	16.81	8.92	4.12	1.37
Aortic smooth muscle cell response to FGF2, 04hr, biol_rep3 (LK24)	12845-137C1	46.14	25.17	16.78	4.19	4.19
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep1 (LK25)	12650-134H4	66.99	16.99	10.68	6.31	1.94
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep2 (LK26)	12748-136A3	56.92	14.42	9.87	2.66	1.52
Aortic smooth muscle cell response to FGF2, 05hr, biol_rep3 (LK27)	12846-137C2	52.09	21.80	12.11	2.42	1.21
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep1 (LK28)	12651-134H5	61.56	16.53	9.12	3.42	1.71
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep2 (LK29)	12749-136A4	52.80	15.82	7.05	4.70	0.86
Aortic smooth muscle cell response to FGF2, 06hr, biol_rep3 (LK30)	12847-137C3	47.23	16.00	7.74	4.90	0.26
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep1 (LK31)	12652-134H6	51.61	19.24	4.69	2.82	0.00
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep2 (LK32)	12750-136A5	51.77	16.72	9.65	2.89	0.32
Aortic smooth muscle cell response to IL1b, 00hr00min, biol_rep3 (LK33)	12848-137C4	40.67	15.70	10.70	8.56	0.71
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep1 (LK34)	12653-134H7	53.82	21.64	9.94	2.92	0.58
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep2 (LK35)	12751-136A6	49.07	21.68	10.24	3.31	0.90
Aortic smooth muscle cell response to IL1b, 00hr15min, biol_rep3 (LK36)	12849-137C5	54.65	8.32	9.50	3.56	1.19
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep1 (LK37)	12654-134H8	61.03	18.31	8.14	4.58	0.51
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep2 (LK38)	12752-136A7	55.27	15.03	11.21	4.08	1.27
Aortic smooth muscle cell response to IL1b, 00hr30min, biol_rep3 (LK39)	12850-137C6	41.30	8.90	6.99	2.54	0.64
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep1 (LK40)	12655-134H9	49.63	18.99	11.22	4.75	0.43
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep2 (LK41)	12753-136A8	47.21	19.26	8.26	3.60	0.21
Aortic smooth muscle cell response to IL1b, 00hr45min, biol_rep3 (LK42)	12851-137C7	51.04	12.47	6.38	4.64	0.29
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep1 (LK43)	12656-134I1	64.24	9.45	9.45	6.61	0.00
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep2 (LK44)	12754-136A9	46.62	16.10	8.14	3.56	1.36
Aortic smooth muscle cell response to IL1b, 01hr, biol_rep3 (LK45)	12852-137C8	60.23	6.95	11.58	0.00	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep1 (LK46)	12657-134I2	57.04	10.56	2.11	2.11	0.00
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep2 (LK47)	12755-136B1	50.39	16.30	7.72	4.50	0.43
Aortic smooth muscle cell response to IL1b, 02hr, biol_rep3 (LK48)	12853-137C9	55.95	13.24	7.82	7.22	1.20
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep1 (LK49)	12658-134I3	59.05	16.04	10.21	5.10	0.73
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep2 (LK50)	12756-136B2	56.32	19.31	9.43	3.91	0.23
Aortic smooth muscle cell response to IL1b, 03hr, biol_rep3 (LK51)	12854-137D1	33.15	10.20	2.55	5.10	0.00
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep1 (LK52)	12659-134I4	81.10	20.85	14.24	5.08	0.51
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep2 (LK53)	12757-136B3	59.87	21.26	7.43	4.75	0.62
Aortic smooth muscle cell response to IL1b, 04hr, biol_rep3 (LK54)	12855-137D2	52.94	10.10	11.02	3.98	1.53
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep1 (LK55)	12660-134I5	56.41	16.73	9.56	3.82	1.43
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep2 (LK56)	12758-136B4	55.88	13.75	9.31	5.10	0.67
Aortic smooth muscle cell response to IL1b, 05hr, biol_rep3 (LK57)	12856-137D3	48.83	21.36	12.21	3.05	1.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep1 (LK58)	12661-134I6	52.62	16.06	8.31	2.22	0.00
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep2 (LK59)	12759-136B5	59.84	15.09	6.09	4.77	0.53
Aortic smooth muscle cell response to IL1b, 06hr, biol_rep3 (LK60)	12857-137D4	43.61	14.17	7.63	4.00	0.36
Astrocyte - cerebellum, donor1	11500-119F6	52.81	12.28	4.05	2.95	0.12
Astrocyte - cerebellum, donor2	11580-120F5	28.24	7.87	1.88	1.20	0.17
Astrocyte - cerebellum, donor3	11661-122F5	20.35	3.57	2.10	1.47	0.42
Astrocyte - cerebral cortex, donor1	11235-116D2	170.46	27.89	17.78	7.32	0.00
Astrocyte - cerebral cortex, donor2	11316-117D2	132.17	24.10	10.03	7.28	1.62
Astrocyte - cerebral cortex, donor3	11392-118C6	137.23	34.61	10.74	5.07	1.49
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep1	10821-111C2	215.15	48.74	16.29	6.54	1.83
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep2	10822-111C3	217.24	50.61	12.90	9.52	0.88
B lymphoblastoid cell line: GM12878 ENCODE, biol_rep3	10823-111C4	198.46	44.15	16.61	8.19	1.14
Basophils, donor1	12241-129G9	181.50	9.15	49.17	14.65	1.83
Basophils, donor2	12242-129H1	216.48	12.99	79.74	20.57	0.36
Basophils, donor3	12243-129H2	181.39	17.35	47.92	18.37	0.88
Bronchial Epithelial Cell, donor1	11511-119G8	28.24	8.19	5.82	2.59	0.22
Bronchial Epithelial Cell, donor2	11591-120G7	10.06	3.66	0.46	0.00	0.00
Bronchial Epithelial Cell, donor3	11672-122G7	121.95	43.04	0.00	14.35	7.17
Bronchial Epithelial Cell, donor4	11453-119A4	67.16	19.46	11.30	6.90	0.63
Bronchial Epithelial Cell, donor5	11457-119A8	35.35	10.19	4.78	3.95	0.00
Bronchial Epithelial Cell, donor6	11461-119B3	53.89	15.20	9.44	5.30	0.69
Bronchial Epithelial Cell, donor7	11769-123I5	100.77	42.29	14.76	5.76	0.90
Burkitt's lymphoma cell line:DAUDI	10422-106C8	191.58	42.25	33.08	25.66	0.72
Burkitt's lymphoma cell line:RAJI	10476-106I8	286.94	65.68	43.32	22.59	0.93
CD133+ stem cells - adult bone marrow derived, pool1	12224-129F1	321.69	28.14	51.16	13.43	0.32
CD133+ stem cells - cord blood derived, pool1	12223-129E9	434.36	10.34	124.10	0.00	0.00
CD14+ Monocytes, donor1	11224-116B9	128.49	5.64	45.65	20.29	0.00
CD14+ Monocytes, donor2	11305-117B9	132.33	7.24	41.39	18.37	1.11
CD14+ Monocytes, donor3	11381-118B4	133.92	7.24	39.52	14.27	0.22
CD14+ monocyte derived endothelial progenitor cells, donor1	11229-116C5	229.27	28.87	17.55	16.98	0.28
CD14+ monocyte derived endothelial progenitor cells, donor2	11310-117C5	223.65	23.50	27.67	26.91	0.00
CD14+ monocyte derived endothelial progenitor cells, donor3	11386-118B9	209.74	22.68	20.05	14.46	0.66
CD14+ monocytes - mock treated, donor1	11863-125A9	199.04	27.75	59.99	31.22	8.96
CD14+ monocytes - mock treated, donor2	11873-125C1	193.42	28.06	47.98	26.86	8.45
CD14+ monocytes - mock treated, donor3	11883-125D2	194.96	23.22	44.77	23.93	4.74
CD14+ monocytes - treated with B-glucan, donor1	11869-125B6	115.34	14.06	43.86	16.57	2.85
CD14+ monocytes - treated with B-glucan, donor2	11879-125C7	101.02	17.39	32.02	13.52	3.86
CD14+ monocytes - treated with B-glucan, donor3	11889-125D8	126.94	16.12	29.50	13.39	2.98
CD14+ monocytes - treated with BCG, donor1	11860-125A6	123.16	14.49	34.07	18.21	2.55
CD14+ monocytes - treated with BCG, donor2	11870-125B7	144.75	17.45	38.46	21.72	4.45
CD14+ monocytes - treated with BCG, donor3	11880-125C8	241.57	32.86	71.60	33.73	6.75
CD14+ monocytes - treated with Candida, donor1	11868-125B5	97.63	8.43	46.83	16.86	2.58
CD14+ monocytes - treated with Candida, donor2	11878-125C6	142.04	12.14	53.33	16.37	4.75
CD14+ monocytes - treated with Candida, donor3	11888-125D7	151.98	15.53	54.36	22.19	6.66
CD14+ monocytes - treated with Cryptococcus, donor1	11867-125B4	172.25	18.89	55.93	23.50	5.21
CD14+ monocytes - treated with Cryptococcus, donor2	11877-125C5	167.42	21.95	39.51	26.54	5.39
CD14+ monocytes - treated with Cryptococcus, donor3	11887-125D6	244.63	23.53	51.22	28.94	7.29
CD14+ monocytes - treated with Group A streptococci, donor1	11864-125B1	94.49	10.75	33.86	14.18	3.43
CD14+ monocytes - treated with Group A streptococci, donor2	11874-125C2	132.10	16.74	39.59	23.98	3.17
CD14+ monocytes - treated with Group A streptococci, donor3	11884-125D3	96.46	11.35	34.48	11.35	6.11
CD14+ monocytes - treated with IFN + N-hexane, donor1	11861-125A7	181.03	23.13	49.23	27.17	7.26
CD14+ monocytes - treated with IFN + N-hexane, donor2	11871-125B8	207.08	28.61	60.54	47.28	8.90
CD14+ monocytes - treated with IFN + N-hexane, donor3	11881-125C9	251.65	40.40	58.91	39.14	8.00
CD14+ monocytes - treated with Salmonella, donor1	11866-125B3	81.02	11.21	26.45	13.59	2.39
CD14+ monocytes - treated with Salmonella, donor2	11876-125C4	86.66	10.22	14.44	9.51	1.41
CD14+ monocytes - treated with Salmonella, donor3	11886-125D5	94.76	15.36	16.23	8.77	2.19
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor1	11862-125A8	137.76	19.36	47.26	24.06	3.31
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor2	11872-125B9	165.02	18.58	43.49	18.21	4.09
CD14+ monocytes - treated with Trehalose dimycolate (TDM), donor3	11882-125D1	239.26	26.30	80.83	34.49	6.68
CD14+ monocytes - treated with lipopolysaccharide, donor1	11865-125B2	98.28	13.92	30.30	8.19	2.05
CD14+ monocytes - treated with lipopolysaccharide, donor2	11875-125C3	113.58	12.98	37.78	14.14	1.39
CD14+ monocytes - treated with lipopolysaccharide, donor3	11885-125D4	135.25	17.40	39.44	15.08	2.78
CD14+CD16+ Monocytes, donor1	11789-124B7	334.79	40.54	59.50	25.07	5.45
CD14+CD16+ Monocytes, donor2	11801-124D1	287.36	26.80	60.06	27.49	2.54
CD14+CD16+ Monocytes, donor3	11912-125G4	369.33	35.09	57.84	29.03	1.95
CD14+CD16- Monocytes, donor1	11788-124B6	424.65	32.55	88.61	40.33	3.11
CD14+CD16- Monocytes, donor2	11799-124C8	374.26	28.99	94.66	41.22	3.49
CD14+CD16- Monocytes, donor3	11910-125G2	373.92	32.78	71.80	33.89	2.90
CD14-CD16+ Monocytes, donor1	11790-124B8	257.98	24.75	29.09	10.97	0.77
CD14-CD16+ Monocytes, donor2	11800-124C9	283.68	31.18	27.23	10.10	1.32
CD14-CD16+ Monocytes, donor3	11911-125G3	326.14	41.48	22.95	10.11	1.05
CD19+ B Cells (pluriselect), donor090309, donation1	12189-129B2	432.88	38.61	24.39	14.23	4.06
CD19+ B Cells (pluriselect), donor090309, donation2	12194-129B7	401.36	51.53	21.70	5.42	0.00
CD19+ B Cells (pluriselect), donor090309, donation3	12199-129C3	432.88	42.46	19.68	5.18	2.07
CD19+ B Cells (pluriselect), donor090325, donation1	12151-128F9	457.88	44.24	25.05	7.46	0.53
CD19+ B Cells (pluriselect), donor090325, donation2	12174-128I5	525.35	50.93	23.05	4.82	2.68
CD19+ B Cells (pluriselect), donor090612, donation1	12204-129C8	405.72	47.73	22.46	5.62	1.40
CD19+ B Cells (pluriselect), donor090612, donation2	12209-129D4	425.12	34.51	25.88	6.27	0.78
CD19+ B Cells (pluriselect), donor090612, donation3	12214-129D9	510.18	50.09	34.28	10.55	1.32
CD19+ B Cells, donor1	11544-120B5	230.13	13.15	26.30	9.04	4.93
CD19+ B Cells, donor2	11624-122B4	191.51	9.43	35.55	2.18	0.73
CD19+ B Cells, donor3	11705-123B4	213.04	11.61	27.77	3.53	1.51
CD34 cells differentiated to erythrocyte lineage, biol_ rep1	11931-125I5	297.79	62.22	14.14	6.46	0.00
CD34 cells differentiated to erythrocyte lineage, biol_ rep2	11932-125I6	250.88	49.94	11.59	4.79	0.00
CD34+ Progenitors, donor1	11545-120B6	144.58	4.02	40.16	9.04	3.01
CD34+ Progenitors, donor2	11625-122B5	167.98	8.99	51.12	9.55	1.12
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep1	12225-129F2	310.00	36.45	35.32	9.02	0.75
CD34+ stem cells - adult bone marrow derived, donor1, tech_rep2	12225-129F2	304.40	33.37	41.94	11.73	0.23
CD4+ T Cells, donor1	11225-116C1	354.20	19.64	49.99	15.00	1.07
CD4+ T Cells, donor2	11306-117C1	294.55	17.15	34.90	12.86	4.29
CD4+ T Cells, donor3	11382-118B5	297.98	18.30	36.90	13.11	3.96
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor1	11793-124C2	395.11	52.58	38.54	20.67	4.34
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor2	11915-125G7	402.48	51.88	48.96	24.71	2.02
CD4+CD25+CD45RA+ naive regulatory T cells expanded, donor3	11919-125H2	396.98	44.56	50.59	19.83	1.44
CD4+CD25+CD45RA+ naive regulatory T cells, donor1	11780-124A7	660.88	51.20	73.48	19.91	3.32
CD4+CD25+CD45RA+ naive regulatory T cells, donor2	11796-124C5	778.87	60.40	82.17	13.34	3.51
CD4+CD25+CD45RA+ naive regulatory T cells, donor3	11907-125F8	662.54	56.04	49.44	13.18	9.89
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor1	11794-124C3	280.36	56.36	32.52	14.60	6.36
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor2	11916-125G8	249.11	42.54	23.89	11.18	3.73
CD4+CD25+CD45RA- memory regulatory T cells expanded, donor3	11920-125H3	258.57	45.46	21.12	13.06	4.19
CD4+CD25+CD45RA- memory regulatory T cells, donor1	11782-124A9	446.51	50.66	31.38	8.07	3.14
CD4+CD25+CD45RA- memory regulatory T cells, donor2	11797-124C6	521.29	54.50	33.54	5.94	3.49
CD4+CD25+CD45RA- memory regulatory T cells, donor3	11908-125F9	450.10	63.80	29.04	9.68	3.08
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor1	11791-124B9	318.76	60.29	26.14	10.12	2.11
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor2	11913-125G5	224.39	45.29	19.11	8.10	2.49
CD4+CD25-CD45RA+ naive conventional T cells expanded, donor3	11917-125G9	237.90	44.44	19.38	11.36	1.67
CD4+CD25-CD45RA+ naive conventional T cells, donor1	11784-124B2	520.21	47.04	39.97	10.61	4.62
CD4+CD25-CD45RA+ naive conventional T cells, donor2	11795-124C4	659.22	43.41	49.31	9.65	2.68
CD4+CD25-CD45RA+ naive conventional T cells, donor3	11906-125F7	543.35	62.76	39.45	7.17	7.17
CD4+CD25-CD45RA- memory conventional T cells expanded, donor1	11792-124C1	301.51	57.67	29.11	11.87	2.97
CD4+CD25-CD45RA- memory conventional T cells expanded, donor2	11914-125G6	248.03	39.64	20.80	8.88	1.08
CD4+CD25-CD45RA- memory conventional T cells expanded, donor3	11918-125H1	267.73	45.18	22.91	11.35	0.84
CD4+CD25-CD45RA- memory conventional T cells, donor1	11786-124B4	499.54	39.94	29.83	7.08	2.53
CD4+CD25-CD45RA- memory conventional T cells, donor2	11798-124C7	501.27	53.29	25.13	12.13	0.87
CD4+CD25-CD45RA- memory conventional T cells, donor3	11909-125G1	502.06	54.91	26.58	10.90	2.18
CD8+ T Cells (pluriselect), donor090309, donation1	12186-129A8	639.87	61.36	39.59	14.85	1.48
CD8+ T Cells (pluriselect), donor090309, donation2	12191-129B4	592.69	62.78	40.62	5.54	1.85
CD8+ T Cells (pluriselect), donor090309, donation3	12196-129B9	598.81	60.02	32.10	15.35	1.40
CD8+ T Cells (pluriselect), donor090325, donation1	12148-128F6	614.50	58.43	42.65	8.86	5.26
CD8+ T Cells (pluriselect), donor090325, donation2	12171-128I2	654.21	73.86	41.23	10.55	3.19
CD8+ T Cells (pluriselect), donor090612, donation1	12201-129C5	625.24	66.22	52.36	13.86	0.00
CD8+ T Cells (pluriselect), donor090612, donation2	12206-129D1	580.87	65.54	43.69	17.55	3.94
CD8+ T Cells (pluriselect), donor090612, donation3	12211-129D6	663.41	45.70	38.78	16.62	0.00
CD8+ T Cells, donor1	11226-116C2	272.72	11.46	51.73	18.66	1.96
CD8+ T Cells, donor2	11307-117C2	214.00	9.76	43.55	17.27	3.38
CD8+ T Cells, donor3	11383-118B6	261.07	14.14	40.65	16.16	2.02
COBL-a rinderpest infection, 00hr, biol_rep1	13553-145I7	158.51	45.65	13.76	5.05	1.15
COBL-a rinderpest infection, 00hr, biol_rep2	13554-145I8	128.93	39.54	6.23	5.51	2.64
COBL-a rinderpest infection, 00hr, biol_rep3	13555-145I9	124.48	40.22	10.67	5.20	2.46
COBL-a rinderpest infection, 06hr, biol_rep1	13556-146A1	195.14	68.45	11.71	3.00	1.50
COBL-a rinderpest infection, 06hr, biol_rep2	13557-146A2	143.27	51.36	12.24	3.60	1.44
COBL-a rinderpest infection, 06hr, biol_rep3	13558-146A3	150.30	43.20	8.19	3.41	1.59
COBL-a rinderpest infection, 12hr, biol_rep1	13559-146A4	182.95	42.59	13.04	4.35	1.74
COBL-a rinderpest infection, 12hr, biol_rep2	13560-146A5	160.82	41.85	14.21	5.26	0.53
COBL-a rinderpest infection, 12hr, biol_rep3	13561-146A6	180.81	48.08	12.43	5.86	2.11
COBL-a rinderpest infection, 24hr, biol_rep1	13562-146A7	185.35	60.38	13.89	9.06	2.72
COBL-a rinderpest infection, 24hr, biol_rep2	13563-146A8	180.98	47.93	14.23	8.42	1.45
COBL-a rinderpest infection, 24hr, biol_rep3	13564-146A9	173.72	49.29	13.59	7.19	1.60
COBL-a rinderpest infection, 48hr, biol_rep1	13565-146B1	112.06	31.96	9.63	11.38	0.44
COBL-a rinderpest infection, 48hr, biol_rep2	13566-146B2	143.92	36.43	13.66	13.66	1.37
COBL-a rinderpest infection, 48hr, biol_rep3	13567-146B3	92.49	17.16	12.68	2.98	0.00
COBL-a rinderpest(-C) infection, 06hr, biol_rep1	13568-146B4	152.35	46.82	8.28	5.76	1.08
COBL-a rinderpest(-C) infection, 06hr, biol_rep2	13569-146B5	148.18	47.76	9.21	5.47	1.44
COBL-a rinderpest(-C) infection, 06hr, biol_rep3	13570-146B6	135.29	37.24	12.73	3.77	1.41
COBL-a rinderpest(-C) infection, 12hr, biol_rep1	13571-146B7	200.92	49.75	17.43	8.56	0.63
COBL-a rinderpest(-C) infection, 12hr, biol_rep2	13572-146B8	203.30	47.06	14.76	8.00	1.54
COBL-a rinderpest(-C) infection, 12hr, biol_rep3	13573-146B9	174.40	48.41	15.39	7.37	2.89
COBL-a rinderpest(-C) infection, 24hr, biol_rep1	13574-146C1	186.64	57.37	16.06	6.12	1.53
COBL-a rinderpest(-C) infection, 24hr, biol_rep2	13575-146C2	176.95	45.72	13.01	7.09	0.39
COBL-a rinderpest(-C) infection, 24hr, biol_rep3	13576-146C3	147.50	42.36	10.59	5.29	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep1	13577-146C4	182.27	57.81	12.04	5.62	0.00
COBL-a rinderpest(-C) infection, 48hr, biol_rep2	13578-146C5	158.77	47.56	12.59	11.19	2.10
COBL-a rinderpest(-C) infection, 48hr, biol_rep3	13579-146C6	187.33	61.11	12.02	9.02	3.01
Cardiac Myocyte, donor1	11525-119I4	36.55	18.28	9.14	1.83	0.00
Cardiac Myocyte, donor2	11605-120I3	82.51	23.72	10.87	3.46	0.49
Cardiac Myocyte, donor3	11686-122I3	109.44	18.84	13.26	5.05	0.32
Chondrocyte - de diff, donor1	11261-116G1	115.79	23.92	15.25	6.24	0.69
Chondrocyte - de diff, donor2	11338-117F6	83.51	11.37	21.68	6.75	0.00
Chondrocyte - de diff, donor3	11410-118E6	102.74	21.62	22.41	7.05	0.46
Chondrocyte - re diff, donor2	11339-117F7	160.25	15.22	24.17	7.16	0.00
Chondrocyte - re diff, donor3	11411-118E7	93.82	10.51	8.90	3.24	0.40
Ciliary Epithelial Cells, donor1	11242-116D9	138.51	30.76	12.74	5.16	0.34
Ciliary Epithelial Cells, donor2	11323-117D9	90.21	23.09	10.69	2.57	1.07
Ciliary Epithelial Cells, donor3	11399-118D4	93.98	27.43	9.12	4.87	0.88
Clontech Human Universal Reference Total RNA, pool1	10000-101A1	160.57	27.05	14.31	6.05	0.37
Corneal Epithelial Cells, donor1	11526-119I5	21.08	9.44	1.54	0.44	0.00
Corneal Epithelial Cells, donor2	11606-120I4	45.50	14.79	5.69	5.69	1.14
Corneal Epithelial Cells, donor3	11687-122I4	31.19	10.23	3.83	3.32	0.00
Dendritic Cells - monocyte immature derived, donor1, rep2	11227-116C3	152.38	23.61	20.47	28.07	0.33
Dendritic Cells - monocyte immature derived, donor1, tech_rep1	11227-116C3	153.60	23.02	18.61	32.80	0.32
Dendritic Cells - monocyte immature derived, donor2	11308-117C3	186.34	24.15	24.15	41.41	0.00
Dendritic Cells - monocyte immature derived, donor3	11384-118B7	114.25	18.14	14.79	16.74	1.19
Dendritic Cells - plasmacytoid, donor1	11228-116C4	216.94	14.35	31.09	6.83	0.00
Dendritic Cells - plasmacytoid, donor2	11309-117C4	263.11	12.40	44.40	10.45	1.31
Dendritic Cells - plasmacytoid, donor3	11385-118B8	241.97	17.42	45.01	3.87	0.00
Endothelial Cells - Aortic, donor0	11207-116A1	60.37	10.01	9.51	5.67	0.00
Endothelial Cells - Aortic, donor1	11263-116G3	43.42	12.32	11.15	1.17	0.00
Endothelial Cells - Aortic, donor2	11340-117F8	57.69	8.77	10.46	3.68	0.00
Endothelial Cells - Aortic, donor3	11412-118E8	57.01	9.04	10.62	9.44	0.00
Endothelial Cells - Artery, donor1	11264-116G4	39.56	6.40	12.80	2.91	0.29
Endothelial Cells - Artery, donor2	11341-117F9	77.88	11.76	12.71	8.23	1.18
Endothelial Cells - Artery, donor3	11413-118E9	56.45	8.24	8.94	5.26	0.18
Endothelial Cells - Lymphatic, donor1	11236-116D3	84.23	19.28	13.08	7.09	0.66
Endothelial Cells - Lymphatic, donor2	11317-117D3	74.55	14.91	9.43	7.30	0.00
Endothelial Cells - Lymphatic, donor3	11393-118C7	74.42	9.02	12.97	2.26	0.00
Endothelial Cells - Microvascular, donor1	11265-116G5	49.62	14.56	6.54	2.08	0.00
Endothelial Cells - Microvascular, donor2	11342-117G1	71.85	10.93	24.47	9.37	0.00
Endothelial Cells - Microvascular, donor3	11414-118F1	31.76	9.36	3.69	1.99	0.28
Endothelial Cells - Thoracic, donor1	11266-116G6	123.64	15.20	22.41	14.00	0.00
Endothelial Cells - Thoracic, donor2	11343-117G2	37.74	6.29	5.77	4.19	0.00
Endothelial Cells - Umbilical vein, donor1	11243-116E1	138.91	32.30	16.77	7.70	0.87
Endothelial Cells - Umbilical vein, donor2	11324-117E1	66.48	19.77	9.99	3.26	0.43
Endothelial Cells - Umbilical vein, donor3	11400-118D5	82.07	22.96	9.89	3.91	0.00
Endothelial Cells - Vein, donor1	11267-116G7	46.64	7.96	10.24	11.38	0.00
Endothelial Cells - Vein, donor2	11344-117G3	79.63	12.57	13.97	4.19	0.70
Endothelial Cells - Vein, donor3	11416-118F3	71.75	14.29	10.99	5.65	0.31
Eosinophils, donor1	12244-129H3	320.19	30.49	30.49	0.00	0.00
Eosinophils, donor2	12245-129H4	818.53	100.67	140.27	125.42	4.95
Eosinophils, donor3	12246-129H5	527.89	74.90	71.34	60.64	0.00
Esophageal Epithelial Cells, donor1	11507-119G4	20.52	6.84	2.20	2.20	0.00
Esophageal Epithelial Cells, donor2	11587-120G3	14.56	0.00	2.08	0.00	0.00
Esophageal Epithelial Cells, donor3	11668-122G3	97.61	0.00	16.27	0.00	16.27
Ewing's sarcoma cell line:Hs 863.T	10705-109H3	71.02	13.55	10.26	4.93	0.82
Fibroblast - Aortic Adventitial donor2 (cytoplasmic fraction)	14331-155F2	38.98	10.95	6.90	6.24	2.30
Fibroblast - Aortic Adventitial donor3 (cytoplasmic fraction)	14310-155C8	71.29	17.88	12.68	5.63	0.76
Fibroblast - Aortic Adventitial, donor1	11245-116E3	99.45	20.01	16.37	9.22	0.73
Fibroblast - Aortic Adventitial, donor2 (nuclear fraction)	14332-155F3	76.29	18.29	10.37	7.37	0.27
Fibroblast - Aortic Adventitial, donor2	11326-117E3	67.29	16.14	12.23	5.17	0.84
Fibroblast - Aortic Adventitial, donor3 (nuclear fraction)	14311-155C9	55.33	13.70	5.27	0.79	0.00
Fibroblast - Aortic Adventitial, donor3	11401-118D6	96.01	27.57	10.96	5.98	1.33
Fibroblast - Cardiac, donor1	11268-116G8	75.30	14.06	12.25	6.80	0.91
Fibroblast - Cardiac, donor2	11345-117G4	46.23	11.37	6.82	2.27	0.00
Fibroblast - Cardiac, donor3	11417-118F4	46.53	10.72	8.36	4.57	0.00
Fibroblast - Cardiac, donor4	11452-119A3	113.97	26.67	12.12	5.76	0.00
Fibroblast - Cardiac, donor5	11456-119A7	105.58	28.30	13.07	7.23	0.89
Fibroblast - Cardiac, donor6	11460-119B2	102.63	21.98	9.25	5.31	0.45
Fibroblast - Choroid Plexus, donor1	11492-119E7	58.96	10.99	8.98	2.81	0.40
Fibroblast - Choroid Plexus, donor2	11572-120E6	87.15	11.65	16.39	3.45	0.43
Fibroblast - Choroid Plexus, donor3	11653-122E6	93.75	39.55	4.39	2.93	0.00
Fibroblast - Conjunctival, donor1	11531-120A1	53.05	17.99	6.23	2.54	0.00
Fibroblast - Conjunctival, donor3	11692-122I9	120.25	18.66	27.31	4.41	0.00
Fibroblast - Dermal, donor1	11269-116G9	92.97	34.28	19.72	6.57	0.94
Fibroblast - Dermal, donor2	11346-117G5	78.77	23.11	12.74	4.72	0.00
Fibroblast - Dermal, donor3	11418-118F5	130.92	32.88	29.62	11.61	0.97
Fibroblast - Dermal, donor4	11450-119A1	134.30	42.62	11.64	7.01	1.81
Fibroblast - Dermal, donor5	11454-119A5	164.51	47.28	15.18	10.64	1.57
Fibroblast - Dermal, donor6	11458-119A9	161.77	45.15	14.13	8.45	1.62
Fibroblast - Gingival, donor1	11237-116D4	118.07	34.57	14.99	10.41	0.83
Fibroblast - Gingival, donor10 (periodontitis)	11928-125I2	93.01	22.27	12.58	5.24	0.79
Fibroblast - Gingival, donor2	11318-117D4	100.55	38.88	9.75	4.35	1.71
Fibroblast - Gingival, donor3	11394-118C8	136.33	33.26	23.78	9.09	0.77
Fibroblast - Gingival, donor4 (GFH2)	11222-116B7	102.85	28.05	10.39	6.23	0.00
Fibroblast - Gingival, donor5 (GFH3)	11303-117B7	62.90	16.92	10.22	2.47	1.06
Fibroblast - Gingival, donor6 (aggressive periodontitis)	11921-125H4	117.55	30.24	16.53	7.33	0.94
Fibroblast - Gingival, donor6 (control)	11922-125H5	98.72	28.80	10.01	5.27	0.68
Fibroblast - Gingival, donor7 (aggressive periodontitis)	11923-125H6	47.29	19.76	4.59	4.23	0.00
Fibroblast - Gingival, donor7 (control)	11924-125H7	95.79	25.01	9.36	7.02	0.44
Fibroblast - Gingival, donor8 (chronic periodontitis)	11925-125H8	107.17	29.18	14.73	8.45	1.23
Fibroblast - Gingival, donor8 (control)	11926-125H9	109.80	30.93	12.83	8.89	0.88
Fibroblast - Gingival, donor9 (control)	11927-125I1	95.23	21.72	17.61	6.60	0.15
Fibroblast - Lung, donor1	11270-116H1	31.27	9.52	8.16	1.36	0.00
Fibroblast - Lung, donor2	11347-117G6	155.18	26.86	28.35	4.48	0.00
Fibroblast - Lung, donor3	11419-118F6	104.88	25.11	14.98	6.75	1.27
Fibroblast - Lymphatic, donor1	11506-119G3	41.65	14.99	1.67	1.67	0.00
Fibroblast - Lymphatic, donor2	11586-120G2	32.17	6.99	0.00	4.20	0.00
Fibroblast - Lymphatic, donor3	11667-122G2	10.36	1.68	0.84	0.84	0.00
Fibroblast - Mammary, donor1	11540-120B1	65.77	23.55	5.28	2.03	0.00
Fibroblast - Mammary, donor2	11620-122A9	51.92	11.98	0.00	0.00	0.00
Fibroblast - Mammary, donor3	11701-123A9	35.74	0.00	5.96	0.00	0.00
Fibroblast - Periodontal Ligament, donor1	11238-116D5	143.93	40.73	18.23	8.73	0.58
Fibroblast - Periodontal Ligament, donor2	11319-117D5	109.21	33.83	11.53	4.85	1.67
Fibroblast - Periodontal Ligament, donor3	11395-118C9	130.04	38.55	20.20	11.02	0.00
Fibroblast - Periodontal Ligament, donor4 (PL29)	11223-116B8	68.31	22.13	7.25	2.67	1.14
Fibroblast - Periodontal Ligament, donor5 (PL30)	11304-117B8	73.71	25.65	9.18	3.78	1.35
Fibroblast - Periodontal Ligament, donor6 (PLH3)	11380-118B3	63.79	17.51	7.31	2.09	0.58
Fibroblast - Pulmonary Artery, donor1	11250-116E8	142.70	26.53	16.36	9.28	0.22
Fibroblast - Villous Mesenchymal, donor1	11535-120A5	36.98	10.97	2.24	1.42	0.00
Fibroblast - Villous Mesenchymal, donor2	11615-122A4	20.05	5.35	6.01	1.34	0.00
Fibroblast - Villous Mesenchymal, donor3	11696-123A4	79.07	17.79	11.86	4.74	0.00
Fibroblast - skin dystrophia myotonica, donor1 (nuclear fraction)	14329-155E9	70.45	11.51	8.33	2.38	0.40
Fibroblast - skin dystrophia myotonica, donor1	11556-120C8	123.44	15.45	13.32	4.09	0.18
Fibroblast - skin dystrophia myotonica, donor2	11557-120C9	137.96	24.44	20.69	6.90	1.18
Fibroblast - skin dystrophia myotonica, donor3 (nuclear fraction)	14308-155C6	71.60	13.24	8.42	3.61	0.00
Fibroblast - skin dystrophia myotonica, donor3	11560-120D3	145.84	19.86	22.13	10.58	0.97
Fibroblast - skin normal, donor1 (nuclear fraction)	14323-155E3	91.61	15.44	9.11	2.53	0.51
Fibroblast - skin normal, donor1	11553-120C5	120.60	18.70	16.24	5.91	1.31
Fibroblast - skin normal, donor2 (nuclear fraction)	14302-155B9	76.99	13.63	7.02	4.21	0.40
Fibroblast - skin normal, donor2	11561-120D4	114.53	22.60	13.66	6.43	0.90
Fibroblast - skin spinal muscular atrophy, donor1 (nuclear fraction)	14326-155E6	91.58	19.34	6.04	4.23	0.30
Fibroblast - skin spinal muscular atrophy, donor1	11555-120C7	136.61	17.81	22.45	7.62	0.83
Fibroblast - skin spinal muscular atrophy, donor2	11558-120D1	152.32	27.52	25.13	4.79	1.37
Fibroblast - skin spinal muscular atrophy, donor3 (nuclear fraction)	14305-155C3	66.34	11.82	3.61	2.30	0.33
Fibroblast - skin spinal muscular atrophy, donor3	11559-120D2	121.22	21.84	11.72	5.65	0.64
Fibroblast - skin walker warburg, donor1	11554-120C6	109.47	21.76	12.48	4.89	0.34
Fibroblast - skin, normal donor1 (cytoplasmic fraction)	14322-155E2	91.90	18.19	14.74	6.43	1.10
Fibroblast - skin, normal donor2 (cytoplasmic fraction)	14301-155B8	243.76	132.96	44.32	44.32	132.96
Fingernail (including nail plate, eponychium and hyponychium), donor2	10301-104H4	171.69	35.73	20.05	7.84	3.49
Gingival epithelial cells, donor1 (GEA11)	11221-116B6	100.37	25.83	13.87	14.39	0.52
Gingival epithelial cells, donor2 (GEA14)	11302-117B6	98.89	28.37	15.61	11.71	0.00
Gingival epithelial cells, donor3 (GEA15)	11379-118B2	99.14	26.06	17.12	16.10	0.51
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep1	13523-145F4	230.43	48.23	27.56	20.67	0.77
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep2	13524-145F5	275.01	77.84	45.30	26.80	3.19
H1 embryonic stem cells differentiation to CD34+ HSC, day00, biol_rep3	13525-145F6	138.07	104.69	6.28	9.70	2.85
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep1	13526-145F7	208.75	76.94	14.06	7.72	4.14
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep2	13527-145F8	128.55	50.46	10.96	9.82	1.60
H1 embryonic stem cells differentiation to CD34+ HSC, day03, biol_rep3	13528-145F9	106.79	80.44	7.53	6.34	1.78
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep1	13529-145G1	171.55	60.27	12.95	4.49	2.64
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep2	13530-145G2	117.09	40.77	12.07	11.42	1.30
H1 embryonic stem cells differentiation to CD34+ HSC, day09, biol_rep3	13531-145G3	126.03	106.58	7.52	10.61	2.21
H9 Embryoid body cells, melanocytic induction, day00, biol_rep1 (H9EB-1 d0)	12627-134E8	211.56	99.63	17.24	7.49	1.41
H9 Embryoid body cells, melanocytic induction, day00, biol_rep2 (H9EB-2 d0)	12725-135G7	181.02	71.42	13.30	8.62	2.46
H9 Embryoid body cells, melanocytic induction, day00, biol_rep3 (H9EB-3 d0)	12823-136I6	137.80	63.40	11.82	6.18	1.61
H9 Embryoid body cells, melanocytic induction, day01, biol_rep1 (H9EB-1 d1)	12628-134E9	171.10	58.97	16.35	9.04	2.48
H9 Embryoid body cells, melanocytic induction, day01, biol_rep2 (H9EB-2 d1)	12726-135G8	168.46	70.46	12.46	7.20	1.25
H9 Embryoid body cells, melanocytic induction, day01, biol_rep3 (H9EB-3 d1)	12824-136I7	105.51	52.86	12.60	5.69	1.42
H9 Embryoid body cells, melanocytic induction, day03, biol_rep1 (H9EB-1 d3)	12629-134F1	133.71	33.31	13.46	6.85	1.60
H9 Embryoid body cells, melanocytic induction, day03, biol_rep2 (H9EB-2 d3)	12727-135G9	135.65	57.55	12.71	6.60	1.37
H9 Embryoid body cells, melanocytic induction, day03, biol_rep3 (H9EB-3 d3)	12825-136I8	118.25	45.46	10.71	3.72	0.87
H9 Embryoid body cells, melanocytic induction, day06, biol_rep1 (H9EB-1 d6)	12630-134F2	155.72	35.46	18.32	7.09	0.89
H9 Embryoid body cells, melanocytic induction, day06, biol_rep2 (H9EB-2 d6)	12728-135H1	164.52	47.37	14.47	7.63	1.91
H9 Embryoid body cells, melanocytic induction, day06, biol_rep3 (H9EB-3 d6)	12826-136I9	132.71	38.20	16.31	7.37	0.89
H9 Embryoid body cells, melanocytic induction, day09, biol_rep1 (H9EB-1 d9)	12631-134F3	145.58	32.87	14.92	6.45	1.61
H9 Embryoid body cells, melanocytic induction, day09, biol_rep2 (H9EB-2 d9)	12729-135H2	174.90	50.04	14.93	7.12	1.19
H9 Embryoid body cells, melanocytic induction, day09, biol_rep3 (H9EB-3 d9)	12827-137A1	165.73	41.59	18.09	11.70	1.15
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	194.38	37.98	23.72	5.72	2.29
H9 Embryoid body cells, melanocytic induction, day12, biol_rep1 (H9EB-1 d12)	12632-134F4	180.68	37.74	27.49	5.12	2.05
H9 Embryoid body cells, melanocytic induction, day12, biol_rep2 (H9EB-2 d12)	12730-135H3	164.98	45.26	14.61	7.64	1.00
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	175.21	33.11	20.55	11.48	0.50
H9 Embryoid body cells, melanocytic induction, day12, biol_rep3 (H9EB-3 d12)	12828-137A2	176.82	41.24	29.81	7.96	1.43
H9 Embryoid body cells, melanocytic induction, day15, biol_rep1 (H9EB-1 d15)	12633-134F5	153.70	34.87	22.69	7.63	1.24
H9 Embryoid body cells, melanocytic induction, day15, biol_rep2 (H9EB-2 d15)	12731-135H4	171.56	46.35	18.91	4.84	1.84
H9 Embryoid body cells, melanocytic induction, day15, biol_rep3 (H9EB-3 d15)	12829-137A3	119.07	26.02	15.68	7.50	1.00
H9 Embryoid body cells, melanocytic induction, day18, biol_rep1 (H9EB-1 d18)	12634-134F6	121.68	31.08	14.55	3.53	1.76
H9 Embryoid body cells, melanocytic induction, day18, biol_rep2 (H9EB-2 d18)	12732-135H5	182.64	43.17	19.31	7.26	0.86
H9 Embryoid body cells, melanocytic induction, day18, biol_rep3 (H9EB-3 d18)	12830-137A4	123.19	29.18	18.32	5.67	0.65
H9 Embryoid body cells, melanocytic induction, day21, biol_rep1 (H9EB-1 d21)	12635-134F7	164.85	26.30	20.21	6.09	2.57
H9 Embryoid body cells, melanocytic induction, day21, biol_rep2 (H9EB-2 d21)	12733-135H6	125.74	35.06	10.71	3.98	1.33
H9 Embryoid body cells, melanocytic induction, day21, biol_rep3 (H9EB-3 d21)	12831-137A5	111.51	28.63	16.29	4.90	0.95
H9 Embryoid body cells, melanocytic induction, day24, biol_rep1 (H9EB-1 d24)	12636-134F8	123.16	24.63	14.60	3.34	2.74
H9 Embryoid body cells, melanocytic induction, day24, biol_rep2 (H9EB-2 d24)	12734-135H7	121.89	34.29	10.56	6.27	1.46
H9 Embryoid body cells, melanocytic induction, day24, biol_rep3 (H9EB-3 d24)	12832-137A6	104.95	30.30	15.37	5.71	1.10
H9 Embryoid body cells, melanocytic induction, day27, biol_rep1 (H9EB-1 d27)	12637-134F9	118.67	25.25	15.15	3.09	1.12
H9 Embryoid body cells, melanocytic induction, day27, biol_rep2 (H9EB-2 d27)	12735-135H8	89.44	31.20	8.70	5.56	1.94
H9 Embryoid body cells, melanocytic induction, day27, biol_rep3 (H9EB-3 d27)	12833-137A7	93.06	25.40	13.64	8.29	1.34
H9 Embryoid body cells, melanocytic induction, day30, biol_rep1 (H9EB-1 d30)	12638-134G1	98.69	29.38	12.39	5.81	0.92
H9 Embryoid body cells, melanocytic induction, day30, biol_rep2 (H9EB-2 d30)	12736-135H9	111.01	31.22	9.59	7.12	0.26
H9 Embryoid body cells, melanocytic induction, day30, biol_rep3 (H9EB-3 d30)	12834-137A8	98.94	18.98	13.01	3.52	0.81
H9 Embryoid body cells, melanocytic induction, day34, biol_rep1 (H9EB-1 d34)	12639-134G2	93.83	16.04	10.88	3.69	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep2 (H9EB-2 d34)	12737-135I1	87.07	16.01	10.53	4.17	0.00
H9 Embryoid body cells, melanocytic induction, day34, biol_rep3 (H9EB-3 d34)	12835-137A9	68.43	13.88	12.89	1.98	1.98
H9 Embryoid body cells, melanocytic induction, day41, biol_rep1 (H9EB-1 d41)	12640-134G3	91.02	14.38	9.89	5.80	0.79
H9 Embryoid body cells, melanocytic induction, day41, biol_rep2 (H9EB-2 d41)	12738-135I2	89.98	13.11	11.50	3.63	1.21
H9 Embryoid body cells, melanocytic induction, day41, biol_rep3 (H9EB-3 d41)	12836-137B1	113.10	13.72	15.50	3.56	0.51
H9 Embryonic Stem cells, biol_rep1 (H9ES-1)	12626-134E7	215.18	137.35	9.75	7.96	2.59
H9 Embryonic Stem cells, biol_rep2 (H9ES-2)	12724-135G6	230.50	95.37	17.87	14.02	1.39
H9 Embryonic Stem cells, biol_rep3 (H9ES-3)	12822-136I5	233.43	154.87	12.27	9.62	2.05
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep1 (UH-1)	13364-143F7	236.89	79.80	29.42	13.46	0.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep2 (UH-2)	13365-143F8	238.76	83.64	23.73	14.41	0.85
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day00, biol_rep3 (UH-3)	13366-143F9	263.81	88.55	35.97	19.37	2.77
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep1	13328-143B7	202.93	74.24	34.65	12.37	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep2	13340-143D1	244.46	85.10	34.43	20.11	1.55
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day01, biol_rep3	13352-143E4	261.53	65.78	27.28	22.46	8.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep1	13329-143B8	177.36	62.60	20.87	6.96	3.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep2	13341-143D2	219.05	73.88	37.10	21.16	2.28
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day02, biol_rep3	13353-143E5	224.02	75.77	35.00	23.88	1.65
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep1	13330-143B9	169.95	56.65	19.99	6.66	3.33
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep2	13342-143D3	215.33	65.16	32.16	17.06	1.12
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day03, biol_rep3	13354-143E6	203.62	60.79	34.32	14.05	1.31
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep1	13331-143C1	183.71	52.01	36.07	10.07	2.52
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep2	13343-143D4	232.83	69.02	45.17	20.67	1.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day04, biol_rep3	13355-143E7	209.57	56.38	43.82	12.23	2.38
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep1	13332-143C2	227.61	62.64	27.15	16.71	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep2	13344-143D5	321.86	85.90	58.42	24.05	2.29
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day05, biol_rep3	13356-143E8	172.85	47.95	34.93	11.54	2.37
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep1	13333-143C3	177.89	60.99	27.11	23.72	5.08
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep2	13345-143D6	197.99	53.85	37.69	21.95	4.14
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day06, biol_rep3	13357-143E9	224.61	50.17	46.72	23.70	0.92
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep1	13334-143C4	194.93	31.61	15.81	15.81	5.27
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep2	13346-143D7	185.67	48.82	33.83	16.53	3.46
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day07, biol_rep3	13358-143F1	168.85	50.53	39.44	15.97	0.98
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep1	13335-143C5	172.56	42.81	36.12	16.72	0.67
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep2	13347-143D8	258.13	75.90	56.63	13.48	1.93
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day08, biol_rep3	13359-143F2	264.97	48.61	66.41	34.92	2.40
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep1	13336-143C6	211.21	47.21	59.63	14.91	0.00
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep2	13348-143D9	303.87	81.63	62.76	16.04	0.94
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day09, biol_rep3	13360-143F3	281.23	68.80	49.49	15.69	3.02
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep1	13337-143C7	201.94	71.72	35.61	10.68	1.53
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep2	13349-143E1	252.86	67.80	55.84	13.16	3.59
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day10, biol_rep3	13361-143F4	284.67	64.14	65.62	16.77	1.48
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep1	13338-143C8	290.39	60.20	47.22	14.17	2.36
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep2	13350-143E2	285.31	64.76	47.84	16.92	1.17
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day11, biol_rep3	13362-143F5	285.27	68.47	51.35	12.29	1.32
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep1	13339-143C9	270.41	55.95	50.86	15.26	1.70
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep2	13351-143E3	171.91	23.88	31.64	16.12	0.60
HES3-GFP Embryonic Stem cells, cardiomyocytic induction, day12, biol_rep3	13363-143F6	148.97	48.04	44.64	13.59	0.97
Hair Follicle Dermal Papilla Cells, donor1	11271-116H2	49.08	9.13	6.85	2.28	2.28
Hair Follicle Dermal Papilla Cells, donor2	11348-117G7	58.21	9.15	9.98	1.66	1.25
Hair Follicle Dermal Papilla Cells, donor3	11420-118F7	53.97	11.24	7.87	4.50	0.00
Hair Follicle Outer Root Sheath Cells, donor1	11504-119G1	66.29	18.71	12.69	5.07	0.00
Hair Follicle Outer Root Sheath Cells, donor2	11584-120F9	58.90	15.04	14.62	5.43	0.84
Hep-2 cells mock treated, biol_rep1	11898-125E8	139.60	49.67	18.91	19.61	1.51
Hep-2 cells mock treated, biol_rep2	11899-125E9	157.49	58.41	19.41	17.72	2.36
Hep-2 cells mock treated, biol_rep3	11900-125F1	155.61	61.65	14.79	16.84	2.28
Hep-2 cells treated with Streptococci strain 5448, biol_rep1	11890-125D9	137.40	50.39	17.38	20.66	2.62
Hep-2 cells treated with Streptococci strain 5448, biol_rep2	11891-125E1	151.73	61.46	15.47	18.70	3.01
Hep-2 cells treated with Streptococci strain 5448, biol_rep3	11892-125E2	157.59	61.36	14.85	17.65	1.94
Hep-2 cells treated with Streptococci strain JRS4, biol_rep1	11894-125E4	140.10	48.45	17.93	24.41	2.99
Hep-2 cells treated with Streptococci strain JRS4, biol_rep2	11895-125E5	135.35	49.92	14.41	22.99	1.37
Hep-2 cells treated with Streptococci strain JRS4, biol_rep3	11896-125E6	137.12	52.54	13.78	20.18	2.88
Hepatic Sinusoidal Endothelial Cells, donor1	11521-119H9	35.26	7.28	1.68	1.12	0.56
Hepatic Sinusoidal Endothelial Cells, donor2	11601-120H8	16.45	3.03	0.87	2.16	0.00
Hepatic Sinusoidal Endothelial Cells, donor3	11682-122H8	68.74	15.86	15.86	0.00	0.00
Hepatic Stellate Cells (lipocyte), donor1	11524-119I3	34.92	6.70	3.88	2.12	0.00
Hepatic Stellate Cells (lipocyte), donor2	11604-120I2	20.34	3.63	2.91	0.73	0.00
Hepatic Stellate Cells (lipocyte), donor3	11685-122I2	100.88	20.98	15.04	7.69	0.52
Hepatocyte, donor1	11523-119I2	226.38	26.63	56.90	29.05	1.21
Hepatocyte, donor2	11603-120I1	248.86	18.31	62.49	22.62	3.23
Hepatocyte, donor3	11684-122I1	168.11	19.02	25.77	17.79	0.00
Hodgkin's lymphoma cell line:HD-Mar2	10435-106E3	261.73	36.55	43.73	22.84	3.26
Intestinal epithelial cells (polarized), donor1	11246-116E4	159.05	51.39	14.86	24.99	1.05
Iris Pigment Epithelial Cells, donor1	11530-119I9	77.93	21.40	9.74	4.25	0.41
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep1	13079-140B1	35.02	19.10	3.18	3.18	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep2	13145-140I4	26.70	6.68	6.68	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr00min, biol_rep3	13211-141G7	81.25	0.00	54.17	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep1	13080-140B2	35.99	8.31	4.15	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep2	13146-140I5	17.52	25.03	7.51	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr15min, biol_rep3	13212-141G8	142.42	23.74	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep1	13081-140B3	56.38	10.25	5.13	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep2	13147-140I6	13.71	9.14	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr30min, biol_rep3	13213-141G9	50.35	25.99	1.62	8.12	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep1	13082-140B4	36.68	13.34	3.33	0.00	1.67
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep2	13148-140I7	54.46	25.41	3.63	0.00	0.00
K562 erythroblastic leukemia response to hemin, 00hr45min, biol_rep3	13214-141H1	47.64	18.53	6.62	3.97	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep1	13083-140B5	36.59	14.41	6.65	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep2	13149-140I8	41.91	10.48	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr00min, biol_rep3	13215-141H2	55.43	22.05	5.04	6.30	0.63
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep1	13084-140B6	44.85	13.92	12.37	3.09	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep2	13150-140I9	43.90	29.27	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr20min, biol_rep3	13216-141H3	55.56	12.92	6.46	3.23	1.94
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep1	13085-140B7	20.93	9.66	3.22	1.61	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep2	13151-141A1	11.95	23.90	11.95	0.00	0.00
K562 erythroblastic leukemia response to hemin, 01hr40min, biol_rep3	13217-141H4	59.49	19.56	4.89	4.89	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep1	13086-140B8	32.33	7.98	3.36	1.26	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep2	13152-141A2	28.74	0.00	0.00	14.37	0.00
K562 erythroblastic leukemia response to hemin, 02hr00min, biol_rep3	13218-141H5	65.90	26.52	3.21	3.21	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep1	13087-140B9	57.24	12.93	11.08	4.62	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep2	13153-141A3	15.08	15.08	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 02hr30min, biol_rep3	13219-141H6	62.31	22.66	6.14	2.36	0.94
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep1	13088-140C1	33.56	17.23	5.44	0.91	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep2	13154-141A4	0.00	0.00	14.74	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr00min, biol_rep3	13220-141H7	50.58	20.45	4.30	2.15	2.15
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep1	13089-140C2	44.47	11.43	5.08	3.81	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep2	13155-141A5	32.86	16.43	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 03hr30min, biol_rep3	13221-141H8	56.12	15.30	5.10	6.38	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep1	13090-140C3	30.99	18.23	5.47	1.82	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep2	13156-141A6	15.80	15.80	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 04hr, biol_rep3	13222-141H9	38.56	11.43	2.86	1.43	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep1	13091-140C4	36.50	0.00	6.64	3.32	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep2	13157-141A7	41.70	0.00	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, 06hr, biol_rep3	13223-141I1	72.23	16.67	7.10	3.70	0.93
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep1	13092-140C5	40.39	14.05	5.27	1.76	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep2	13158-141A8	44.00	18.86	6.29	3.14	0.00
K562 erythroblastic leukemia response to hemin, 12hr, biol_rep3	13224-141I2	63.28	14.60	6.26	3.48	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep1	13093-140C6	26.56	8.85	4.43	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep2	13159-141A9	45.39	6.48	6.48	0.00	0.00
K562 erythroblastic leukemia response to hemin, 24hr, biol_rep3	13225-141I3	54.93	15.69	1.74	0.87	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep1	13094-140C7	40.50	18.00	4.50	2.25	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep2	13160-141B1	31.36	0.00	10.45	3.48	0.00
K562 erythroblastic leukemia response to hemin, day02, biol_rep3	13226-141I4	39.47	4.27	6.40	3.20	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep1	13095-140C8	33.25	6.93	4.16	2.77	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep2	13161-141B2	25.65	8.55	5.70	0.00	0.00
K562 erythroblastic leukemia response to hemin, day03, biol_rep3	13227-141I5	44.18	11.05	2.76	1.84	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep1	13096-140C9	24.20	18.15	0.00	0.00	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep2	13162-141B3	74.50	0.00	0.00	6.21	0.00
K562 erythroblastic leukemia response to hemin, day04, biol_rep3	13228-141I6	30.66	16.92	4.23	0.00	0.00
Keratinocyte - epidermal, donor1	11272-116H3	71.40	10.44	16.73	11.10	0.49
Keratinocyte - epidermal, donor2	11349-117G8	59.73	14.64	8.78	5.27	0.59
Keratinocyte - epidermal, donor3	11421-118F8	146.91	30.20	14.86	10.41	0.85
Keratinocyte - oral, donor1	11251-116E9	204.33	67.43	19.75	8.17	1.25
Keratocytes, donor1	11527-119I6	82.18	16.50	10.31	5.16	0.00
Keratocytes, donor2	11607-120I5	22.26	5.86	10.55	0.00	0.00
Keratocytes, donor3	11688-122I5	125.47	38.14	23.91	5.73	0.59
Krukenberg tumor cell line:HSKTC	10687-109F3	114.29	24.18	6.59	2.20	0.00
Lens Epithelial Cells, donor1	11529-119I8	106.80	32.36	15.10	5.39	0.00
Lens Epithelial Cells, donor2	11609-120I7	129.17	26.07	9.69	2.19	0.23
Lens Epithelial Cells, donor3	11690-122I7	87.69	18.57	8.58	4.84	0.20
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep1 (MM XIX - 1)	12260-130A1	91.78	17.31	12.81	4.74	0.36
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep2 (MM XIV - 1)	12382-131E6	68.65	12.56	9.21	6.42	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr00min, biol_rep3 (MM XXII - 1 )	12504-133A2	104.84	18.89	13.85	8.19	1.10
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep1 (MM XIX - 2)	12261-130A2	80.66	13.98	12.91	4.84	1.08
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep2 (MM XIV - 2)	12383-131E7	48.54	10.72	6.30	2.52	0.95
Lymphatic Endothelial cells response to VEGFC, 00hr15min, biol_rep3 (MM XXII - 2)	12505-133A3	68.79	12.08	9.92	5.28	0.43
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep1 (MM XIX - 3)	12262-130A3	96.44	20.11	15.18	4.51	1.23
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep2 (MM XIV - 3)	12384-131E8	47.78	10.11	6.32	4.30	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr30min, biol_rep3 (MM XXII - 3)	12506-133A4	73.61	14.78	12.10	5.77	0.14
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep1 (MM XIX - 4)	12263-130A4	95.32	23.73	13.84	3.16	0.00
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep2 (MM XIV - 4)	12385-131E9	87.25	16.67	11.83	6.20	1.16
Lymphatic Endothelial cells response to VEGFC, 00hr45min, biol_rep3 (MM XXII - 4)	12507-133A5	57.21	6.67	5.55	3.33	0.37
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep1 (MM XIX - 5)	12264-130A5	88.50	19.51	11.15	5.23	0.35
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep2 (MM XIV - 5)	12386-131F1	75.85	14.07	6.68	4.53	0.24
Lymphatic Endothelial cells response to VEGFC, 01hr00min, biol_rep3 (MM XXII - 5)	12508-133A6	74.85	11.81	9.06	4.40	0.27
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep1 (MM XIX - 6)	12265-130A6	112.10	20.63	15.40	4.93	0.31
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep2 (MM XIV - 6)	12387-131F2	45.20	15.28	6.23	2.49	0.00
Lymphatic Endothelial cells response to VEGFC, 01hr20min, biol_rep3 (MM XXII - 6)	12509-133A7	69.17	12.08	10.61	5.12	0.18
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep1 (MM XIX - 7)	12266-130A7	98.08	21.72	12.84	3.62	0.33
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep2 (MM XIV - 7)	12388-131F3	50.67	10.84	5.27	4.39	0.29
Lymphatic Endothelial cells response to VEGFC, 01hr40min, biol_rep3 (MM XXII - 7)	12510-133A8	45.31	7.47	8.71	3.49	0.25
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep1 (MM XIX - 8)	12267-130A8	108.63	23.76	16.49	5.82	0.48
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep2 (MM XIV - 8)	12389-131F4	97.75	18.58	11.85	5.12	0.00
Lymphatic Endothelial cells response to VEGFC, 02hr00min, biol_rep3 (MM XXII - 8)	12511-133A9	90.37	14.23	13.78	5.15	0.61
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep1 (MM XIX - 9)	12268-130A9	92.28	22.81	15.55	5.18	0.52
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep2 (MM XIV - 9)	12390-131F5	96.32	19.26	14.03	3.77	0.63
Lymphatic Endothelial cells response to VEGFC, 02hr30min, biol_rep3 (MM XXII - 9)	12512-133B1	75.64	9.92	11.58	5.41	0.60
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep1 (MM XIX - 10)	12269-130B1	108.00	22.01	13.76	10.32	0.00
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep2 (MM XIV - 10)	12391-131F6	77.71	18.06	9.22	4.33	0.38
Lymphatic Endothelial cells response to VEGFC, 03hr00min, biol_rep3 (MM XXII - 10)	12513-133B2	59.69	9.22	9.86	3.39	0.74
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep1 (MM XIX - 11)	12270-130B2	103.70	19.38	13.57	5.33	0.48
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep2 (MM XIV - 11)	12392-131F7	85.01	16.54	8.60	4.96	0.33
Lymphatic Endothelial cells response to VEGFC, 03hr30min, biol_rep3 (MM XXII - 11)	12514-133B3	55.63	9.29	8.67	2.97	0.12
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep1 (MM XIX - 12)	12271-130B3	104.77	30.36	17.40	5.92	0.37
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep2 (MM XIV - 12)	12393-131F8	91.67	17.54	9.39	7.66	0.25
Lymphatic Endothelial cells response to VEGFC, 04hr, biol_rep3 (MM XXII - 12)	12515-133B4	60.63	10.17	6.46	2.89	0.69
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep1 (MM XIX - 13)	12272-130B4	106.46	18.66	13.19	4.82	0.64
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep2 (MM XIV - 13)	12394-131F9	120.51	22.22	15.52	10.65	0.30
Lymphatic Endothelial cells response to VEGFC, 05hr, biol_rep3 (MM XXII - 13)	12516-133B5	91.12	15.26	14.14	6.44	1.12
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep1 (MM XIX - 14)	12273-130B5	94.22	20.98	13.87	2.84	0.71
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep2 (MM XIV - 14)	12395-131G1	58.66	14.54	11.15	0.48	0.97
Lymphatic Endothelial cells response to VEGFC, 06hr, biol_rep3 (MM XXII - 14)	12517-133B6	41.24	5.76	7.00	2.18	0.31
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep1 (MM XIX - 15)	12274-130B6	84.51	18.98	8.95	5.01	0.72
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep2 (MM XIV - 15)	12396-131G2	83.96	14.70	13.72	3.92	0.65
Lymphatic Endothelial cells response to VEGFC, 07hr, biol_rep3 (MM XXII - 15)	12518-133B7	43.79	5.89	5.41	1.88	0.24
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep1 (MM XIX - 16)	12275-130B7	85.02	16.58	13.49	5.20	0.25
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep2 (MM XIV - 16)	12397-131G3	56.86	9.99	7.17	2.05	0.51
Lymphatic Endothelial cells response to VEGFC, 08hr, biol_rep3 (MM XXII - 16)	12519-133B8	52.21	11.64	8.06	4.48	0.90
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep1	13031-139E7	149.56	74.78	24.93	13.60	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep2	13097-140D1	107.40	35.29	5.37	5.37	0.00
MCF7 breast cancer cell line response to EGF1, 00hr00min, biol_rep3	13163-141B4	106.88	43.05	10.39	6.68	0.00
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep1	13032-139E8	113.40	30.47	12.69	5.92	3.39
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep2	13098-140D2	97.06	35.87	11.25	2.81	2.11
MCF7 breast cancer cell line response to EGF1, 00hr15min, biol_rep3	13164-141B5	100.87	40.16	13.08	7.47	0.93
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep1	13033-139E9	94.81	29.89	9.79	9.79	3.09
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep2	13099-140D3	92.78	24.98	8.33	7.14	1.19
MCF7 breast cancer cell line response to EGF1, 00hr30min, biol_rep3	13165-141B6	129.83	33.25	12.67	9.27	0.68
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep1	13034-139F1	132.62	46.82	14.83	10.18	4.36
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep2	13100-140D4	154.41	46.82	17.56	9.45	1.80
MCF7 breast cancer cell line response to EGF1, 00hr45min, biol_rep3	13166-141B7	135.35	36.85	13.68	11.25	1.76
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep1	13035-139F2	111.43	31.32	10.78	7.19	2.05
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep2	13101-140D5	136.20	41.28	14.11	7.41	1.06
MCF7 breast cancer cell line response to EGF1, 01hr00min, biol_rep3	13167-141B8	130.60	49.31	12.66	9.33	2.00
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep1	13036-139F3	119.20	35.15	15.79	9.68	1.02
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep2	13102-140D6	140.61	44.82	18.14	8.54	2.13
MCF7 breast cancer cell line response to EGF1, 01hr20min, biol_rep3	13168-141B9	154.75	46.29	12.09	8.88	4.53
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep1	13037-139F4	122.10	44.18	7.36	8.59	1.84
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep2	13103-140D7	115.79	45.66	17.94	11.42	4.08
MCF7 breast cancer cell line response to EGF1, 01hr40min, biol_rep3	13169-141C1	136.40	42.90	14.79	8.54	2.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep1	13038-139F5	164.23	52.69	15.41	15.69	3.92
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep2	13104-140D8	124.67	34.00	9.27	10.30	1.03
MCF7 breast cancer cell line response to EGF1, 02hr00min, biol_rep3	13170-141C2	156.76	49.64	12.19	8.13	3.77
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep1	13039-139F6	164.41	49.02	14.05	11.36	2.69
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep2	13105-140D9	142.74	47.03	13.28	8.30	4.43
MCF7 breast cancer cell line response to EGF1, 02hr30min, biol_rep3	13171-141C3	125.84	45.60	9.19	8.48	3.53
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep1	13040-139F7	128.70	42.78	13.64	8.85	2.58
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep2	13106-140E1	108.22	36.84	6.91	3.45	1.15
MCF7 breast cancer cell line response to EGF1, 03hr00min, biol_rep3	13172-141C4	125.49	41.83	11.51	6.14	3.07
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep1	13041-139F8	125.68	37.93	9.06	10.19	3.96
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep2	13107-140E2	104.20	48.41	8.20	5.74	2.46
MCF7 breast cancer cell line response to EGF1, 03hr30min, biol_rep3	13173-141C5	116.59	34.80	6.78	5.42	2.26
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep1	13042-139F9	113.47	38.78	14.36	9.34	3.59
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep2	13108-140E3	126.23	39.59	11.20	11.95	1.49
MCF7 breast cancer cell line response to EGF1, 04hr, biol_rep3	13174-141C6	122.63	40.88	10.03	8.92	4.09
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep1	13043-139G1	119.75	49.54	9.91	7.32	1.72
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep2	13109-140E4	127.59	39.39	11.13	11.99	2.57
MCF7 breast cancer cell line response to EGF1, 05hr, biol_rep3	13175-141C7	115.28	42.31	11.99	9.66	3.33
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep1	13044-139G2	121.26	44.64	11.46	4.22	3.62
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep2	13110-140E5	110.92	35.55	12.80	4.98	0.71
MCF7 breast cancer cell line response to EGF1, 06hr, biol_rep3	13176-141C8	107.93	38.84	7.56	7.56	1.72
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep1	13045-139G3	128.28	42.40	9.66	6.98	1.61
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep2	13111-140E6	93.60	32.32	8.08	4.71	1.35
MCF7 breast cancer cell line response to EGF1, 07hr, biol_rep3	13177-141C9	115.57	39.63	9.26	7.78	1.85
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep1	13046-139G4	124.43	36.05	23.26	11.63	1.16
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep2	13112-140E7	89.91	32.79	9.52	4.23	1.06
MCF7 breast cancer cell line response to EGF1, 08hr, biol_rep3	13178-141D1	131.65	43.22	10.80	5.20	2.80
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep1	13048-139G6	97.40	36.34	9.45	7.27	2.18
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep2	13114-140E9	119.58	30.66	13.80	8.43	1.53
MCF7 breast cancer cell line response to HRG, 00hr15min, biol_rep3	13180-141D3	117.40	27.13	13.32	4.93	3.45
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep1	13049-139G7	103.50	51.75	18.82	6.59	4.70
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep2	13115-140F1	109.62	41.23	7.54	6.03	1.51
MCF7 breast cancer cell line response to HRG, 00hr30min, biol_rep3	13181-141D4	127.53	38.30	13.52	7.66	3.15
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep1	13050-139G8	134.25	30.98	8.61	5.16	3.44
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep2	13116-140F2	118.46	36.96	13.81	6.23	2.67
MCF7 breast cancer cell line response to HRG, 00hr45min, biol_rep3	13182-141D5	102.84	42.62	11.73	8.99	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep1	13051-139G9	113.47	35.63	9.90	6.60	0.66
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep2	13117-140F3	118.83	44.63	14.01	6.75	1.56
MCF7 breast cancer cell line response to HRG, 01hr00min, biol_rep3	13183-141D6	112.89	51.20	14.00	10.50	3.06
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep1	13052-139H1	130.27	44.17	12.86	10.62	0.56
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep2	13118-140F4	111.29	40.19	8.83	5.74	1.32
MCF7 breast cancer cell line response to HRG, 01hr20min, biol_rep3	13184-141D7	120.73	43.97	12.34	10.03	2.31
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep1	13053-139H2	115.96	37.98	9.62	9.62	1.52
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep2	13119-140F5	137.46	45.66	8.65	6.73	0.48
MCF7 breast cancer cell line response to HRG, 01hr40min, biol_rep3	13185-141D8	132.78	46.12	14.71	9.54	2.78
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep1	13054-139H3	123.95	42.53	13.37	7.90	2.43
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep2	13120-140F6	115.51	34.59	11.76	7.61	1.38
MCF7 breast cancer cell line response to HRG, 02hr00min, biol_rep3	13186-141D9	124.26	37.62	11.02	9.50	1.14
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep1	13055-139H4	124.46	44.41	7.75	10.84	3.61
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep2	13121-140F7	111.26	30.84	11.49	8.47	1.81
MCF7 breast cancer cell line response to HRG, 02hr30min, biol_rep3	13187-141E1	143.56	49.12	10.77	6.97	4.12
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep1	13056-139H5	118.88	47.44	12.79	10.66	3.20
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep2	13122-140F8	117.23	33.33	8.62	10.34	1.72
MCF7 breast cancer cell line response to HRG, 03hr00min, biol_rep3	13188-141E2	121.87	50.39	10.80	8.23	2.06
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep1	13057-139H6	130.86	39.61	12.73	12.73	2.83
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep2	13123-140F9	120.87	38.59	8.51	7.94	1.70
MCF7 breast cancer cell line response to HRG, 03hr30min, biol_rep3	13189-141E3	148.10	52.84	14.56	8.32	2.08
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep1	13058-139H7	125.29	54.03	10.96	14.88	1.57
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep2	13124-140G1	113.16	33.40	8.35	8.35	1.25
MCF7 breast cancer cell line response to HRG, 04hr, biol_rep3	13190-141E4	119.41	44.14	6.97	9.76	4.65
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep1	13059-139H8	119.76	42.15	8.70	6.02	0.67
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep2	13125-140G2	124.04	41.70	9.62	9.09	1.60
MCF7 breast cancer cell line response to HRG, 05hr, biol_rep3	13191-141E5	132.95	45.26	9.29	9.29	2.02
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep1	13060-139H9	128.49	40.38	11.93	8.26	3.67
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep2	13126-140G3	138.70	33.79	4.45	5.33	0.89
MCF7 breast cancer cell line response to HRG, 06hr, biol_rep3	13192-141E6	125.94	40.46	10.26	7.41	1.14
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep1	13061-139I1	131.91	58.28	8.44	13.80	1.53
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep2	13127-140G4	112.17	44.32	8.21	9.85	1.09
MCF7 breast cancer cell line response to HRG, 07hr, biol_rep3	13193-141E7	108.69	54.34	5.79	8.91	1.34
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep1	13062-139I2	154.15	51.21	7.54	13.26	1.56
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep2	13128-140G5	124.66	56.36	5.30	8.62	0.00
MCF7 breast cancer cell line response to HRG, 08hr, biol_rep3	13194-141E8	116.40	24.94	6.24	14.55	2.08
Macrophage - monocyte derived, donor1	11232-116C8	167.06	17.78	28.49	30.08	0.91
Macrophage - monocyte derived, donor2	11313-117C8	136.16	17.07	19.45	26.98	0.37
Macrophage - monocyte derived, donor3	11389-118C3	116.27	15.47	20.97	25.82	0.92
Mallassez-derived cells, donor1 (MZH3)	12142-128E9	131.69	41.95	21.77	23.36	0.00
Mallassez-derived cells, donor2	11929-125I3	106.64	23.29	15.85	9.19	0.16
Mallassez-derived cells, donor3	11930-125I4	133.57	27.10	23.49	15.57	0.83
Mammary Epithelial Cell, donor1	11273-116H4	226.79	61.18	31.79	17.94	0.40
Mammary Epithelial Cell, donor2	11350-117G9	187.63	52.70	26.35	13.90	0.00
Mammary Epithelial Cell, donor3	11422-118F9	48.64	18.96	5.99	3.99	0.50
Mast cell - stimulated, donor1	11487-119E2	289.48	44.07	16.27	3.39	2.03
Mast cell, donor1	11563-120D6	218.88	30.06	12.76	3.46	0.54
Mast cell, donor2	11565-120D8	402.37	58.84	19.91	7.73	1.78
Mast cell, donor3	11566-120D9	435.17	66.41	18.69	6.30	2.03
Mast cell, donor4	11567-120E1	396.60	84.39	18.97	5.67	1.77
Mast cell, expanded and stimulated, donor5	11940-126A5	229.77	34.04	7.54	2.33	0.89
Mast cell, expanded and stimulated, donor8	11942-126A7	139.50	46.11	5.84	2.33	0.00
Mast cell, expanded, donor5	11939-126A4	251.70	35.79	9.75	4.13	1.26
Mast cell, expanded, donor8	11941-126A6	164.69	34.14	11.21	6.19	1.17
Melanocyte - dark, donor1	11502-119F8	146.36	25.37	23.38	9.65	0.40
Melanocyte - dark, donor2	11582-120F7	77.87	16.61	13.84	4.50	0.35
Melanocyte - dark, donor3	11663-122F7	145.97	21.95	14.56	8.77	0.14
Melanocyte - light, donor1	11274-116H5	34.09	9.87	1.88	0.94	0.00
Melanocyte - light, donor2	11351-117H1	31.39	6.82	6.82	4.09	0.00
Melanocyte - light, donor3	11423-118G1	39.89	9.54	5.20	1.73	0.00
Melanocyte, donor1 (MC+1)	12641-134G4	136.82	30.40	6.56	5.10	0.83
Melanocyte, donor2 (MC+2)	12739-135I3	96.55	23.94	7.53	3.50	0.27
Melanocyte, donor3 (MC+3)	12837-137B2	124.55	26.25	13.12	2.41	0.27
Meningeal Cells, donor1	11493-119E8	74.93	20.72	5.95	3.47	0.37
Meningeal Cells, donor2	11573-120E7	89.35	19.81	5.72	3.08	0.44
Meningeal Cells, donor3	11654-122E7	157.95	31.87	20.70	9.62	0.73
Mesenchymal Stem Cells - Vertebral, donor1	11219-116B4	109.79	28.80	13.69	6.56	0.57
Mesenchymal Stem Cells - Wharton's Jelly, donor1	11548-120B9	79.70	14.69	16.60	8.55	0.40
Mesenchymal Stem Cells - adipose, donor1	11537-120A7	15.77	3.94	3.94	0.00	0.00
Mesenchymal Stem Cells - adipose, donor2	11617-122A6	14.39	2.62	3.92	1.31	0.00
Mesenchymal Stem Cells - adipose, donor3	11698-123A6	124.86	39.47	9.33	6.46	0.72
Mesenchymal Stem Cells - amniotic membrane, donor1	11547-120B8	88.94	16.09	11.44	3.60	0.21
Mesenchymal Stem Cells - amniotic membrane, donor2	11627-122B7	80.93	20.11	8.54	1.51	1.01
Mesenchymal Stem Cells - bone marrow, donor1	11536-120A6	29.67	11.65	2.64	1.10	0.00
Mesenchymal Stem Cells - bone marrow, donor2	11616-122A5	27.03	13.88	5.11	0.73	0.00
Mesenchymal Stem Cells - bone marrow, donor3	11697-123A5	21.28	9.21	2.05	2.86	0.00
Mesenchymal Stem Cells - bone marrow, donor4	11464-119B6	115.79	37.12	14.13	3.60	0.28
Mesenchymal Stem Cells - hepatic, donor1	11538-120A8	35.31	2.97	7.06	3.72	0.00
Mesenchymal Stem Cells - hepatic, donor2	11618-122A7	116.44	17.63	27.10	10.00	0.53
Mesenchymal Stem Cells - umbilical, donor1	11539-120A9	36.80	5.04	11.57	4.15	0.00
Mesenchymal Stem Cells - umbilical, donor2	11619-122A8	35.03	2.34	9.34	2.34	0.00
Mesenchymal Stem Cells - umbilical, donor3	11700-123A8	19.85	5.12	3.20	1.28	0.00
Mesenchymal stem cells - adipose, donor0	11217-116B2	178.99	52.10	15.95	8.51	0.00
Mesenchymal stem cells - hepatic, donor0	11218-116B3	124.15	22.52	21.89	10.01	0.00
Mesenchymal stem cells - umbilical, donor0	11214-116A8	110.31	48.62	9.43	5.08	0.00
Mesothelial Cells, donor1	11247-116E5	80.08	14.58	11.67	14.32	0.80
Mesothelial Cells, donor2	12156-128G5	68.06	15.51	9.51	11.51	0.50
Mesothelial Cells, donor3	11402-118D7	59.91	10.98	8.02	6.43	1.37
Monocyte-derived macrophages response to LPS, 00hr00min, donor1 (t1 Subject1)	12698-135D7	82.37	9.45	8.10	22.96	0.00
Monocyte-derived macrophages response to LPS, 00hr00min, donor2 (t1 Subject2)	12796-136F6	115.26	16.25	17.73	17.24	1.72
Monocyte-derived macrophages response to LPS, 00hr00min, donor3 (t1 Subject3)	12894-137H5	117.49	15.02	16.20	26.21	0.59
Monocyte-derived macrophages response to LPS, 00hr15min, donor1 (t2 Subject1)	12699-135D8	65.68	3.46	20.74	17.29	0.00
Monocyte-derived macrophages response to LPS, 00hr15min, donor2 (t2 Subject2)	12797-136F7	106.62	16.12	14.26	20.15	4.34
Monocyte-derived macrophages response to LPS, 00hr15min, donor3 (t2 Subject3)	12895-137H6	99.15	15.76	14.73	20.74	0.83
Monocyte-derived macrophages response to LPS, 00hr30min, donor1 (t3 Subject1)	12700-135D9	39.37	4.63	9.26	11.58	0.00
Monocyte-derived macrophages response to LPS, 00hr30min, donor2 (t3 Subject2)	12798-136F8	117.37	15.52	16.02	20.27	1.75
Monocyte-derived macrophages response to LPS, 00hr30min, donor3 (t3 Subject3)	12896-137H7	101.47	16.76	19.55	20.02	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor1 (t4 Subject1)	12701-135E1	38.93	0.00	19.47	38.93	0.00
Monocyte-derived macrophages response to LPS, 00hr45min, donor2 (t4 Subject2)	12799-136F9	108.11	13.82	15.85	20.32	1.22
Monocyte-derived macrophages response to LPS, 00hr45min, donor3 (t4 Subject3)	12897-137H8	98.59	10.69	13.86	20.19	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor1 (t5 Subject1)	12702-135E2	17.10	0.00	8.55	8.55	0.00
Monocyte-derived macrophages response to LPS, 01hr00min, donor2 (t5 Subject2)	12800-136G1	92.92	12.39	15.93	12.39	0.88
Monocyte-derived macrophages response to LPS, 01hr00min, donor3 (t5 Subject3)	12898-137H9	105.62	16.72	14.06	28.88	1.52
Monocyte-derived macrophages response to LPS, 01hr20min, donor1 (t6 Subject1)	12703-135E3	47.37	2.63	7.90	7.90	2.63
Monocyte-derived macrophages response to LPS, 01hr20min, donor2 (t6 Subject2)	12801-136G2	100.59	10.61	16.55	17.40	1.27
Monocyte-derived macrophages response to LPS, 01hr20min, donor3 (t6 Subject3)	12899-137I1	51.57	4.60	7.37	14.73	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor1 (t7 Subject1)	12704-135E4	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 01hr40min, donor2 (t7 Subject2)	12802-136G3	67.66	7.45	8.94	9.54	0.60
Monocyte-derived macrophages response to LPS, 01hr40min, donor3 (t7 Subject3)	12900-137I2	20.12	1.68	6.71	10.06	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor1 (t8 Subject1)	12705-135E5	0.00	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 02hr00min, donor2 (t8 Subject2)	12803-136G4	76.78	10.54	15.56	17.56	2.51
Monocyte-derived macrophages response to LPS, 02hr00min, donor3 (t8 Subject3)	12901-137I3	71.54	10.70	7.13	14.02	0.71
Monocyte-derived macrophages response to LPS, 02hr30min, donor1 (t9 Subject1)	12706-135E6	34.28	2.21	6.08	13.27	0.00
Monocyte-derived macrophages response to LPS, 02hr30min, donor2 (t9 Subject2)	12804-136G5	56.64	8.98	11.51	8.75	1.84
Monocyte-derived macrophages response to LPS, 02hr30min, donor3 (t9 Subject3)	12902-137I4	72.36	11.36	7.15	14.09	0.84
Monocyte-derived macrophages response to LPS, 03hr00min, donor1 (t10 Subject1)	12707-135E7	53.40	6.73	7.54	8.56	0.82
Monocyte-derived macrophages response to LPS, 03hr00min, donor2 (t10 Subject2)	12805-136G6	69.73	11.80	10.51	9.23	1.07
Monocyte-derived macrophages response to LPS, 03hr00min, donor3 (t10 Subject3)	12903-137I5	54.24	10.45	8.89	12.89	0.22
Monocyte-derived macrophages response to LPS, 03hr30min, donor1 (t11 Subject1)	12708-135E8	30.96	0.00	0.00	0.00	0.00
Monocyte-derived macrophages response to LPS, 03hr30min, donor2 (t11 Subject2)	12806-136G7	38.98	6.13	9.86	5.48	0.44
Monocyte-derived macrophages response to LPS, 03hr30min, donor3 (t11 Subject3)	12904-137I6	35.99	5.58	3.55	8.62	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor1 (t12 Subject1)	12709-135E9	28.17	0.00	1.66	4.97	0.00
Monocyte-derived macrophages response to LPS, 04hr, donor2 (t12 Subject2)	12807-136G8	36.42	6.25	8.43	7.34	0.54
Monocyte-derived macrophages response to LPS, 04hr, donor3 (t12 Subject3)	12905-137I7	53.52	8.53	4.71	13.23	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor1 (t13 Subject1)	12710-135F1	22.90	3.27	4.36	11.99	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor2 (t13 Subject2)	12808-136G9	52.86	10.57	5.29	4.81	0.00
Monocyte-derived macrophages response to LPS, 05hr, donor3 (t13 Subject3)	12906-137I8	64.04	10.81	12.41	13.61	0.80
Monocyte-derived macrophages response to LPS, 06hr, donor1 (t14 Subject1)	12711-135F2	23.31	0.00	1.37	10.97	0.00
Monocyte-derived macrophages response to LPS, 06hr, donor2 (t14 Subject2)	12809-136H1	51.06	9.51	8.01	4.00	0.50
Monocyte-derived macrophages response to LPS, 06hr, donor3 (t14 Subject3)	12907-137I9	53.89	0.00	26.95	26.95	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor1 (t15 Subject1)	12712-135F3	28.54	4.08	2.04	2.04	0.00
Monocyte-derived macrophages response to LPS, 07hr, donor2 (t15 Subject2)	12810-136H2	84.08	11.82	8.76	12.26	0.88
Monocyte-derived macrophages response to LPS, 07hr, donor3 (t15 Subject3)	12908-138A1	27.59	3.31	3.31	8.83	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor1 (t16 Subject1)	12713-135F4	32.02	4.48	5.76	7.04	0.00
Monocyte-derived macrophages response to LPS, 08hr, donor2 (t16 Subject2)	12811-136H3	93.71	14.38	13.88	11.65	0.74
Monocyte-derived macrophages response to LPS, 08hr, donor3 (t16 Subject3)	12909-138A2	40.36	9.74	5.57	19.49	0.00
Monocyte-derived macrophages response to LPS, 10hr, donor1 (t17 Subject1)	12714-135F5	22.10	4.42	11.05	11.05	2.21
Monocyte-derived macrophages response to LPS, 10hr, donor2 (t17 Subject2)	12812-136H4	99.83	12.99	19.49	12.99	1.37
Monocyte-derived macrophages response to LPS, 10hr, donor3 (t17 Subject3)	12910-138A3	65.64	8.75	10.94	21.01	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor1 (t18 Subject1)	12715-135F6	39.77	2.84	6.04	9.59	0.00
Monocyte-derived macrophages response to LPS, 12hr, donor2 (t18 Subject2)	12813-136H5	114.75	11.78	22.16	19.08	1.68
Monocyte-derived macrophages response to LPS, 12hr, donor3 (t18 Subject3)	12911-138A4	73.98	14.55	14.96	25.35	0.83
Monocyte-derived macrophages response to LPS, 14hr, donor1 (t19 Subject1)	12716-135F7	38.46	4.66	5.83	10.49	0.58
Monocyte-derived macrophages response to LPS, 14hr, donor2 (t19 Subject2)	12814-136H6	83.26	9.05	17.19	14.18	0.90
Monocyte-derived macrophages response to LPS, 14hr, donor3 (t19 Subject3)	12912-138A5	104.77	21.29	16.70	21.70	1.67
Monocyte-derived macrophages response to LPS, 16hr, donor1 (t20 Subject1)	12717-135F8	21.66	7.22	14.44	14.44	0.00
Monocyte-derived macrophages response to LPS, 16hr, donor2 (t20 Subject2)	12815-136H7	68.34	4.62	21.24	11.08	1.85
Monocyte-derived macrophages response to LPS, 16hr, donor3 (t20 Subject3)	12913-138A6	126.34	19.92	17.07	22.76	0.00
Monocyte-derived macrophages response to LPS, 18hr, donor1 (t21 Subject1)	12718-135F9	76.83	7.05	12.99	17.00	0.14
Monocyte-derived macrophages response to LPS, 18hr, donor2 (t21 Subject2)	12816-136H8	98.48	11.66	21.25	19.18	2.85
Monocyte-derived macrophages response to LPS, 18hr, donor3 (t21 Subject3)	12914-138A7	96.52	17.16	17.59	17.16	0.86
Monocyte-derived macrophages response to LPS, 20hr, donor1 (t22 Subject1)	12719-135G1	43.83	3.81	13.34	10.16	0.00
Monocyte-derived macrophages response to LPS, 20hr, donor2 (t22 Subject2)	12817-136H9	70.46	5.07	20.55	16.81	1.07
Monocyte-derived macrophages response to LPS, 20hr, donor3 (t22 Subject3)	12915-138A8	152.96	19.76	23.05	35.02	1.80
Monocyte-derived macrophages response to LPS, 22hr, donor1 (t23 Subject1)	12720-135G2	79.53	6.78	15.26	20.20	0.57
Monocyte-derived macrophages response to LPS, 22hr, donor2 (t23 Subject2)	12818-136I1	110.84	9.87	21.98	20.38	1.91
Monocyte-derived macrophages response to LPS, 22hr, donor3 (t23 Subject3)	12916-138A9	151.47	24.55	18.80	21.45	0.44
Monocyte-derived macrophages response to LPS, 24hr, donor1 (t24 Subject1)	12721-135G3	62.19	5.69	18.58	17.06	0.38
Monocyte-derived macrophages response to LPS, 24hr, donor2 (t24 Subject2)	12819-136I2	121.60	9.38	28.41	21.59	1.14
Monocyte-derived macrophages response to LPS, 24hr, donor3 (t24 Subject3)	12917-138B1	140.85	26.55	22.86	33.68	2.46
Monocyte-derived macrophages response to LPS, 36hr, donor1 (t25 Subject1)	12722-135G4	47.57	5.21	20.85	15.64	0.00
Monocyte-derived macrophages response to LPS, 36hr, donor2 (t25 Subject2)	12820-136I3	100.85	6.47	33.52	22.35	0.88
Monocyte-derived macrophages response to LPS, 36hr, donor3 (t25 Subject3)	12918-138B2	142.43	18.74	33.73	32.29	0.86
Monocyte-derived macrophages response to LPS, 48hr, donor1 (t26 Subject1)	12723-135G5	144.25	9.07	35.86	37.92	1.65
Monocyte-derived macrophages response to LPS, 48hr, donor2 (t26 Subject2)	12821-136I4	131.92	8.04	39.90	30.08	1.19
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor1 (868_121:MI_0h)	13304-142I1	188.34	37.67	15.07	7.53	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor2 (150_120:MI_0h)	13316-143A4	135.45	23.17	23.17	12.48	0.00
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor3 (536_119:MI_0h)	13322-143B1	152.79	15.77	25.63	17.74	1.64
Monocyte-derived macrophages response to mock influenza infection, 00hr00min, donor4 (227_121:MI_0h)	13310-142I7	108.35	10.52	15.78	11.57	2.10
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor1 (868_121:MI_24h)	13309-142I6	194.13	13.44	31.43	19.77	0.59
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor2 (150_120:MI_24h)	13321-143A9	148.08	18.63	38.18	13.97	0.00
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor3 (536_119:MI_24h)	13327-143B6	155.47	22.91	35.68	24.78	1.50
Monocyte-derived macrophages response to mock influenza infection, 24hr00min, donor4 (227_121:MI_24h)	13315-143A3	111.86	16.78	15.98	12.78	0.80
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor1 (868_121:Ud_0h)	13305-142I2	191.82	16.97	19.57	17.76	0.90
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor2 (150_120:Ud_0h)	13317-143A5	109.77	12.52	16.94	8.10	0.00
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor3 (536_119:Ud_0h)	13323-143B2	127.52	11.36	15.39	16.86	2.93
Monocyte-derived macrophages response to udorn influenza infection, 00hr00min, donor4 (227_121:Ud_0h)	13311-142I8	110.45	15.56	18.67	10.89	3.11
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor1 (868_121:Ud_2h)	13306-142I3	241.57	31.53	20.84	22.98	1.60
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor2 (150_120:Ud_2h)	13318-143A6	69.55	3.86	7.73	3.86	3.86
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor3 (536_119:Ud_2h)	13324-143B3	107.05	9.09	13.13	7.07	3.03
Monocyte-derived macrophages response to udorn influenza infection, 02hr00min, donor4 (227_121:Ud_2h)	13312-142I9	109.63	12.65	13.91	8.85	1.69
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor1 (868_121:Ud_7h)	13307-142I4	126.66	16.34	32.69	14.98	0.00
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor2 (150_120:Ud_7h)	13319-143A7	105.54	22.25	24.80	13.35	0.64
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor3 (536_119:Ud_7h)	13325-143B4	153.87	12.96	20.25	20.25	0.81
Monocyte-derived macrophages response to udorn influenza infection, 07hr00min, donor4 (227_121:Ud_7h)	13313-143A1	48.33	10.57	7.55	13.59	3.02
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor1 (868_121:Ud_24h)	13308-142I5	125.62	5.71	0.00	28.55	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor2 (150_120:Ud_24h)	13320-143A8	166.38	32.62	42.41	42.41	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor3 (536_119:Ud_24h)	13326-143B5	147.33	28.51	19.01	19.01	0.00
Monocyte-derived macrophages response to udorn influenza infection, 24hr00min, donor4 (227_121:Ud_24h)	13314-143A2	50.20	25.10	12.55	50.20	0.00
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor1	11549-120C1	97.38	19.60	12.71	7.97	0.22
Multipotent Cord Blood Unrestricted Somatic Stem Cells, donor2	11629-122B9	65.33	12.54	10.97	1.05	1.57
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor1	13496-145C4	36.71	9.34	6.67	4.67	0.00
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor2	13505-145D4	26.71	6.26	7.93	2.50	0.42
Myoblast differentiation to myotubes, day00, Duchenne Muscular Dystrophy donor3	13514-145E4	64.27	18.44	8.18	5.70	0.76
Myoblast differentiation to myotubes, day00, control donor1	13469-144I4	137.24	25.53	27.13	11.17	0.00
Myoblast differentiation to myotubes, day00, control donor2	13478-145A4	28.56	6.12	4.08	0.68	0.00
Myoblast differentiation to myotubes, day00, control donor3	13487-145B4	75.34	25.73	1.84	3.68	1.84
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor1	13497-145C5	28.46	6.28	7.12	3.77	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor2	13506-145D5	48.58	9.99	8.83	7.21	0.00
Myoblast differentiation to myotubes, day01, Duchenne Muscular Dystrophy donor3	13515-145E5	37.29	7.30	7.84	2.97	0.54
Myoblast differentiation to myotubes, day01, control donor1	13470-144I5	80.94	12.40	11.14	3.99	0.21
Myoblast differentiation to myotubes, day01, control donor2	13479-145A5	133.62	77.94	0.00	0.00	11.13
Myoblast differentiation to myotubes, day01, control donor3	13488-145B5	56.58	12.91	9.43	0.99	0.00
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor1	13498-145C6	47.64	10.56	8.39	3.25	0.27
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor2	13507-145D6	42.39	7.25	6.80	3.17	0.68
Myoblast differentiation to myotubes, day02, Duchenne Muscular Dystrophy donor3	13516-145E6	37.72	6.70	8.33	2.29	0.00
Myoblast differentiation to myotubes, day02, control donor1	13471-144I6	85.66	10.21	20.96	6.20	1.46
Myoblast differentiation to myotubes, day02, control donor2	13480-145A6	40.84	10.08	6.90	2.65	1.06
Myoblast differentiation to myotubes, day02, control donor3	13489-145B6	41.42	6.00	9.00	1.80	0.00
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor1	13499-145C7	55.79	9.19	13.46	7.22	0.66
Myoblast differentiation to myotubes, day03, Duchenne Muscular Dystrophy donor2	13508-145D7	32.69	7.81	6.99	2.60	0.49
Myoblast differentiation to myotubes, day03, control donor1	13472-144I7	96.13	10.76	19.75	5.47	0.00
Myoblast differentiation to myotubes, day03, control donor2	13481-145A7	49.23	9.85	15.47	6.33	0.70
Myoblast differentiation to myotubes, day03, control donor3	13490-145B7	40.91	5.98	10.11	2.30	0.92
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor1	13500-145C8	50.45	10.28	9.64	3.53	0.64
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor2	13509-145D8	56.22	11.04	13.11	6.90	1.38
Myoblast differentiation to myotubes, day04, Duchenne Muscular Dystrophy donor3	13518-145E8	75.85	17.70	12.64	2.53	0.00
Myoblast differentiation to myotubes, day04, control donor1	13473-144I8	83.99	12.03	18.49	4.68	0.67
Myoblast differentiation to myotubes, day04, control donor2	13482-145A8	42.34	8.89	7.20	2.54	0.00
Myoblast differentiation to myotubes, day04, control donor3	13491-145B8	37.98	4.27	7.60	3.80	0.24
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor1	13501-145C9	62.67	9.44	9.44	4.29	0.43
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor2	13510-145D9	162.50	0.00	9.03	27.08	0.00
Myoblast differentiation to myotubes, day06, Duchenne Muscular Dystrophy donor3	13519-145E9	44.98	6.00	7.66	5.33	0.33
Myoblast differentiation to myotubes, day06, control donor1	13474-144I9	63.57	5.41	13.08	6.76	0.00
Myoblast differentiation to myotubes, day06, control donor2	13483-145A9	40.47	5.56	7.54	3.57	0.40
Myoblast differentiation to myotubes, day06, control donor3	13492-145B9	52.93	7.43	7.43	0.93	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor1	13502-145D1	52.97	7.57	8.70	3.78	1.14
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor2	13511-145E1	39.43	5.21	6.52	4.24	0.00
Myoblast differentiation to myotubes, day08, Duchenne Muscular Dystrophy donor3	13520-145F1	30.07	7.84	7.84	1.74	0.87
Myoblast differentiation to myotubes, day08, control donor1	13475-145A1	81.86	11.31	9.50	4.98	0.90
Myoblast differentiation to myotubes, day08, control donor2	13484-145B1	35.28	7.06	7.94	3.53	0.00
Myoblast differentiation to myotubes, day08, control donor3	13493-145C1	55.18	7.98	7.31	2.66	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor1	13503-145D2	60.52	5.46	8.43	0.99	0.50
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor2	13512-145E2	28.33	3.83	5.74	3.45	0.00
Myoblast differentiation to myotubes, day10, Duchenne Muscular Dystrophy donor3	13521-145F2	78.64	16.03	7.86	3.02	0.30
Myoblast differentiation to myotubes, day10, control donor1	13476-145A2	73.60	11.27	15.03	5.75	0.22
Myoblast differentiation to myotubes, day10, control donor2	13485-145B2	42.01	9.49	9.49	2.03	0.68
Myoblast differentiation to myotubes, day10, control donor3	13494-145C2	117.52	15.33	0.00	10.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor1	13504-145D3	58.53	4.27	9.75	1.22	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor2	13513-145E3	32.10	4.72	5.67	2.83	0.00
Myoblast differentiation to myotubes, day12, Duchenne Muscular Dystrophy donor3	13522-145F3	42.98	7.26	7.57	1.51	0.30
Myoblast differentiation to myotubes, day12, control donor1	13477-145A3	49.84	7.91	6.33	0.79	0.00
Myoblast differentiation to myotubes, day12, control donor2	13486-145B3	43.08	10.20	5.67	9.07	2.27
Myoblast differentiation to myotubes, day12, control donor3	13495-145C3	126.45	10.12	15.17	15.17	5.06
Myoblast, donor1	11241-116D8	100.25	23.35	16.40	13.29	0.37
Myoblast, donor2	11322-117D8	89.76	23.40	14.38	7.10	1.92
Myoblast, donor3	11398-118D3	132.68	29.43	17.32	14.46	0.50
NK T cell leukemia cell line:KHYG-1	10777-110G3	187.96	24.22	31.96	29.48	1.02
Natural Killer Cells, donor1	11230-116C6	265.69	17.22	40.28	10.46	0.00
Natural Killer Cells, donor2	11311-117C6	193.90	12.97	28.65	13.87	3.32
Natural Killer Cells, donor3	11387-118C1	189.39	14.36	36.07	13.80	1.29
Neural stem cells, donor1	11275-116H6	184.74	27.22	21.78	9.07	2.18
Neural stem cells, donor2	11352-117H2	167.53	38.51	13.48	5.78	3.85
Neurons, donor1	11494-119E9	193.44	22.76	35.27	4.55	1.14
Neurons, donor2	11574-120E8	136.50	14.09	10.13	1.98	0.88
Neurons, donor3	11655-122E8	163.61	18.91	18.91	10.69	0.00
Neutrophils, donor1	11233-116C9	390.69	132.70	38.98	28.77	2.78
Neutrophils, donor2	11314-117C9	298.58	98.56	28.99	17.39	8.70
Neutrophils, donor3	11390-118C4	575.41	161.26	53.75	50.09	3.67
Nucleus Pulposus Cell, donor1	11252-116F1	128.35	26.83	22.32	4.39	0.36
Nucleus Pulposus Cell, donor2	11409-118E5	61.21	20.51	14.98	0.65	0.65
Nucleus Pulposus Cell, donor3	11462-119B4	99.88	29.68	13.04	3.61	0.40
Olfactory epithelial cells, donor1	11933-125I7	73.37	9.64	11.70	3.58	0.69
Olfactory epithelial cells, donor2	11934-125I8	80.04	14.33	9.41	4.49	0.87
Olfactory epithelial cells, donor3	11935-125I9	64.47	11.69	7.38	2.95	0.45
Olfactory epithelial cells, donor4	11936-126A1	86.68	14.51	8.67	3.21	0.49
Oligodendrocyte - precursors, donor1	11496-119F2	126.98	25.28	18.66	9.63	0.60
Osteoblast - differentiated, donor1	11276-116H7	58.28	10.63	9.57	3.62	0.00
Osteoblast - differentiated, donor2	11353-117H3	34.29	18.29	10.29	3.43	2.29
Osteoblast - differentiated, donor3	11425-118G3	75.11	22.35	14.90	1.24	0.62
Osteoblast, donor1	11277-116H8	37.33	8.79	5.86	1.37	0.00
Osteoblast, donor2	11354-117H4	136.95	27.39	18.26	7.02	0.70
Osteoblast, donor3	11426-118G4	75.54	18.31	11.91	4.80	0.36
Pancreatic stromal cells, donor1	11249-116E7	124.25	23.67	17.44	10.02	1.01
Pericytes, donor1	11491-119E6	17.80	4.23	2.34	0.33	0.11
Pericytes, donor2	11571-120E5	19.24	3.17	3.85	0.45	0.23
Pericytes, donor3	11652-122E5	28.48	7.32	3.66	1.63	0.20
Perineurial Cells, donor1	11499-119F5	111.78	28.82	13.11	4.86	0.11
Perineurial Cells, donor2	11579-120F4	103.97	19.32	14.91	4.88	0.28
Peripheral Blood Mononuclear Cells, donor1	11231-116C7	340.10	25.50	37.29	16.57	0.32
Peripheral Blood Mononuclear Cells, donor2	11312-117C7	190.01	17.87	26.93	9.79	3.43
Peripheral Blood Mononuclear Cells, donor3	11388-118C2	191.54	16.69	28.08	8.28	1.16
Placental Epithelial Cells, donor1	11278-116H9	159.76	17.46	26.07	30.37	0.48
Placental Epithelial Cells, donor2	11355-117H5	102.02	6.65	13.31	9.98	1.11
Placental Epithelial Cells, donor3	11427-118G5	96.59	11.39	27.68	14.33	0.59
Preadipocyte - breast donor2 (cytoplasmic fraction)	14319-155D8	66.45	11.39	6.01	3.48	1.90
Preadipocyte - breast, donor1	11467-119B9	85.54	13.32	13.51	7.69	1.13
Preadipocyte - breast, donor2 (nuclear fraction)	14320-155D9	65.52	9.14	6.92	3.65	0.52
Preadipocyte - breast, donor2	11328-117E5	76.33	17.11	7.88	2.93	2.25
Preadipocyte - omental, donor1	11468-119C1	95.48	12.47	15.34	9.80	1.39
Preadipocyte - omental, donor2	11329-117E6	89.48	14.84	14.40	5.67	0.00
Preadipocyte - omental, donor3	11403-118D8	85.09	13.75	10.74	6.30	0.57
Preadipocyte - perirenal, donor1	11469-119C2	57.09	7.87	8.86	2.95	0.00
Preadipocyte - subcutaneous, donor1	11279-116I1	37.16	9.83	3.99	1.84	0.00
Preadipocyte - subcutaneous, donor2	11356-117H6	140.25	34.53	16.11	10.27	2.66
Preadipocyte - subcutaneous, donor3	11428-118G6	127.54	29.29	15.84	5.96	1.02
Preadipocyte - visceral, donor1	11280-116I2	156.21	36.42	17.60	10.90	0.28
Preadipocyte - visceral, donor2	11357-117H7	70.41	29.91	9.20	5.98	1.38
Preadipocyte - visceral, donor3	11429-118G7	109.82	32.18	10.34	6.27	1.46
Prostate Epithelial Cells (polarized), donor1	11253-116F2	185.25	44.05	25.95	51.29	1.51
Prostate Epithelial Cells, donor2	11331-117E8	48.88	19.36	9.48	7.85	1.90
Prostate Epithelial Cells, donor3	11404-118D9	71.46	20.15	13.23	7.78	1.04
Prostate Stromal Cells, donor1	11254-116F3	115.15	22.89	25.63	19.36	0.91
Prostate Stromal Cells, donor2	11332-117E9	94.85	25.28	15.78	8.43	1.43
Prostate Stromal Cells, donor3	11405-118E1	73.93	18.35	26.59	11.26	0.83
Renal Cortical Epithelial Cells, donor1	11516-119H4	21.53	10.22	2.55	0.00	0.00
Renal Cortical Epithelial Cells, donor2	11596-120H3	88.51	41.31	9.15	2.91	0.49
Renal Epithelial Cells, donor1	11517-119H5	18.77	4.57	2.03	1.52	0.00
Renal Epithelial Cells, donor2	11597-120H4	22.05	8.54	0.00	1.42	0.00
Renal Epithelial Cells, donor3	11678-122H4	135.08	31.44	16.09	6.46	0.53
Renal Glomerular Endothelial Cells, donor1	11514-119H2	14.98	3.40	0.68	0.68	0.00
Renal Glomerular Endothelial Cells, donor2	11594-120H1	42.86	10.24	4.18	2.70	0.13
Renal Glomerular Endothelial Cells, donor3	11675-122H1	102.57	22.65	12.65	3.77	1.33
Renal Glomerular Endothelial Cells, donor4	11783-124B1	15.31	2.66	2.00	1.33	0.67
Renal Mesangial Cells, donor1	11518-119H6	17.61	6.82	1.76	1.10	0.00
Renal Mesangial Cells, donor2	11598-120H5	23.83	4.39	2.51	1.25	0.00
Renal Mesangial Cells, donor3	11679-122H5	13.59	3.33	0.55	0.55	0.00
Renal Proximal Tubular Epithelial Cell, donor1	11515-119H3	39.73	36.24	0.54	1.34	0.00
Renal Proximal Tubular Epithelial Cell, donor2	11595-120H2	23.61	13.92	0.84	1.27	0.00
Renal Proximal Tubular Epithelial Cell, donor3	11676-122H2	19.09	11.38	2.89	1.93	0.00
Retinal Pigment Epithelial Cells, donor0	11215-116A9	118.49	48.49	7.52	1.81	0.26
Retinal Pigment Epithelial Cells, donor1	11528-119I7	41.22	15.92	2.56	1.71	0.00
Retinal Pigment Epithelial Cells, donor2	11608-120I6	24.70	7.20	1.03	1.03	0.00
Retinal Pigment Epithelial Cells, donor3	11689-122I6	116.17	25.59	24.59	6.02	0.50
SABiosciences XpressRef Human Universal Total RNA, pool1	10002-101A5	223.04	33.01	35.81	16.04	0.40
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep1 (B1 T17)	12697-135D6	137.58	47.35	21.44	2.68	0.89
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep2 (B2 T17)	12795-136F5	177.22	62.19	23.12	7.71	0.00
Saos-2 osteosarcoma cell line, untreated control, day28, biol_rep3 (B3 T17)	12893-137H4	154.29	44.08	19.72	3.48	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep1 (A1 T0)	12662-134I7	181.26	41.09	17.42	10.66	0.26
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep2 (A2 T0)	12760-136B6	148.36	30.49	11.62	8.14	0.99
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr00min, biol_rep3 (A3 T0)	12858-137D5	233.34	47.29	22.98	15.84	1.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep1 (A1 T1)	12663-134I8	207.52	46.39	21.21	11.91	1.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep2 (A2 T1)	12761-136B7	156.17	37.41	13.40	8.51	1.86
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr15min, biol_rep3 (A3 T1)	12859-137D6	203.40	53.39	19.88	11.09	0.92
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep1 (A1 T2)	12664-134I9	133.08	37.51	15.20	6.30	0.14
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep2 (A2 T2)	12762-136B8	141.44	31.77	14.22	7.26	1.82
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr30min, biol_rep3 (A3 T2)	12860-137D7	214.13	48.20	20.43	11.29	0.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep1 (A1 T3)	12665-135A1	152.21	40.60	12.62	6.60	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep2 (A2 T3)	12763-136B9	148.74	34.88	14.27	5.90	1.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 00hr45min, biol_rep3 (A3 T3)	12861-137D8	184.10	46.69	20.14	11.51	1.11
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep1 (A1 T4)	12666-135A2	129.43	34.22	16.06	5.54	0.57
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep2 (A2 T4)	12764-136C1	141.89	32.23	14.25	6.99	0.93
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr00min, biol_rep3 (A3 T4)	12862-137D9	217.97	44.35	24.05	12.21	0.75
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep1 (A1 T5)	12667-135A3	126.87	31.98	13.14	6.24	0.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep2 (A2 T5)	12765-136C2	170.44	33.58	15.57	7.69	1.27
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr20min, biol_rep3 (A3 T5)	12863-137E1	196.31	44.88	18.90	11.84	0.76
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep1 (A1 T6)	12668-135A4	147.70	30.86	12.28	7.58	0.32
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep2 (A2 T6)	12766-136C3	130.90	37.00	12.89	12.05	0.56
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 01hr40min, biol_rep3 (A3 T6)	12864-137E2	185.08	40.84	15.21	8.37	1.20
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep1 (A1 T7)	12669-135A5	138.21	32.45	12.95	5.83	0.18
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep2 (A2 T7)	12767-136C4	150.84	33.11	15.21	6.50	1.72
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr00min, biol_rep3 (A3 T7)	12865-137E3	209.41	53.19	17.06	11.15	0.94
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep1 (A1 T8)	12670-135A6	175.49	41.28	15.80	7.78	0.71
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep2 (A2 T8)	12768-136C5	171.03	29.56	17.46	7.94	1.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 02hr30min, biol_rep3 (A3 T8)	12866-137E4	205.78	52.62	21.75	13.56	0.47
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep1 (A1 T9)	12671-135A7	156.14	34.21	17.42	7.26	0.62
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep2 (A2 T9)	12769-136C6	186.48	41.81	19.91	10.18	3.10
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 03hr, biol_rep3 (A3 T9)	12867-137E5	181.52	41.15	15.04	10.03	0.63
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep1 (A1 T10)	12672-135A8	157.33	39.43	15.88	6.46	0.13
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep2 (A2 T10)	12770-136C7	153.95	29.63	13.96	8.51	0.34
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 04hr, biol_rep3 (A3 T10)	12868-137E6	180.26	42.41	20.24	9.25	0.19
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep1 (A1 T11)	12673-135A9	153.71	41.27	14.79	6.02	1.03
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep2 (A2 T11)	12771-136C8	134.56	28.12	13.58	7.54	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 08hr, biol_rep3 (A3 T11)	12869-137E7	162.20	43.50	17.24	12.15	1.48
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep1 (A1 T12)	12674-135B1	127.31	32.38	12.78	5.62	1.53
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep2 (A2 T12)	12772-136C9	190.13	40.98	18.64	11.84	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, 24hr, biol_rep3 (A3 T12)	12870-137E8	139.41	40.78	16.79	5.33	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep1 (A1 T13)	12675-135B2	126.79	39.41	19.08	7.60	0.41
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep2 (A2 T13)	12773-136D1	183.81	51.67	15.71	7.62	0.24
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day04, biol_rep3 (A3 T13)	12871-137E9	159.62	43.94	15.52	10.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep1 (A1 T14)	12676-135B3	130.81	32.87	19.49	9.04	1.04
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep2 (A2 T14)	12774-136D2	177.48	44.37	26.90	8.38	0.70
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day07, biol_rep3 (A3 T14)	12872-137F1	136.30	36.57	23.87	8.76	0.30
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep1 (A1 T15)	12677-135B4	156.65	36.72	17.62	8.69	0.98
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep2 (A2 T15)	12775-136D3	297.51	66.66	43.52	20.52	0.15
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day14, biol_rep3 (A3 T15)	12873-137F2	158.80	43.20	21.90	6.08	0.00
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep1 (A1 T16)	12678-135B5	143.77	33.15	18.39	7.53	1.51
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep2 (A2 T16)	12776-136D4	137.52	37.77	15.83	8.60	0.90
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day21, biol_rep3 (A3 T16)	12874-137F3	180.02	45.83	20.67	8.99	2.40
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep1 (A1 T17)	12679-135B6	166.37	40.15	19.13	11.81	0.59
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep2 (A2 T17)	12777-136D5	130.20	39.06	16.44	22.41	9.39
Saos-2 osteosarcoma treated with ascorbic acid and BGP to induce calcification, day28, biol_rep3 (A3 T17)	12875-137F4	119.59	36.66	18.03	9.62	4.81
Schwann Cells, donor1	11498-119F4	25.01	5.45	3.20	1.32	0.19
Schwann Cells, donor2	11578-120F3	102.07	20.41	17.01	3.40	0.00
Schwann Cells, donor3	11659-122F3	68.57	19.28	9.20	2.85	1.10
Sebocyte, donor1	11220-116B5	106.27	31.77	15.34	10.41	0.00
Sebocyte, donor2	11301-117B5	61.12	16.08	12.41	11.03	0.46
Sebocyte, donor3	11378-118B1	53.80	10.10	9.69	4.53	0.00
Sertoli Cells, donor1	11255-116F4	106.02	21.54	11.60	8.28	0.00
Sertoli Cells, donor2	11333-117F1	84.73	16.95	22.59	2.82	2.82
Skeletal Muscle Cells, donor1	11281-116I3	119.39	17.68	18.39	6.07	0.18
Skeletal Muscle Cells, donor2	11358-117H8	26.02	2.17	7.95	2.17	0.00
Skeletal Muscle Cells, donor3	11430-118G8	70.23	10.03	6.69	1.67	0.00
Skeletal Muscle Cells, donor4	11451-119A2	131.64	38.02	12.25	4.40	1.10
Skeletal Muscle Cells, donor5	11455-119A6	110.59	33.15	11.00	5.65	0.59
Skeletal Muscle Cells, donor6	11459-119B1	161.60	47.86	12.00	6.77	1.39
Skeletal Muscle Satellite Cells, donor1	11240-116D7	130.42	31.50	14.99	5.04	0.50
Skeletal Muscle Satellite Cells, donor2	11321-117D7	101.74	21.40	8.85	3.71	0.71
Skeletal Muscle Satellite Cells, donor3	11397-118D2	146.14	42.36	11.71	7.24	1.29
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor1	11282-116I4	106.07	17.27	17.02	5.48	0.34
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor2	11359-117H9	59.35	10.86	4.34	1.45	0.72
Skeletal muscle cells differentiated into Myotubes - multinucleated, donor3	11431-118G9	42.38	9.91	6.05	1.93	1.10
Skin - palm, donor1	10286-104F7	163.85	34.92	21.49	10.74	2.69
Small Airway Epithelial Cells donor2 (cytoplasmic fraction)	14334-155F5	48.00	10.81	9.66	7.06	0.58
Small Airway Epithelial Cells donor2 (nuclear fraction)	14335-155F6	67.88	22.08	9.81	0.82	1.64
Small Airway Epithelial Cells donor3 (cytoplasmic fraction)	14316-155D5	55.18	16.88	7.53	8.18	0.91
Small Airway Epithelial Cells, donor1	11256-116F5	95.64	30.86	16.40	14.87	0.28
Small Airway Epithelial Cells, donor2	11334-117F2	53.31	15.61	7.60	10.41	0.28
Small Airway Epithelial Cells, donor3 (nuclear fraction)	14317-155D6	77.81	22.62	11.00	8.03	0.00
Small Airway Epithelial Cells, donor3	11406-118E2	60.93	16.56	9.59	5.25	0.75
Smooth Muscle Cells - Aortic, donor0 (cytoplasmic fraction)	14313-155D2	62.95	26.85	12.34	5.86	0.31
Smooth Muscle Cells - Aortic, donor0 (nuclear fraction)	14314-155D3	30.68	8.00	6.45	2.22	0.22
Smooth Muscle Cells - Aortic, donor0	11210-116A4	51.14	16.46	11.17	3.53	0.00
Smooth Muscle Cells - Aortic, donor1	11283-116I5	98.78	16.57	5.08	4.64	0.22
Smooth Muscle Cells - Aortic, donor2	11360-117I1	33.87	10.63	6.69	2.76	0.00
Smooth Muscle Cells - Aortic, donor3	11432-118H1	61.03	9.27	6.95	5.41	0.00
Smooth Muscle Cells - Bladder, donor1	11519-119H7	130.10	23.02	83.06	31.02	1.00
Smooth Muscle Cells - Brachiocephalic, donor1	11284-116I6	44.31	9.32	7.19	3.59	0.13
Smooth Muscle Cells - Brachiocephalic, donor2	11361-117I2	93.54	24.16	11.53	5.10	0.22
Smooth Muscle Cells - Brachiocephalic, donor3	11433-118H2	49.29	13.96	11.27	7.30	1.66
Smooth Muscle Cells - Brain Vascular, donor1	11234-116D1	90.84	15.95	9.77	1.95	0.65
Smooth Muscle Cells - Brain Vascular, donor2	11315-117D1	91.55	23.33	10.34	5.91	0.30
Smooth Muscle Cells - Brain Vascular, donor3	11391-118C5	59.08	16.09	7.83	2.99	0.57
Smooth Muscle Cells - Bronchial, donor1	11512-119G9	19.85	8.95	1.30	0.98	0.00
Smooth Muscle Cells - Bronchial, donor2	11592-120G8	59.97	23.44	10.66	2.74	0.61
Smooth Muscle Cells - Carotid, donor1	11285-116I7	67.94	9.85	10.36	4.29	0.00
Smooth Muscle Cells - Carotid, donor2	11362-117I3	281.55	97.93	0.00	0.00	0.00
Smooth Muscle Cells - Carotid, donor3	11434-118H3	31.95	8.11	1.91	1.43	0.00
Smooth Muscle Cells - Colonic, donor1	11239-116D6	96.60	26.25	12.09	7.82	0.59
Smooth Muscle Cells - Colonic, donor2	11320-117D6	62.20	16.57	10.76	3.23	1.08
Smooth Muscle Cells - Colonic, donor3	11396-118D1	83.86	25.40	11.97	6.82	0.73
Smooth Muscle Cells - Coronary Artery, donor1	11286-116I8	35.27	8.35	4.64	4.18	0.31
Smooth Muscle Cells - Coronary Artery, donor2	11363-117I4	32.34	9.70	5.39	3.23	0.00
Smooth Muscle Cells - Coronary Artery, donor3	11435-118H4	43.93	14.05	5.08	4.48	0.90
Smooth Muscle Cells - Esophageal, donor1	11508-119G5	21.85	4.44	3.41	1.37	0.34
Smooth Muscle Cells - Esophageal, donor2	11588-120G4	105.54	19.40	26.23	9.74	0.31
Smooth Muscle Cells - Internal Thoracic Artery, donor1	11287-116I9	85.85	18.42	19.22	11.47	0.81
Smooth Muscle Cells - Internal Thoracic Artery, donor2	11364-117I5	116.96	20.02	13.88	10.92	0.91
Smooth Muscle Cells - Internal Thoracic Artery, donor3	11436-118H5	28.98	7.25	3.62	1.21	0.00
Smooth Muscle Cells - Intestinal, donor1	11509-119G6	162.40	45.30	18.81	13.25	1.06
Smooth Muscle Cells - Prostate, donor1	11257-116F6	99.34	22.90	17.44	8.92	0.40
Smooth Muscle Cells - Prostate, donor2	11335-117F3	82.27	19.28	24.54	12.90	0.75
Smooth Muscle Cells - Prostate, donor3	11465-119B7	89.54	19.28	26.13	7.86	0.51
Smooth Muscle Cells - Pulmonary Artery, donor1	11288-117A1	85.79	20.05	14.17	9.35	0.15
Smooth Muscle Cells - Pulmonary Artery, donor2	11365-117I6	51.01	9.00	6.00	2.25	0.00
Smooth Muscle Cells - Pulmonary Artery, donor3	11437-118H6	364.40	52.98	1.29	2.58	0.00
Smooth Muscle Cells - Subclavian Artery, donor1	11289-117A2	55.34	10.70	13.95	7.91	0.00
Smooth Muscle Cells - Subclavian Artery, donor2	11366-117I7	61.60	14.64	7.07	4.54	0.00
Smooth Muscle Cells - Subclavian Artery, donor3	11438-118H7	49.20	14.10	6.89	6.89	1.88
Smooth Muscle Cells - Tracheal, donor1	11513-119H1	18.29	10.32	2.36	2.65	0.00
Smooth Muscle Cells - Tracheal, donor2	11593-120G9	152.62	45.74	17.83	9.00	0.17
Smooth Muscle Cells - Tracheal, donor3	11674-122G9	59.80	14.48	13.08	2.80	0.47
Smooth Muscle Cells - Umbilical Artery, donor1	11290-117A3	47.49	8.92	7.48	4.75	0.00
Smooth Muscle Cells - Umbilical Artery, donor2	11367-117I8	60.93	17.34	8.16	5.35	0.51
Smooth Muscle Cells - Umbilical Artery, donor3	11439-118H8	45.32	11.66	6.77	3.38	0.00
Smooth Muscle Cells - Umbilical Vein, donor1	11541-120B2	120.74	33.12	11.74	5.03	0.14
Smooth Muscle Cells - Umbilical Vein, donor2	11621-122B1	106.33	28.15	10.89	4.52	0.25
Smooth Muscle Cells - Umbilical Vein, donor3	11702-123B1	19.52	3.81	3.81	0.95	0.48
Smooth Muscle Cells - Umbilical artery, donor0	11212-116A6	43.79	11.74	4.89	3.91	0.00
Smooth Muscle Cells - Uterine, donor1	11258-116F7	100.53	18.78	12.15	7.51	0.00
Smooth Muscle Cells - Uterine, donor3	11466-119B8	78.41	20.48	9.07	5.27	1.76
Smooth muscle cells - airway, asthmatic, donor1	11960-126C7	65.89	11.08	20.99	3.89	0.58
Smooth muscle cells - airway, asthmatic, donor2	11961-126C8	41.78	13.49	6.61	1.59	1.06
Smooth muscle cells - airway, asthmatic, donor3	11962-126C9	82.94	18.97	26.78	7.81	2.23
Smooth muscle cells - airway, asthmatic, donor4	11963-126D1	70.43	26.95	14.73	3.23	1.44
Smooth muscle cells - airway, asthmatic, donor5	11964-126D2	58.48	29.53	7.38	5.39	0.57
Smooth muscle cells - airway, asthmatic, donor6	11965-126D3	102.41	31.12	11.03	4.33	0.39
Smooth muscle cells - airway, control, donor1	11966-126D4	70.60	17.27	16.25	6.09	1.02
Smooth muscle cells - airway, control, donor2	11967-126D5	75.47	23.16	16.37	2.40	0.80
Smooth muscle cells - airway, control, donor3	11968-126D6	68.97	12.54	12.96	5.43	0.84
Smooth muscle cells - airway, control, donor4	11969-126D7	82.05	13.29	27.96	4.13	0.46
Synoviocyte, donor1	11291-117A4	106.72	10.77	18.52	6.73	0.67
Synoviocyte, donor2	11368-117I9	130.58	20.28	28.66	6.03	1.68
Synoviocyte, donor3	11440-118H9	105.45	16.31	13.85	3.80	0.67
Trabecular Meshwork Cells, donor1	11532-120A2	45.38	10.01	9.65	1.79	0.00
Trabecular Meshwork Cells, donor2	11612-122A1	37.66	17.84	5.95	0.00	0.00
Trabecular Meshwork Cells, donor3	11693-123A1	26.40	7.18	3.70	0.69	0.23
Tracheal Epithelial Cells, donor1	11292-117A5	66.16	17.56	9.89	6.16	0.22
Tracheal Epithelial Cells, donor2	11369-118A1	34.02	8.12	9.66	5.03	0.00
Tracheal Epithelial Cells, donor3	11441-118I1	44.67	12.03	5.15	5.15	0.00
Universal RNA - Human Normal Tissues Biochain, pool1	10007-101B4	228.95	32.48	35.55	19.68	0.62
Urethra, donor2	10319-105A4	95.32	17.98	8.99	8.99	1.80
Urothelial Cells, donor1	11520-119H8	27.10	9.03	2.92	1.59	0.00
Urothelial Cells, donor2	11600-120H7	22.03	5.61	1.60	2.00	0.00
Urothelial Cells, donor3	11681-122H7	18.34	4.81	1.60	0.92	0.23
Urothelial cells, donor0	11216-116B1	131.51	30.98	10.70	8.02	0.45
Whole blood (ribopure), donor090309, donation1	12179-129A1	496.50	97.88	36.48	15.13	3.56
Whole blood (ribopure), donor090309, donation2	12180-129A2	541.82	124.38	35.74	10.01	0.00
Whole blood (ribopure), donor090309, donation3	12181-129A3	245.74	58.87	8.21	10.27	2.05
Whole blood (ribopure), donor090325, donation1	12176-128I7	349.85	50.96	23.07	12.40	1.03
Whole blood (ribopure), donor090325, donation2	12177-128I8	378.25	59.85	21.50	11.62	0.00
Whole blood (ribopure), donor090612, donation1	12182-129A4	484.18	85.38	20.82	17.70	1.04
Whole blood (ribopure), donor090612, donation2	12183-129A5	432.28	97.29	25.70	14.68	0.92
Whole blood (ribopure), donor090612, donation3	12184-129A6	231.88	44.73	15.52	11.87	0.91
Wilms' tumor cell line:G-401	10809-111A8	144.09	41.45	11.97	10.24	1.23
Wilms' tumor cell line:HFWT	10597-108E3	64.24	14.08	8.80	1.76	0.88
acantholytic squamous carcinoma cell line:HCC1806	10717-109I6	92.45	85.75	7.82	3.35	1.68
achilles tendon, donor2	10292-104G4	165.32	59.93	22.73	14.47	6.20
acute lymphoblastic leukemia (B-ALL) cell line:BALL-1	10455-106G5	249.35	45.64	33.14	30.85	1.53
acute lymphoblastic leukemia (B-ALL) cell line:NALM-6	10534-107G3	361.96	56.42	27.63	17.65	0.93
acute lymphoblastic leukemia (T-ALL) cell line:HPB-ALL	10429-106D6	358.85	68.61	45.23	29.56	0.71
acute lymphoblastic leukemia (T-ALL) cell line:Jurkat	10464-106H5	255.51	46.26	20.68	18.23	0.54
acute myeloid leukemia (FAB M0) cell line:KG-1	10827-111C8	309.19	52.00	23.05	13.77	4.50
acute myeloid leukemia (FAB M0) cell line:Kasumi-3	10789-110H6	301.78	50.54	21.36	8.67	1.48
acute myeloid leukemia (FAB M1) cell line:HYT-1	10828-111C9	176.12	64.24	13.88	7.89	1.91
acute myeloid leukemia (FAB M2) cell line:Kasumi-1	10788-110H5	237.50	40.98	25.56	15.42	2.64
acute myeloid leukemia (FAB M2) cell line:Kasumi-6	10792-110H9	263.39	40.84	17.56	9.39	7.35
acute myeloid leukemia (FAB M2) cell line:NKM-1	10765-110E9	218.22	34.17	19.41	9.71	0.78
acute myeloid leukemia (FAB M3) cell line:HL60	10829-111D1	209.39	65.87	18.03	13.06	2.58
acute myeloid leukemia (FAB M4) cell line:FKH-1	10830-111D2	241.83	27.30	42.91	19.50	3.90
acute myeloid leukemia (FAB M4) cell line:HNT-34	10831-111D3	217.74	60.88	19.29	12.55	1.16
acute myeloid leukemia (FAB M4eo) cell line:EoL-1	10832-111D4	267.70	35.99	44.53	20.97	2.33
acute myeloid leukemia (FAB M4eo) cell line:EoL-3	10833-111D5	260.68	41.50	37.11	23.67	4.09
acute myeloid leukemia (FAB M5) cell line:NOMO-1	10764-110E8	152.91	26.49	19.06	6.04	0.00
acute myeloid leukemia (FAB M5) cell line:P31/FUJ	10770-110F5	169.02	30.84	9.05	4.11	1.65
acute myeloid leukemia (FAB M5) cell line:THP-1 (cytoplasmic fraction)	14298-155B5	64.77	18.11	5.22	1.23	0.31
acute myeloid leukemia (FAB M5) cell line:THP-1 (fresh)	10399-106A3	148.92	27.74	5.97	7.25	1.28
acute myeloid leukemia (FAB M5) cell line:THP-1 (revived)	10400-106A4	160.44	31.54	10.31	6.98	0.00
acute myeloid leukemia (FAB M5) cell line:THP-1 (thawed)	10405-106A9	181.73	34.42	6.02	5.78	0.72
acute myeloid leukemia (FAB M5) cell line:U-937 DE-4	10834-111D6	164.60	40.98	11.81	5.12	3.12
acute myeloid leukemia (FAB M6) cell line:EEB	10835-111D7	159.44	31.69	16.68	7.67	0.33
acute myeloid leukemia (FAB M6) cell line:F-36E	10836-111D8	273.16	46.46	31.59	14.87	0.00
acute myeloid leukemia (FAB M6) cell line:F-36P	10837-111D9	257.64	61.77	21.09	6.03	3.77
acute myeloid leukemia (FAB M7) cell line:M-MOK	10699-109G6	213.70	26.60	23.99	10.03	0.44
acute myeloid leukemia (FAB M7) cell line:MKPL-1	10802-111A1	86.23	15.00	13.12	5.62	0.00
adenocarcinoma cell line:IM95m	10796-110I4	193.11	35.09	7.54	3.06	1.41
adipose tissue, adult, pool1	10010-101C1	213.44	24.66	14.58	8.38	0.78
adipose, donor1	10184-103D4	203.48	88.55	24.04	14.07	3.52
adipose, donor2	10185-103D5	83.54	38.52	7.70	1.22	0.41
adipose, donor3	10186-103D6	133.97	43.84	7.08	4.08	3.00
adipose, donor4	10187-103D7	337.17	130.01	9.53	9.53	5.20
adrenal cortex adenocarcinoma cell line:SW-13	10810-111A9	50.66	36.61	2.84	1.74	0.63
adrenal gland, adult, pool1	10081-102A9	101.85	21.83	21.83	10.91	0.00
adult T-cell leukemia cell line:ATN-1	10421-106C7	255.21	44.56	13.61	7.74	0.13
alveolar cell carcinoma cell line:SW 1573	10708-109H6	194.73	28.23	15.01	5.00	1.43
amniotic membrane cells, donor1	12235-129G3	283.32	42.20	17.85	13.68	1.39
amniotic membrane cells, donor2	12236-129G4	287.05	45.98	20.29	7.10	1.69
amniotic membrane cells, donor3	12237-129G5	337.02	65.40	18.27	16.20	1.47
amygdala - adult, donor10196	10167-103B5	128.07	42.69	9.49	0.00	2.37
amygdala, adult, donor10252	10151-102I7	148.63	21.90	11.56	2.43	0.41
amygdala, newborn, donor10223	10360-105E9	94.57	13.56	12.59	12.59	0.65
anaplastic carcinoma cell line:8305C	10428-106D5	210.60	27.38	26.99	11.08	0.51
anaplastic large cell lymphoma cell line:Ki-JK	10795-110I3	198.56	34.20	23.61	17.87	1.76
anaplastic squamous cell carcinoma cell line:RPMI 2650	10805-111A4	234.83	29.73	20.04	13.03	1.00
aorta, adult, pool1	10052-101G7	191.62	28.24	14.12	3.92	1.57
appendix, adult	10189-103D9	183.19	26.39	14.75	6.21	2.72
argyrophil small cell carcinoma cell line:TC-YIK	10589-108D4	185.38	31.30	61.56	18.92	1.38
artery, adult	10190-103E1	414.40	73.37	57.06	163.04	1.36
astrocytoma cell line:TM-31	10425-106D2	250.77	29.99	19.99	8.98	0.29
b cell line:RPMI1788	10427-106D4	433.46	93.53	46.10	19.78	0.74
basal cell carcinoma cell line:TE 354.T	10702-109G9	92.67	18.03	8.60	7.49	0.55
bile duct carcinoma cell line:HuCCT1	10432-106D9	146.37	42.77	16.08	13.89	0.69
bile duct carcinoma cell line:TFK-1	10496-107C1	295.42	84.36	30.13	38.83	1.34
biphenotypic B myelomonocytic leukemia cell line:MV-4-11	10718-109I7	128.07	16.22	29.64	8.39	1.68
bladder, adult, pool1	10011-101C2	286.27	37.05	33.14	14.23	1.09
blood, adult, pool1	10053-101G8	221.46	19.93	37.65	11.07	4.43
bone marrow stromal cell line:StromaNKtert	10686-109F2	71.93	11.99	8.56	3.43	1.71
bone marrow, adult	10192-103E3	196.37	45.89	14.17	6.75	2.02
brain, adult, donor1	10084-102B3	85.08	35.88	11.28	1.03	0.00
brain, adult, pool1	10012-101C3	179.51	31.18	13.47	5.01	0.45
brain, fetal, pool1	10085-102B4	104.18	10.69	16.03	2.67	0.00
breast carcinoma cell line:MCF7	10482-107A5	139.41	49.22	14.54	8.59	2.97
breast carcinoma cell line:MDA-MB-453	10419-106C5	161.90	38.57	5.99	5.37	0.12
breast, adult, donor1	10080-102A8	144.58	13.89	12.63	3.79	1.26
bronchial squamous cell carcinoma cell line:KNS-62	10760-110E4	154.73	82.96	17.40	9.65	2.16
bronchioalveolar carcinoma cell line:NCI-H358	10709-109H7	113.79	58.44	4.95	7.11	1.24
bronchioalveolar carcinoma cell line:NCI-H650	10715-109I4	77.81	109.12	3.22	2.99	1.84
bronchogenic carcinoma cell line:ChaGo-K-1	10710-109H8	104.10	52.29	10.65	12.10	1.45
carcinoid cell line:NCI-H1770	10703-109H1	61.12	81.34	0.47	0.47	0.47
carcinoid cell line:NCI-H727	10735-110B6	99.21	31.39	13.67	8.75	0.33
carcinoid cell line:SK-PN-DW	10719-109I8	238.31	50.39	33.27	13.63	1.90
carcinosarcoma cell line:JHUCS-1	10642-109A3	246.75	40.73	39.93	15.97	1.60
caudate nucleus - adult, donor10196	10177-103C6	154.28	44.90	8.06	4.61	2.30
caudate nucleus, adult, donor10252	10164-103B2	156.28	28.78	11.38	2.18	1.17
caudate nucleus, adult, donor10258	10379-105H1	158.94	38.97	5.35	5.35	0.00
caudate nucleus, newborn, donor10223	10354-105E3	118.66	20.88	9.89	15.38	0.37
cerebellum - adult, donor10196	10173-103C2	355.42	55.35	20.39	2.91	0.00
cerebellum, adult, donor10252	10166-103B4	256.21	24.13	26.05	7.47	1.92
cerebellum, adult, pool1	10083-102B2	169.37	17.94	20.01	7.24	1.03
cerebellum, newborn, donor10223	10357-105E6	179.34	17.44	36.53	24.91	1.66
cerebral meninges, adult	10188-103D8	172.72	38.07	16.64	7.31	3.28
cerebrospinal fluid, donor2	10294-104G6	116.21	21.93	19.73	35.81	2.19
cervical cancer cell line:D98-AH2	10552-107I3	307.55	91.01	52.91	14.95	0.43
cervical cancer cell line:ME-180	10553-107I4	218.75	48.39	30.82	29.66	0.50
cervix, adult, pool1	10013-101C4	295.23	32.23	36.96	9.55	0.73
cholangiocellular carcinoma cell line:HuH-28	10536-107G5	186.30	20.62	38.04	38.04	0.98
chondrosarcoma cell line:SW 1353	10700-109G7	39.19	3.92	11.76	1.31	1.31
choriocarcinoma cell line:BeWo	10423-106C9	208.78	44.62	21.38	12.55	0.37
choriocarcinoma cell line:SCH	10785-110H2	196.40	53.84	11.58	9.73	1.48
choriocarcinoma cell line:T3M-3	10618-108G6	87.52	32.49	5.22	5.22	0.24
chorionic membrane cells, donor1	12238-129G6	215.40	34.48	17.67	8.83	0.28
chorionic membrane cells, donor2	12239-129G7	118.02	22.47	12.13	8.75	0.89
chorionic membrane cells, donor3	12240-129G8	212.10	37.36	11.54	6.59	0.55
chronic lymphocytic leukemia (T-CLL) cell line:SKW-3	10416-106C2	238.31	32.31	42.41	54.53	5.05
chronic myeloblastic leukemia (CML) cell line:KCL-22	10801-110I9	176.35	28.05	27.47	14.02	1.15
chronic myelogenous leukemia (CML) cell line:MEG-A2	10766-110F1	154.59	19.64	22.39	6.76	0.63
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep1	10824-111C5	127.63	50.08	11.56	7.45	0.26
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep2	10825-111C6	137.39	47.65	13.55	6.05	0.48
chronic myelogenous leukemia cell line:K562 ENCODE, biol_rep3	10826-111C7	128.48	43.17	11.20	4.28	0.41
chronic myelogenous leukemia cell line:K562	10454-106G4	201.41	40.93	15.90	6.48	0.29
chronic myelogenous leukemia cell line:KU812	10409-106B4	255.93	22.67	49.78	12.25	0.26
clear cell carcinoma cell line:JHOC-5	10638-108I8	127.09	47.32	5.26	3.43	3.43
clear cell carcinoma cell line:TEN	10636-108I6	172.64	38.69	12.84	10.76	2.60
colon carcinoma cell line:CACO-2	10513-107D9	121.17	87.49	7.87	10.62	0.92
colon carcinoma cell line:COLO-320	10420-106C6	472.82	120.49	29.27	10.64	0.76
colon, adult, donor1	10082-102B1	115.43	15.47	9.52	4.76	0.00
colon, adult, pool1	10014-101C5	193.88	32.08	23.38	13.51	0.71
colon, fetal, donor1	10070-101I7	135.34	19.78	18.54	12.98	1.24
common myeloid progenitor CMP, donor1	12130-128D6	96.25	13.75	32.08	22.92	0.00
common myeloid progenitor CMP, donor2	12134-128E1	400.59	0.00	50.07	25.04	0.00
cord blood derived cell line:COBL-a 24h infection(-C)	10452-106G2	270.26	57.37	26.35	25.07	3.40
cord blood derived cell line:COBL-a 24h infection	10453-106G3	241.19	53.28	17.51	17.51	0.91
cord blood derived cell line:COBL-a untreated	10449-106F8	255.23	55.14	17.34	13.68	0.56
corpus callosum, adult, pool1	10042-101F6	206.86	34.16	10.50	3.21	0.22
cruciate ligament, donor2	10295-104G7	176.68	34.04	21.88	4.86	0.81
diaphragm, fetal, donor1	10069-101I6	176.56	27.29	32.91	65.81	1.61
diencephalon, adult	10193-103E4	134.63	33.12	7.68	2.64	0.24
diffuse large B-cell lymphoma cell line:CTB-1	10631-108I1	191.50	45.23	30.08	9.18	4.36
ductal cell carcinoma cell line:KLM-1	10438-106E6	305.16	80.27	24.36	19.23	0.26
ductal cell carcinoma cell line:MIA Paca2	10488-107B2	203.65	40.68	43.81	26.96	1.44
ductus deferens, adult	10196-103E7	174.42	26.91	18.44	8.47	1.99
duodenum, fetal, donor1, tech_rep1	10071-101I8	112.34	18.72	12.96	1.44	0.00
duodenum, fetal, donor1, tech_rep2	10071-101I8	217.02	33.10	16.18	11.03	2.21
dura mater, adult, donor1	10041-101F5	227.61	16.77	37.66	14.54	0.41
embryonic kidney cell line: HEK293/SLAM infection, 24hr	10451-106G1	114.15	21.32	31.76	80.17	0.22
embryonic kidney cell line: HEK293/SLAM untreated	10450-106F9	136.99	28.95	34.96	21.78	0.86
embryonic pancreas cell line:1B2C6	10604-108F1	110.37	31.45	8.02	5.55	0.00
embryonic pancreas cell line:1C3D3	10605-108F2	145.30	31.78	6.36	5.15	0.61
embryonic pancreas cell line:1C3IKEI	10606-108F3	131.22	23.16	11.42	6.79	0.31
embryonic pancreas cell line:2C6	10603-108E9	120.84	39.40	13.13	5.25	0.00
endometrial carcinoma cell line:OMC-2	10497-107C2	210.50	56.31	28.49	23.46	1.01
endometrial stromal sarcoma cell line:OMC-9	10448-106F7	225.82	40.42	17.40	14.50	0.91
endometrioid adenocarcinoma cell line:JHUEM-1	10643-109A4	116.91	25.41	7.08	8.84	1.93
epidermoid carcinoma cell line:A431	10426-106D3	301.57	55.13	38.35	23.68	0.67
epidermoid carcinoma cell line:Ca Ski	10431-106D8	157.39	33.00	14.85	15.40	0.33
epididymis, adult	10197-103E8	208.68	25.95	19.47	20.51	5.44
epithelioid sarcoma cell line:HS-ES-1	10443-106F2	179.18	32.11	33.89	24.48	1.06
epithelioid sarcoma cell line:HS-ES-2R	10495-107B9	98.70	23.99	13.37	5.90	0.00
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep1	10815-111B5	188.19	57.79	19.79	34.34	0.92
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep2	10816-111B6	226.66	59.54	29.43	43.11	2.76
epitheloid carcinoma cell line: HelaS3 ENCODE, biol_rep3	10817-111B7	175.33	53.66	20.73	31.48	1.34
esophagus, adult, pool1	10015-101C6	208.22	30.79	17.41	9.87	1.06
extraskeletal myxoid chondrosarcoma cell line:H-EMC-SS	10410-106B5	177.08	20.04	26.55	7.76	0.38
eye - muscle inferior rectus, donor1	10272-104E2	130.39	19.32	24.15	12.07	0.00
eye - muscle lateral, donor2	10298-104H1	202.00	35.77	25.25	31.56	0.00
eye - muscle medial, donor2	10299-104H2	98.22	22.32	17.86	23.81	0.00
eye - muscle superior, donor2	10297-104G9	136.43	17.20	16.05	11.46	1.15
eye - vitreous humor, donor1	10268-104D7	128.25	29.15	18.95	2.91	0.00
eye, fetal, donor1	10054-101G9	205.42	32.03	18.30	9.41	2.54
fibrosarcoma cell line:HT-1080	10758-110E2	185.80	42.31	22.18	13.21	0.38
fibrous histiocytoma cell line:GCT TIB-223	10711-109H9	112.54	38.22	14.48	12.58	0.71
frontal lobe, adult, pool1	10040-101F4	184.08	35.65	13.89	4.13	0.56
gall bladder carcinoma cell line:TGBC14TKB	10470-106I2	264.82	49.84	24.02	12.91	0.60
gall bladder carcinoma cell line:TGBC2TKB	10415-106C1	160.84	40.78	8.23	7.04	0.18
gall bladder, adult	10198-103E9	179.63	28.25	28.49	18.83	1.21
gamma delta positive T cells, donor1	11937-126A2	414.45	40.80	12.88	4.83	0.54
gamma delta positive T cells, donor2	11938-126A3	312.61	25.02	23.53	6.72	1.49
gastric adenocarcinoma cell line:MKN1	10614-108G2	143.42	25.56	29.57	22.81	2.32
gastric adenocarcinoma cell line:MKN45	10612-108F9	192.06	74.47	17.41	6.38	0.77
gastric cancer cell line:AZ521	10549-107H9	165.43	71.65	15.58	10.17	0.33
gastric cancer cell line:GSS	10560-108A2	211.42	89.69	6.41	0.00	0.00
gastrointestinal carcinoma cell line:ECC12	10615-108G3	219.55	30.84	75.85	31.53	1.83
giant cell carcinoma cell line:LU65	10487-107B1	269.53	58.17	41.08	23.18	1.15
giant cell carcinoma cell line:Lu99B	10433-106E1	207.98	57.24	27.43	11.62	0.14
glassy cell carcinoma cell line:HOKUG	10688-109F4	198.79	56.87	16.96	17.21	1.25
glioblastoma cell line:A172, tech_rep1	10444-106F3	171.73	28.18	16.36	15.20	0.74
glioblastoma cell line:A172, tech_rep2	10444-106F3	171.19	28.37	17.13	13.90	0.42
glioblastoma cell line:T98G	10485-107A8	114.46	18.76	20.64	8.39	0.22
glioma cell line:GI-1	10413-106B8	121.84	12.89	26.36	7.91	0.88
globus pallidus - adult, donor10196	10175-103C4	161.82	25.51	10.20	1.46	0.73
globus pallidus, adult, donor10252	10161-103A8	205.28	31.00	11.23	4.15	1.22
globus pallidus, adult, donor10258	10367-105F7	124.60	26.01	6.85	0.00	2.74
globus pallidus, newborn, donor10223	10364-105F4	119.37	22.38	12.26	13.32	0.53
granulocyte macrophage progenitor, donor1	12131-128D7	102.78	7.34	48.94	4.89	0.00
granulocyte macrophage progenitor, donor2	12135-128E2	240.42	32.79	32.79	10.93	0.00
granulocyte macrophage progenitor, donor3	12139-128E6	188.16	10.45	20.91	5.23	0.00
granulosa cell tumor cell line:KGN	10624-108H3	66.24	12.80	6.72	2.24	0.96
hIPS +CCl2, biol_rep1	14383-156B9	233.23	113.40	16.99	5.97	0.92
hIPS +CCl2, biol_rep2	14384-156C1	216.29	107.91	16.92	2.29	1.37
hIPS +CCl2, biol_rep3	14385-156C2	245.40	144.92	17.39	3.86	2.58
hIPS, biol_rep1	14380-156B6	217.03	201.22	14.37	0.00	4.31
hIPS, biol_rep2	14381-156B7	219.48	124.83	15.09	3.43	2.06
hIPS, biol_rep3	14382-156B8	145.66	46.35	12.14	5.52	0.00
hairy cell leukemia cell line:Mo	10712-109I1	159.48	40.23	14.37	7.76	1.15
heart - mitral valve, adult	10205-103F7	211.67	25.11	13.75	5.68	2.39
heart - pulmonic valve, adult	10206-103F8	251.02	37.65	29.02	21.70	0.78
heart - tricuspid valve, adult	10207-103F9	186.51	23.31	9.99	8.33	0.00
heart, adult, diseased post-infarction, donor1	10050-101G5	125.09	18.37	17.75	18.16	0.41
heart, adult, diseased, donor1	10051-101G6	183.96	16.18	33.21	37.47	2.13
heart, adult, pool1	10016-101C7	268.84	23.69	36.57	48.76	0.92
heart, fetal, pool1	10046-101G1	271.69	23.41	36.04	16.43	0.72
hepatic mesenchymal tumor cell line:LI90	10778-110G4	58.00	11.42	2.78	1.54	0.62
hepatoblastoma cell line:HuH-6	10633-108I3	173.62	28.54	65.40	59.46	1.19
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep1	10818-111B8	161.77	32.26	30.94	22.76	1.10
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep2	10819-111B9	179.75	35.32	29.01	25.37	1.82
hepatocellular carcinoma cell line: HepG2 ENCODE, biol_rep3	10820-111C1	176.54	34.26	32.34	25.36	1.52
hepatoma cell line:Li-7	10484-107A7	212.64	26.25	32.14	23.47	0.89
hereditary spherocytic anemia cell line:WIL2-NS	10808-111A7	181.60	45.63	26.73	13.47	0.70
hippocampus - adult, donor10196	10169-103B7	120.18	20.82	5.68	0.95	0.00
hippocampus, adult, donor10252	10153-102I9	172.06	19.19	11.02	5.10	0.61
hippocampus, adult, donor10258	10374-105G5	148.39	46.31	14.94	1.00	0.50
hippocampus, newborn, donor10223	10363-105F3	78.25	15.51	10.22	11.28	0.70
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep1	13421-144D1	182.49	144.04	7.32	12.82	5.49
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep2	13425-144D5	108.98	88.75	6.48	6.68	1.18
iPS differentiation to neuron, control donor C11-CRL2429, day00, rep3	13429-144D9	124.41	94.70	7.87	8.63	0.51
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep1	13422-144D2	196.22	72.17	16.35	9.59	2.26
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep2	13426-144D6	178.68	62.49	13.94	8.52	6.71
iPS differentiation to neuron, control donor C11-CRL2429, day06, rep3	13430-144E1	245.23	94.90	19.36	9.11	3.04
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep1	13423-144D3	144.81	44.38	14.31	8.76	2.34
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep2	13427-144D7	149.72	59.24	12.71	9.69	2.80
iPS differentiation to neuron, control donor C11-CRL2429, day12, rep3	13431-144E2	144.31	46.30	14.18	10.01	2.09
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep1	13424-144D4	226.85	52.57	25.34	15.63	1.42
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep2	13428-144D8	171.81	40.50	20.41	8.68	3.21
iPS differentiation to neuron, control donor C11-CRL2429, day18, rep3	13432-144E3	238.35	43.76	23.57	20.20	0.67
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep1	13433-144E4	95.77	82.15	5.48	3.91	2.35
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep2	13437-144E8	90.40	90.89	7.86	2.95	3.44
iPS differentiation to neuron, control donor C32-CRL1502, day00, rep3	13441-144F3	162.33	131.79	8.73	6.98	2.62
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep1	13434-144E5	190.72	61.86	16.61	8.97	3.05
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep2	13438-144E9	176.17	69.77	13.95	10.47	2.18
iPS differentiation to neuron, control donor C32-CRL1502, day06, rep3	13442-144F4	191.91	49.48	14.49	7.00	2.50
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep1	13435-144E6	121.89	57.84	11.87	5.65	2.26
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep2	13439-144F1	125.50	59.11	9.09	6.82	0.45
iPS differentiation to neuron, control donor C32-CRL1502, day12, rep3	13443-144F5	145.97	53.56	11.90	3.13	1.88
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep1	13436-144E7	128.85	28.58	11.59	6.70	2.78
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep2	13440-144F2	124.83	30.77	11.90	6.68	1.45
iPS differentiation to neuron, control donor C32-CRL1502, day18, rep3	13444-144F6	127.04	26.60	12.85	5.08	2.39
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep1	13445-144F7	168.67	77.78	14.78	10.53	3.33
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep2	13449-144G2	146.64	82.16	13.12	9.70	2.00
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day00, rep3	13453-144G6	231.92	120.45	21.23	12.25	1.63
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep1	13446-144F8	133.44	60.56	13.73	5.99	4.58
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep2	13450-144G3	133.03	51.31	12.99	6.33	2.22
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day06, rep3	13454-144G7	157.67	50.54	13.32	8.78	2.12
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep1	13447-144F9	123.59	43.44	8.27	6.72	2.07
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep2	13451-144G4	119.55	53.80	5.98	4.65	0.66
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day12, rep3	13455-144G8	132.37	41.05	12.57	6.67	1.28
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep1	13448-144G1	125.78	26.33	11.25	5.62	2.56
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep2	13452-144G5	150.69	36.35	19.69	7.57	0.76
iPS differentiation to neuron, down-syndrome donor C11-CCL54, day18, rep3	13456-144G9	127.37	27.22	12.10	6.39	1.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep1	13457-144H1	172.92	82.60	12.56	14.73	2.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep2	13461-144H5	201.44	88.24	15.15	15.15	2.23
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day00, rep3	13465-144H9	185.86	82.93	20.00	8.78	3.90
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep1	13458-144H2	167.78	72.74	14.67	11.00	2.75
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep2	13462-144H6	585.58	286.29	74.82	55.31	22.77
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day06, rep3	13466-144I1	240.60	93.33	18.86	6.95	3.31
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep1	13459-144H3	131.90	64.03	8.21	4.93	1.64
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep2	13463-144H7	123.76	61.88	11.58	7.60	1.09
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day12, rep3	13467-144I2	148.75	56.58	12.46	6.41	1.42
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep1	13460-144H4	159.91	28.64	10.74	11.93	3.58
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep2	13464-144H8	186.62	44.15	20.45	8.13	0.68
iPS differentiation to neuron, down-syndrome donor C18-CCL54, day18, rep3	13468-144I3	130.93	26.94	15.62	8.89	1.08
immature langerhans cells, donor1	11904-125F5	216.24	31.72	33.17	14.77	0.48
immature langerhans cells, donor2	11905-125F6	143.38	31.69	12.67	7.13	1.58
insula, adult, pool1	10039-101F3	163.53	32.46	12.78	4.64	0.38
keratoacanthoma cell line:HKA-1	10791-110H8	123.88	31.86	12.68	10.40	0.65
kidney, adult, pool1	10017-101C8	148.49	25.33	8.01	5.01	0.90
kidney, fetal, pool1	10045-101F9	152.22	20.87	15.49	4.81	0.35
large cell lung carcinoma cell line:IA-LM	10509-107D5	219.28	29.97	54.11	29.54	0.57
large cell lung carcinoma cell line:NCI-H460	10839-111E2	77.14	38.57	8.85	8.29	0.97
large cell non-keratinizing squamous carcinoma cell line:SKG-II-SF	10692-109F8	119.27	13.76	11.74	10.46	0.18
left atrium, adult, donor1	10079-102A7	136.76	12.53	14.71	9.81	1.09
left ventricle, adult, donor1	10078-102A6	178.50	19.72	25.79	32.36	1.52
leiomyoblastoma cell line:G-402	10721-110A1	125.59	15.87	14.77	4.10	0.27
leiomyoma cell line:10964C	10569-108B2	70.77	18.32	12.57	13.65	2.51
leiomyoma cell line:15242A	10570-108B3	67.39	14.67	9.24	15.76	0.54
leiomyoma cell line:15425	10571-108B4	76.73	23.55	7.77	8.01	1.70
leiomyosarcoma cell line:Hs 5.T	10722-110A2	88.89	69.84	19.05	19.05	0.00
lens epithelial cell line:SRA 01/04	10647-109A8	63.78	5.23	16.73	8.36	0.00
leukemia, chronic megakaryoblastic cell line:MEG-01	10752-110D5	214.63	26.80	55.49	18.42	1.06
liposarcoma cell line:KMLS-1	10782-110G8	47.18	8.44	5.78	4.06	0.62
liposarcoma cell line:SW 872	10726-110A6	104.17	19.98	7.80	7.43	0.00
liver, adult, pool1	10018-101C9	197.07	23.82	45.22	25.44	0.65
liver, fetal, pool1	10086-102B5	71.49	6.58	11.29	4.70	0.94
locus coeruleus - adult, donor10196	10182-103D2	114.18	16.48	7.73	4.96	0.73
locus coeruleus, adult, donor10252	10165-103B3	159.82	24.91	7.94	3.69	0.92
locus coeruleus, adult, donor10258	10375-105G6	115.68	13.26	7.62	3.10	2.26
locus coeruleus, newborn, donor10223	10362-105F2	106.00	18.51	7.99	6.31	1.26
lung adenocarcinoma cell line:A549	10499-107C4	84.84	21.73	4.98	4.29	0.28
lung adenocarcinoma cell line:PC-14	10408-106B3	81.35	12.41	6.89	8.27	0.00
lung adenocarcinoma, papillary cell line:NCI-H441	10742-110C4	159.76	43.24	15.16	11.60	1.32
lung, adult, pool1	10019-101D1	238.85	28.00	24.57	10.28	1.06
lung, fetal, donor1	10068-101I5	380.73	52.51	66.79	13.70	2.85
lung, right lower lobe, adult, donor1	10075-102A3	122.34	21.08	15.12	5.04	0.92
lymph node, adult, donor1	10077-102A5	136.80	13.25	9.94	7.10	1.42
lymphangiectasia cell line:DS-1	10727-110A7	139.62	34.85	22.14	8.99	0.22
lymphoma, malignant, hairy B-cell cell line:MLMA	10775-110G1	168.59	52.67	16.60	15.09	3.17
malignant trichilemmal cyst cell line:DJM-1	10412-106B7	308.37	39.08	40.78	20.39	0.85
mature adipocyte, donor1	12231-129F8	186.03	62.60	13.32	9.32	1.33
mature adipocyte, donor2	12232-129F9	161.25	50.01	6.64	7.26	1.04
mature adipocyte, donor3	12233-129G1	190.60	56.66	13.04	9.01	0.71
mature adipocyte, donor4	12234-129G2	243.21	59.22	21.58	10.27	1.58
maxillary sinus tumor cell line:HSQ-89	10414-106B9	235.16	50.75	19.30	11.20	0.71
medial frontal gyrus - adult, donor10196	10170-103B8	129.72	48.51	4.51	2.26	4.51
medial frontal gyrus, adult, donor10252	10150-102I6	151.72	18.94	9.20	2.94	0.92
medial frontal gyrus, adult, donor10258	10368-105F8	129.30	26.69	8.26	1.59	0.32
medial frontal gyrus, newborn, donor10223	10352-105E1	104.49	31.56	9.38	12.79	0.85
medial temporal gyrus - adult, donor10196	10183-103D3	132.81	31.39	8.27	3.54	2.36
medial temporal gyrus, adult, donor10252	10156-103A3	137.95	19.95	9.55	5.09	0.42
medial temporal gyrus, adult, donor10258, tech_rep1	10376-105G7	161.81	104.02	23.12	0.00	0.00
medial temporal gyrus, adult, donor10258, tech_rep2	10376-105G7	387.55	57.41	14.35	14.35	0.00
medial temporal gyrus, newborn, donor10223	10353-105E2	86.50	20.10	10.41	11.84	0.36
medulla oblongata - adult, donor10196	10174-103C3	146.67	22.71	12.33	2.60	2.60
medulla oblongata, adult, donor10252	10155-103A2	171.37	20.28	12.07	5.11	0.46
medulla oblongata, adult, pool1	10038-101F2	167.50	23.67	11.84	4.49	0.73
medulla oblongata, newborn, donor10223	10361-105F1	122.55	19.44	10.76	9.72	0.69
medulloblastoma cell line:D283 Med	10838-111E1	335.88	67.31	52.25	15.28	4.87
medulloblastoma cell line:ONS-76	10759-110E3	99.90	26.90	13.69	9.66	0.61
melanoma cell line:COLO 679	10514-107E1	172.35	49.16	21.56	11.07	0.57
melanoma cell line:G-361	10465-106H6	192.47	57.82	29.59	13.03	0.54
meningioma cell line:HKBMM	10691-109F7	152.14	36.90	19.54	9.95	3.62
merkel cell carcinoma cell line:MKL-1	10843-111E6	248.49	29.96	26.43	15.86	1.76
merkel cell carcinoma cell line:MS-1	10844-111E7	259.48	48.47	22.81	11.67	2.59
mesenchymal precursor cell - adipose, donor1	11747-123G1	118.14	26.85	15.04	6.75	0.46
mesenchymal precursor cell - adipose, donor2	11748-123G2	80.53	20.36	14.18	5.82	0.18
mesenchymal precursor cell - adipose, donor3	11749-123G3	89.03	31.89	9.52	5.38	0.00
mesenchymal precursor cell - bone marrow, donor1	11750-123G4	74.17	20.51	9.27	3.79	0.70
mesenchymal precursor cell - bone marrow, donor2	11751-123G5	72.02	20.03	11.36	3.47	0.19
mesenchymal precursor cell - bone marrow, donor3	11840-124H4	101.34	32.62	15.96	2.78	4.16
mesenchymal precursor cell - cardiac, donor1	11752-123G6	74.49	18.19	16.13	8.75	0.17
mesenchymal precursor cell - cardiac, donor2	11753-123G7	89.02	18.17	13.92	7.94	0.46
mesenchymal precursor cell - cardiac, donor3	11754-123G8	89.66	20.16	11.01	5.17	0.13
mesenchymal precursor cell - cardiac, donor4	11755-123G9	78.73	18.37	10.53	7.43	0.27
mesenchymal precursor cell - ovarian cancer left ovary, donor1	11756-123H1	80.81	17.64	9.96	7.11	0.43
mesenchymal precursor cell - ovarian cancer left ovary, donor2	11833-124G6	65.87	17.79	16.14	6.26	0.99
mesenchymal precursor cell - ovarian cancer left ovary, donor3	11760-123H5	67.39	14.81	6.23	3.60	0.14
mesenchymal precursor cell - ovarian cancer left ovary, donor4	11836-124G9	91.11	17.11	11.87	4.89	1.40
mesenchymal precursor cell - ovarian cancer metastasis, donor1	11758-123H3	74.72	18.99	8.37	4.29	0.20
mesenchymal precursor cell - ovarian cancer metastasis, donor2	11835-124G8	60.75	20.85	8.27	2.16	1.08
mesenchymal precursor cell - ovarian cancer metastasis, donor3	11762-123H7	68.90	12.52	5.59	2.38	0.41
mesenchymal precursor cell - ovarian cancer metastasis, donor4	11838-124H2	45.83	11.40	5.93	4.10	0.68
mesenchymal precursor cell - ovarian cancer right ovary, donor1	11757-123H2	125.87	41.12	12.17	10.91	2.10
mesenchymal precursor cell - ovarian cancer right ovary, donor2	11759-123H4	70.68	14.64	8.97	4.33	0.60
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02)	11761-123H6	67.40	14.71	7.70	5.16	0.44
mesenchymal precursor cell - ovarian cancer right ovary, donor3 (SOC-57-02-G)	11842-124H6	83.57	19.88	10.68	2.21	0.74
mesenchymal precursor cell - ovarian cancer right ovary, donor4	11837-124H1	63.53	18.60	8.30	4.86	2.00
mesenchymal stem cell line:Hu5/E18	10568-108B1	173.04	40.00	12.63	12.63	2.95
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep1	13229-141I7	78.55	21.01	15.53	4.57	0.46
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep2	13230-141I8	81.85	20.46	13.05	4.86	0.26
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr00min, biol_rep3	13231-141I9	90.04	24.08	12.30	5.24	0.52
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep1	13232-142A1	81.64	20.03	13.25	7.09	0.62
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep2	13233-142A2	92.02	20.24	11.77	4.47	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr15min, biol_rep3	13234-142A3	90.37	22.34	12.86	5.42	1.35
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep1	13235-142A4	94.71	18.47	7.86	7.86	0.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep2	13236-142A5	83.41	16.22	7.41	4.63	1.39
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr30min, biol_rep3	13237-142A6	144.91	0.00	0.00	48.30	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep1	13238-142A7	115.37	23.36	16.73	9.23	0.29
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep2	13239-142A8	95.71	24.76	14.50	5.58	1.56
mesenchymal stem cells (adipose derived), adipogenic induction, 00hr45min, biol_rep3	13240-142A9	96.38	24.28	14.66	5.05	0.48
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep1	13241-142B1	72.60	18.33	13.93	4.40	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep2	13242-142B2	88.61	16.11	19.47	3.69	1.01
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr00min, biol_rep3	13243-142B3	97.02	18.83	18.01	5.73	1.23
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep1	13244-142B4	90.64	18.47	19.33	6.01	0.86
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep2	13245-142B5	65.63	16.41	24.61	2.73	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr20min, biol_rep3	13246-142B6	123.96	20.66	20.66	5.16	5.16
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep1	13247-142B7	99.06	21.11	14.62	6.82	2.60
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep2	13248-142B8	93.12	24.73	29.10	4.36	5.82
mesenchymal stem cells (adipose derived), adipogenic induction, 01hr40min, biol_rep3	13249-142B9	103.95	26.65	21.86	5.33	2.67
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep1	13250-142C1	91.59	22.90	16.36	6.54	2.45
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep2	13251-142C2	84.74	19.82	17.10	3.50	5.44
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr00min, biol_rep3	13252-142C3	113.33	14.69	25.18	2.10	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep1	13253-142C4	78.48	20.86	17.88	6.95	1.99
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep2	13254-142C5	143.02	4.77	14.30	4.77	4.77
mesenchymal stem cells (adipose derived), adipogenic induction, 02hr30min, biol_rep3	13255-142C6	83.61	23.72	11.86	5.34	10.08
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep1	13256-142C7	109.66	26.81	15.84	7.31	3.66
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep2	13257-142C8	81.16	54.10	0.00	0.00	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, 03hr00min, biol_rep3	13258-142C9	93.74	18.37	19.00	9.50	1.90
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep1	13259-142D1	114.16	13.11	36.90	11.38	2.41
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep2	13260-142D2	107.46	21.49	23.64	12.90	2.15
mesenchymal stem cells (adipose derived), adipogenic induction, 12hr00min, biol_rep3	13261-142D3	95.80	15.97	35.93	7.98	0.00
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep1	13262-142D4	82.65	6.89	34.44	3.44	3.44
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep2	13263-142D5	103.50	16.30	38.30	7.74	1.63
mesenchymal stem cells (adipose derived), adipogenic induction, day01, biol_rep3	13264-142D6	87.39	8.74	52.43	7.94	0.79
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep1	13265-142D7	90.79	12.38	40.09	3.54	1.77
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep2	13266-142D8	99.75	9.04	32.11	7.79	0.94
mesenchymal stem cells (adipose derived), adipogenic induction, day02, biol_rep3	13267-142D9	106.93	12.03	36.09	5.35	1.34
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep1	13268-142E1	93.43	15.37	31.93	3.55	2.37
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep2	13269-142E2	154.08	7.70	28.25	7.70	2.57
mesenchymal stem cells (adipose derived), adipogenic induction, day04, biol_rep3	13270-142E3	115.65	14.46	28.91	6.88	2.75
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep1	13271-142E4	94.51	22.76	22.76	3.46	1.48
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep2	13272-142E5	95.33	24.67	12.34	3.36	2.24
mesenchymal stem cells (adipose derived), adipogenic induction, day08, biol_rep3	13273-142E6	124.67	19.08	15.27	3.82	2.54
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep1	13274-142E7	117.67	33.04	12.90	6.85	0.81
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep2	13275-142E8	119.93	52.33	13.08	6.54	2.18
mesenchymal stem cells (adipose derived), adipogenic induction, day12, biol_rep3	13276-142E9	98.83	22.81	12.67	12.67	1.27
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep1	13277-142F1	117.74	37.63	15.78	8.50	1.82
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep2	13278-142F2	131.05	49.71	22.59	9.04	9.04
mesenchymal stem cells (adipose derived), adipogenic induction, day14, biol_rep3	13279-142F3	98.84	32.12	19.77	7.41	1.65
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep1	13280-142F4	128.58	26.39	19.64	6.35	0.40
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep2	13281-142F5	108.71	21.74	12.98	5.19	0.97
mesenchymal stem cells (adipose derived), undifferentiated control, biol_rep3	13282-142F6	116.12	15.28	18.34	3.06	1.02
mesodermal tumor cell line:HIRS-BM	10696-109G3	66.54	7.74	6.19	0.77	0.77
mesothelioma cell line:ACC-MESO-1	10493-107B7	235.77	55.28	25.75	16.30	0.24
mesothelioma cell line:ACC-MESO-4	10494-107B8	194.14	32.67	20.62	21.78	0.93
mesothelioma cell line:Mero-14, tech_rep1	10849-111F3	158.12	12.82	29.92	42.74	0.00
mesothelioma cell line:Mero-14, tech_rep2	10849-111F3	130.80	14.90	43.05	50.66	1.44
mesothelioma cell line:Mero-25	10850-111F4	83.07	23.60	8.40	7.26	1.59
mesothelioma cell line:Mero-41	10851-111F5	151.09	38.14	13.20	10.51	2.44
mesothelioma cell line:Mero-48a	10852-111F6	95.22	22.81	12.18	7.09	0.89
mesothelioma cell line:Mero-82	10853-111F7	178.71	27.07	48.62	44.94	2.89
mesothelioma cell line:Mero-83	10854-111F8	114.73	21.96	18.21	12.77	0.85
mesothelioma cell line:Mero-84	10855-111F9	109.20	38.67	6.82	8.59	1.52
mesothelioma cell line:Mero-95	10856-111G1	104.76	19.46	15.32	10.77	1.24
mesothelioma cell line:NCI-H2052	10847-111F1	126.06	44.56	11.60	12.59	2.15
mesothelioma cell line:NCI-H226	10846-111E9	124.16	24.25	28.96	31.31	1.45
mesothelioma cell line:NCI-H2452	10848-111F2	187.73	49.54	16.40	12.30	2.90
mesothelioma cell line:NCI-H28	10845-111E8	107.38	20.61	12.21	7.89	1.02
mesothelioma cell line:No36	10857-111G2	120.69	25.77	13.05	11.42	0.33
mesothelioma cell line:ONE58	10858-111G3	234.64	43.08	30.89	21.41	2.44
migratory langerhans cells, donor1	11901-125F2	350.45	55.27	13.05	15.55	4.41
migratory langerhans cells, donor2	11902-125F3	221.88	28.70	9.89	9.89	1.95
migratory langerhans cells, donor3	11903-125F4	287.53	42.90	23.69	10.05	3.41
mixed mullerian tumor cell line:HTMMT	10689-109F5	166.83	29.71	23.83	9.47	3.59
mucinous adenocarcinoma cell line:JHOM-1	10648-109A9	126.10	30.94	11.23	9.75	4.03
mucinous cystadenocarcinoma cell line:MCAS	10784-110H1	117.02	28.79	15.89	11.29	0.00
mycosis fungoides, T cell lymphoma cell line:HuT 102 TIB-162	10744-110C6	136.82	31.59	6.09	3.43	0.76
myelodysplastic syndrome cell line:SKM-1	10772-110F7	224.34	38.25	36.77	20.88	2.03
myeloma cell line:PCM6	10474-106I6	347.30	61.08	27.48	9.29	0.40
myxofibrosarcoma cell line:MFH-ino	10600-108E6	87.25	13.70	9.64	6.09	0.00
myxofibrosarcoma cell line:NMFH-1	10684-109E9	93.75	22.16	11.38	2.75	0.20
nasal epithelial cells, donor1, tech_rep1	12226-129F3	135.05	36.99	20.61	9.92	0.33
nasal epithelial cells, donor1, tech_rep2	12226-129F3	133.92	34.86	23.24	11.40	0.37
nasal epithelial cells, donor2	12227-129F4	378.66	86.66	25.94	11.59	0.55
neuroblastoma cell line:CHP-134	10508-107D4	300.69	40.26	52.45	15.18	0.69
neuroblastoma cell line:NB-1	10539-107G8	231.61	31.62	37.04	8.61	0.56
neuroblastoma cell line:NBsusSR	10607-108F4	241.05	32.90	34.16	17.29	0.63
neuroblastoma cell line:NH-12	10555-107I6	341.95	64.10	73.98	20.87	1.30
neuroectodermal tumor cell line:FU-RPNT-1	10637-108I7	126.92	18.27	44.36	10.68	0.95
neuroectodermal tumor cell line:FU-RPNT-2	10663-109C6	222.52	33.10	40.07	12.67	2.22
neuroectodermal tumor cell line:TASK1	10774-110F9	264.25	57.56	59.17	11.67	1.81
neuroepithelioma cell line:SK-N-MC	10728-110A8	259.39	24.79	37.51	13.35	1.91
neurofibroma cell line:Hs 53.T	10729-110A9	66.28	13.31	9.85	5.59	0.53
neutrophil PMN, donor1	12133-128D9	74.37	14.87	14.87	0.00	0.00
neutrophil PMN, donor2	12137-128E4	146.09	39.84	0.00	13.28	0.00
neutrophil PMN, donor3	12141-128E8	170.47	28.41	0.00	0.00	0.00
non T non B acute lymphoblastic leukemia (ALL) cell line:P30/OHK	10430-106D7	596.83	69.68	42.96	12.35	1.52
non-small cell lung cancer cell line:NCI-H1385	10730-110B1	213.74	58.44	24.02	20.81	1.60
normal embryonic palatal mesenchymal cell line:HEPM	10813-111B3	106.44	17.63	16.67	6.73	1.60
normal intestinal epithelial cell line:FHs 74 Int	10812-111B2	88.55	16.29	13.40	10.51	1.31
nucleus accumbens, adult, pool1	10037-101F1	161.42	33.18	10.69	3.56	0.19
occipital cortex - adult, donor10196	10172-103C1	135.99	35.03	6.18	2.06	0.00
occipital cortex, adult, donor10252	10163-103B1	174.17	17.44	15.83	4.56	1.61
occipital cortex, newborn, donor10223	10355-105E4	84.07	22.20	11.65	13.10	0.36
occipital lobe, adult, donor1	10076-102A4	115.72	37.00	11.55	4.72	4.72
occipital lobe, fetal, donor1	10073-102A1	123.58	16.73	9.87	1.29	3.43
occipital pole, adult, pool1	10036-101E9	124.41	25.70	9.38	2.68	0.24
olfactory region, adult	10195-103E6	125.52	26.56	10.13	2.48	0.96
optic nerve, donor1	10277-104E7	136.07	26.01	12.01	8.00	2.00
oral squamous cell carcinoma cell line:Ca9-22	10434-106E2	205.03	41.23	26.88	24.72	0.46
oral squamous cell carcinoma cell line:HO-1-u-1	10550-107I1	297.58	82.16	18.00	11.40	0.55
oral squamous cell carcinoma cell line:HSC-3	10545-107H5	133.26	32.00	15.75	8.80	2.54
oral squamous cell carcinoma cell line:SAS	10544-107H4	205.95	66.07	21.37	10.74	0.69
osteoclastoma cell line:Hs 706.T	10704-109H2	69.38	17.34	4.70	1.76	0.29
osteosarcoma cell line:143B/TK^(-)neo^(R)	10510-107D6	179.39	8.41	53.26	35.50	0.00
osteosarcoma cell line:HS-Os-1	10558-107I9	151.41	13.57	27.99	5.51	0.21
ovary, adult, pool1	10020-101D2	251.05	29.96	32.93	7.16	0.52
pagetoid sarcoma cell line:Hs 925.T	10732-110B3	60.68	10.27	8.98	5.68	0.55
pancreas, adult, donor1	10049-101G4	175.90	24.46	79.95	31.98	1.88
pancreatic carcinoma cell line:NOR-P1	10698-109G5	112.93	21.52	11.74	8.39	0.00
papillary adenocarcinoma cell line:8505C	10437-106E5	140.88	23.00	28.11	22.49	3.58
papillotubular adenocarcinoma cell line:TGBC18TKB	10417-106C3	85.77	29.14	3.15	4.31	0.17
paracentral gyrus, adult, pool1	10035-101E8	152.75	36.15	10.43	4.21	0.37
parietal cortex, adult, donor10258	10373-105G4	202.59	43.31	7.34	0.00	1.47
parietal lobe - adult, donor10196	10171-103B9	135.43	37.62	9.40	1.88	0.94
parietal lobe, adult, donor10252	10157-103A4	159.91	26.22	13.40	7.13	2.57
parietal lobe, adult, pool1	10034-101E7	150.24	29.96	11.81	4.67	0.53
parietal lobe, fetal, donor1	10072-101I9	144.51	21.34	12.61	1.94	0.00
parietal lobe, newborn, donor10223	10356-105E5	107.67	22.43	8.22	10.84	0.00
parotid gland, adult	10199-103F1	213.37	41.93	16.03	7.40	3.08
penis, adult	10200-103F2	268.02	44.58	27.93	37.60	2.15
peripheral neuroectodermal tumor cell line:KU-SN	10697-109G4	254.92	25.47	23.80	6.14	1.49
pharyngeal carcinoma cell line:Detroit 562	10723-110A3	109.71	64.40	6.12	7.72	0.44
pineal gland - adult, donor10196	10179-103C8	107.07	15.48	8.39	1.29	1.94
pineal gland, adult, donor10252	10160-103A7	201.35	28.43	13.03	2.37	1.18
pineal gland, adult, donor10258	10377-105G8	149.87	25.71	5.02	1.88	0.00
pituitary gland - adult, donor10196	10180-103C9	177.07	29.34	18.21	4.05	2.02
pituitary gland, adult, donor10252	10162-103A9	300.20	30.23	22.41	3.13	1.04
pituitary gland, adult, donor10258	10378-105G9	247.71	38.31	15.32	5.11	0.85
placenta, adult, pool1	10021-101D3	159.21	25.80	10.43	6.67	0.32
plasma cell leukemia cell line:ARH-77	10840-111E3	188.31	52.57	14.43	11.65	1.59
pleomorphic hepatocellular carcinoma cell line:SNU-387	10706-109H4	133.69	14.79	16.81	7.94	1.71
pons, adult, pool1	10033-101E6	146.66	28.32	11.71	6.02	0.17
postcentral gyrus, adult, pool1	10032-101E5	138.61	29.20	10.03	3.23	0.17
promyelocytes/myelocytes PMC, donor1	12132-128D8	89.93	10.46	29.28	16.73	0.00
promyelocytes/myelocytes PMC, donor2	12136-128E3	214.81	27.54	27.54	11.02	0.00
promyelocytes/myelocytes PMC, donor3	12140-128E7	211.24	11.74	0.00	35.21	0.00
prostate cancer cell line:DU145	10490-107B4	134.01	52.44	12.38	11.36	0.44
prostate cancer cell line:PC-3	10439-106E7	154.46	31.58	15.06	9.26	0.54
prostate, adult, pool1	10022-101D4	252.30	32.47	37.27	13.60	0.45
putamen, adult, donor10196	10176-103C5	161.70	34.70	11.80	2.12	2.12
putamen, adult, donor10252	10152-102I8	164.70	23.53	9.80	1.96	0.00
putamen, adult, donor10258, tech_rep1	10372-105G3	173.76	106.00	8.74	2.19	1.09
putamen, adult, donor10258, tech_rep2	10372-105G3	124.19	37.45	6.77	2.66	0.97
putamen, newborn, donor10223	10365-105F5	116.95	23.99	8.25	12.74	0.75
rectal cancer cell line:TT1TKB	10469-106I1	171.94	32.88	16.58	10.47	0.29
rectum, fetal, donor1	10067-101I4	123.80	11.13	18.08	4.17	1.39
renal cell carcinoma cell line:OS-RC-2	10411-106B6	115.75	37.31	5.30	1.91	0.42
renal cell carcinoma cell line:TUHR10TKB	10471-106I3	128.82	30.24	5.80	0.41	1.24
retina, adult, pool1	10030-101E3	226.73	29.22	16.20	5.77	0.60
retinoblastoma cell line:Y79	10475-106I7	318.00	73.52	48.84	23.64	2.08
rhabdomyosarcoma cell line:KYM-1	10787-110H4	124.42	40.45	7.50	4.79	0.86
rhabdomyosarcoma cell line:RMS-YM	10477-106I9	265.17	44.43	22.78	9.00	0.84
sacrococcigeal teratoma cell line:HTST	10695-109G2	87.15	6.82	37.89	14.40	0.76
salivary acinar cells, donor1	11771-123I7	84.81	31.08	20.56	7.77	0.65
salivary acinar cells, donor2	11772-123I8	109.60	35.25	18.86	7.71	1.10
salivary acinar cells, donor3	11773-123I9	99.31	26.48	12.58	11.92	1.32
salivary gland, adult, pool1	10093-102C3	255.09	42.90	20.02	7.44	0.00
schwannoma cell line:HS-PSS, tech_rep1	10442-106F1	172.25	34.99	21.75	11.55	0.25
schwannoma cell line:HS-PSS, tech_rep2	10442-106F1	158.93	36.44	24.69	12.34	0.59
seminal vesicle, adult	10201-103F3	202.63	27.51	18.52	6.88	7.94
serous adenocarcinoma cell line:JHOS-2	10639-108I9	191.91	24.05	29.64	20.16	2.67
serous adenocarcinoma cell line:SK-OV-3-R after co-culture with SOC-57-02-G, biol_rep1	11843-124H7	127.07	27.93	13.34	7.05	2.26
serous adenocarcinoma cell line:SK-OV-3-R, biol_rep1	11841-124H5	149.53	36.13	8.03	5.02	1.00
serous cystadenocarcinoma cell line:HTOA	10693-109F9	173.00	25.79	27.80	18.13	1.21
signet ring carcinoma cell line:Kato III	10436-106E4	245.59	58.91	19.78	18.79	0.66
signet ring carcinoma cell line:NUGC-4	10483-107A6	175.35	51.87	26.32	17.68	0.65
skeletal muscle - soleus muscle, donor1	10282-104F3	329.13	89.38	34.05	109.95	4.97
skeletal muscle, adult, pool1	10023-101D5	407.07	69.92	97.51	222.96	1.92
skeletal muscle, fetal, donor1	10066-101I3	89.45	13.07	28.14	8.04	1.01
skin, adult, donor1	10074-102A2	162.85	27.14	13.57	0.00	0.00
skin, fetal, donor1	10065-101I2	152.13	31.56	13.26	8.21	8.84
small cell cervical cancer cell line:HCSC-1	10800-110I8	176.43	54.70	14.68	8.67	1.67
small cell gastrointestinal carcinoma cell line:ECC10	10610-108F7	267.61	27.74	85.11	35.93	4.41
small cell lung carcinoma cell line:DMS 144	10841-111E4	146.68	71.89	7.32	3.28	1.73
small cell lung carcinoma cell line:LK-2	10541-107H1	395.59	87.36	73.84	48.62	0.49
small cell lung carcinoma cell line:NCI-H82	10842-111E5	626.03	170.50	51.47	16.57	5.79
small cell lung carcinoma cell line:WA-hT	10562-108A4	438.01	96.97	44.02	38.79	1.09
small intestine, adult, pool1	10024-101D6	210.58	31.17	17.80	8.24	0.48
small intestine, fetal, donor1	10064-101I1	133.90	23.83	14.00	4.18	1.47
small-cell gastrointestinal carcinoma cell line:ECC4	10609-108F6	183.11	45.65	23.08	16.93	4.10
smooth muscle, adult, pool1	10048-101G3	238.04	42.39	33.60	12.15	2.58
somatostatinoma cell line:QGP-1	10781-110G7	115.52	19.03	23.85	8.04	1.07
spinal cord - adult, donor10196	10181-103D1	111.49	18.35	7.80	4.36	0.92
spinal cord, adult, donor10252	10159-103A6	199.50	22.87	12.22	3.94	0.00
spinal cord, adult, donor10258	10369-105F9	148.04	33.90	7.61	1.38	2.77
spinal cord, fetal, donor1	10056-101H2	112.82	26.83	6.10	4.27	1.83
spinal cord, newborn, donor10223	10359-105E8	118.48	30.31	9.64	8.73	0.92
spindle cell sarcoma cell line:Hs 132.T	10737-110B8	73.18	12.55	10.45	3.44	0.15
spleen, adult, pool1	10025-101D7	178.09	22.58	10.57	7.16	0.11
spleen, fetal, pool1	10044-101F8	134.84	16.84	8.18	4.53	0.32
splenic lymphoma with villous lymphocytes cell line:SLVL	10424-106D1	169.24	47.20	16.56	10.14	0.93
squamous cell carcinoma cell line:EC-GI-10	10463-106H4	200.32	48.80	12.15	9.87	0.19
squamous cell carcinoma cell line:JHUS-nk1	10646-109A7	104.14	28.31	13.28	9.44	1.05
squamous cell carcinoma cell line:T3M-5	10616-108G4	111.02	20.33	18.76	13.29	1.17
squamous cell lung carcinoma cell line:EBC-1	10486-107A9	364.02	93.54	39.28	19.47	1.35
squamous cell lung carcinoma cell line:LC-1F	10457-106G7	202.06	49.56	20.76	16.94	4.24
squamous cell lung carcinoma cell line:RERF-LC-AI	10501-107C6	209.00	20.73	22.85	12.27	0.42
stomach, fetal, donor1	10062-101H8	174.08	19.22	43.79	13.88	2.14
submaxillary gland, adult	10202-103F4	194.83	42.16	13.67	12.53	6.27
substantia nigra - adult, donor10196	10178-103C7	162.82	108.55	0.00	54.27	0.00
substantia nigra, adult, donor10252	10158-103A5	214.56	31.16	10.80	4.98	1.04
substantia nigra, adult, donor10258	10371-105G2	142.24	34.14	11.38	0.52	0.52
substantia nigra, newborn, donor10223	10358-105E7	109.52	12.01	16.25	10.60	0.00
synovial sarcoma cell line:HS-SY-II	10441-106E9	132.74	55.25	10.55	7.34	0.69
temporal lobe, adult, pool1	10031-101E4	114.61	23.31	7.04	2.71	0.42
temporal lobe, fetal, donor1, tech_rep1	10063-101H9	75.50	15.67	7.12	2.85	2.85
temporal lobe, fetal, donor1, tech_rep2	10063-101H9	116.48	19.34	9.67	4.83	2.64
tenocyte, donor1	11763-123H8	97.05	23.04	17.46	6.28	2.44
tenocyte, donor2	11765-123I1	113.69	26.71	22.51	7.63	1.91
tenocyte, donor3	11768-123I4	100.45	20.39	12.23	7.41	2.97
teratocarcinoma cell line:NCC-IT-A3	10790-110H7	256.64	82.09	34.16	17.68	3.06
teratocarcinoma cell line:NCR-G1	10798-110I6	173.26	29.13	19.73	9.09	1.85
teratocarcinoma cell line:PA-1	10807-111A6	126.31	43.08	16.12	4.96	1.08
testicular germ cell embryonal carcinoma cell line:ITO-II	10786-110H3	150.18	19.17	41.89	27.29	1.90
testicular germ cell embryonal carcinoma cell line:NEC14	10591-108D6	361.53	69.58	49.92	18.15	0.76
testicular germ cell embryonal carcinoma cell line:NEC15	10593-108D8	193.48	19.85	56.49	24.43	0.87
testicular germ cell embryonal carcinoma cell line:NEC8	10590-108D5	188.91	37.13	28.34	17.26	2.61
testis, adult, pool1	10026-101D8	206.91	41.34	20.62	9.23	0.32
testis, adult, pool2	10096-102C6	171.86	64.05	13.08	5.86	3.61
thalamus - adult, donor10196	10168-103B6	155.66	29.81	5.52	2.21	0.00
thalamus, adult, donor10252	10154-103A1	188.01	31.57	9.69	2.66	0.78
thalamus, adult, donor10258, tech_rep1	10370-105G1	203.23	69.28	20.02	0.00	0.00
thalamus, adult, donor10258, tech_rep2	10370-105G1	87.61	14.99	7.91	2.47	1.65
thalamus, newborn, donor10223	10366-105F6	74.22	12.66	1.73	8.63	1.15
throat, adult	10209-103G2	224.95	37.45	34.95	45.19	13.48
throat, fetal, donor1	10061-101H7	127.37	19.20	21.02	12.49	1.83
thymic carcinoma cell line:Ty-82	10803-111A2	241.66	55.64	24.25	12.12	2.58
thymus, adult, pool1	10027-101D9	173.38	16.70	21.87	8.35	0.30
thymus, fetal, pool1	10043-101F7	184.85	23.48	22.24	11.53	0.21
thyroid carcinoma cell line:KHM-5M	10776-110G2	113.15	24.33	13.69	9.84	0.27
thyroid carcinoma cell line:TCO-1	10783-110G9	185.37	42.19	26.82	15.92	1.82
thyroid, adult, pool1	10028-101E1	268.74	29.49	71.66	30.89	1.12
thyroid, fetal, donor1	10060-101H6	121.81	15.03	26.37	16.87	1.32
tongue epidermis (fungiform papillae), donor1	10288-104F9	138.58	21.56	12.32	21.56	0.00
tongue, adult	10203-103F5	246.53	42.33	37.91	47.21	3.02
tongue, fetal, donor1	10059-101H5	247.10	37.04	32.32	65.81	1.97
tonsil, adult, pool1	10047-101G2	207.86	26.65	17.33	12.52	0.30
trachea, adult, pool1	10029-101E2	173.74	20.45	16.61	9.90	0.41
trachea, fetal, donor1	10058-101H4	166.96	30.01	15.39	17.70	0.00
transitional cell carcinoma cell line:Hs 769.T	10707-109H5	94.24	16.65	19.13	9.21	0.00
transitional-cell carcinoma cell line:5637	10418-106C4	121.58	29.79	10.74	8.61	0.41
transitional-cell carcinoma cell line:JMSU1	10492-107B6	413.97	55.00	38.55	19.90	1.57
tridermal teratoma cell line:HGRT	10694-109G1	60.88	1.90	15.22	11.42	0.00
tubular adenocarcinoma cell line:SUIT-2	10797-110I5	99.72	27.09	14.98	7.70	0.17
umbilical cord, fetal, donor1	10057-101H3	135.62	12.52	12.52	8.35	0.00
uterus, adult, pool1	10100-102D1	298.26	33.44	28.32	7.17	0.68
uterus, fetal, donor1	10055-101H1	174.06	26.62	18.94	5.12	0.00
vagina, adult	10204-103F6	223.58	26.49	26.49	16.15	1.29
vein, adult	10191-103E2	195.74	24.11	17.32	6.36	5.04
xeroderma pigentosum b cell line:XPL 17	10563-108A5	117.50	25.64	10.95	2.40	1.07